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ABSTRACT 
 
Introduction: Evidences indicate that human immuno-deficiency virus (HIV) and 
diabetes (DM) impact pregnancy outcomes but no experience on the integrated service 
delivery of HIV, DM and pregnancy care. This study explored the domains and levels of 
integration among DM, HIV and pregnancy care to prepare a service delivery model in 
Ethiopia. 
Methods: A sequential exploratory mixed method and the integration theoretical 
framework guided the study. An exploratory qualitative phase used focused group 
discussion, in-depth interview and observation to explore the level of integration and to 
refine a questionnaire for the quantitative phase. The data were transcribed and coded 
for theme-based analysis. The descriptive quantitative phase described HIV, DM and 
pregnancy care services, and determined the burden of DM among HIV patients and 
the prevalence of pregnancy and pregnancy outcomes. Data was analysed using Epi-
info. The findings were triangulated, discussed and interpreted. 
Results: Seven themes were generated: joint plan, shared budget, monitoring system, 
structural location, the need of policy guide, the practice of integrated service delivery 
and suggested integration approaches. A coordinated HIV and pregnancy care services 
were noted. There was a linkage between diabetes and HIV, and diabetes and 
pregnancy care. The 1.5% of diabetes among HIV, the low number of pregnancies per a 
mother in diabetes (1.8) and  HIV (1.3); the high adverse pregnancy outcomes among 
 
 
HIV (13.4% abortion, 12.4% low birth weight (LBW), 3.5% pre-term birth, 2.1% 
congenital malformation) and diabetes (3.2% big baby, 3.2% LBW, 3.1% Cesarean-
section); the respective absent and low (16.2%) diabetes screening service at anti-natal 
and HIV clinics, the absent pregnancy care service for diabetic females justified the 
development of the tripartite integrated service delivery model of diabetes, HIV and 
pregnancy care. 
Conclusions: The model suggests active diabetes screening, evaluation and treatment 
at HIV and antenatal clinics. It considers the coordination between non-communicable 
diseases (NCD), HIV and maternal health units. Pregnancy care could be coordinated 
at HIV and NCD units. Full integration can be practiced between HIV and pregnancy 
care units. Preparing policy guide, building the capacity of health providers, advocating 
and piloting the model may be prioritized before the implementation of the model. 
 
KEYWORDS: Diabetes care; HIV care; Integration; pregnancy care; linkage; 
coordination; tripartite model; pregnancy rate, adverse pregnancy outcome, pregnancy 
outcome 
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
In 2014, there were 0.79 million people living with Human Immunodeficiency Virus (HIV) 
in Ethiopia. About 40% of these have access to anti-retroviral therapy (ART) and more 
than half of pregnant women got ART to prevent mother to child HIV transmission 
(PMTCT) (Federal Democratic Republic of Ethiopia (FDRE) 2014:10).  However, the 
improved treatment of HIV has translated into an increasing number of patients 
developing chronic complications, including DM (Kalra, Kalra, Agrawal and 
Unnikrishnan 2011:2; Young, Critchley, Johnstone and Unwin 2009:1). The risk of 
developing DM is related to HIV itself or its treatment (Alves, Oliveira & Brites 
2008:342). The occurrence of diabetes in HIV infected patients has complicated 
adherence to the treatment of HIV and DM. There is also an interaction between HIV 
and DM medication leading to poor treatment outcomes of HIV and DM patients 
(Monroe, Rowe, Moore & Chander 2013:1).  
 
Literature present the clinical complications of HIV and DM with limited information 
regarding their effect on pregnancy outcomes (DOS REIS, Araujo, Ribeiro, Da Rocha, 
Rosato, PASSOS & Mercon De Vargas 2015:111; Kim, Kasonde, Mwiya, Thea, 
Kankasa, Sinkala, Aldrovandi & Kuhn 2012:138). Nonetheless HIV and DM are related 
to fertility (Livshits & Seidman 2009:701) and can affect pregnancy outcome if they are 
not treated per the standard. HIV and DM services can be integrated to reduce adverse 
pregnancy outcomes. However, there are few experiences with the integration of HIV 
and DM services to deal with adverse pregnancy outcomes related to HIV and DM. 
Thisstudy, hence will explore and describe the level of DM and HIV service integration 
to reduce adverse pregnancy outcomes among reproductive age women in Addis 
Ababa Ethiopia. 
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1.1.1 Levels of integration 
 
According to Pike and Mongan (2014:25) there are three levels of integration; namely, 
linkage, collaboration and full integration.  
 
1.1.1.1.Linkage  
 
Linkage is the system that services the whole population without relying on outside 
system. It is information sharing, which provides when asked and ask when needed. 
Multidisciplinary teams in health facilities can be established, but tends to focus on 
communication (linkage) rather than decision making, planning and coordination. It 
focuses on improving the link between providers. It depends heavily on education as a 
mechanism for change. The dissemination of information is difficult to sustain.  
 
1.1.1.2 Collaboration  
 
Collaboration is more structured referral linkage than only linkage. There are structures 
and individual to facilitate and coordinate. In collaboration, reports are defined and 
provided. It requires someone specifically designed to do the coordination. There is a 
formal arrangement such as protocols and a memorandum of understanding but are 
difficult to sustain.  
 
1.1.1.3 Full integration 
 
Full integration shares information using a common record as part of daily practice. It is 
applied when a new program or unit which pools resources from multiple system. It 
merges all cases. 
 
1.1.2 Adverse pregnancy outcomes 
 
Short-term maternal and perinatal complications, including diseases have been 
considered as they are consistent with the way in which maternal and perinatal 
outcomes are grouped for monitoring and research purposes. The following adverse 
pregnancy outcomes on the foetal sides will be evaluated: low birth weight (live infant 
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weighing <2500g at birth), preterm delivery (live infant delivered at <37 weeks’ 
gestation), stillbirths (macerated and fresh stillbirths), severe neonatal conditions 
(neonates presenting with any of the following conditions: birth weight <1500g, 
gestational age <32 weeks and Apgar score at 5 minutes) and early neonatal death 
(deaths that occurred within 7 days after birth), preterm deliveries (deliveries before 34 
weeks of gestation). Besides, Intra uterine growth retardation (IUGR), congenital 
malformation, Respiratory distress syndrome (RDS) and Sepsis were looked into 
(Ouyang, Zhang, Betrán, Yang, Souza and Merialdi 2013:357). As defined by Ouyang 
et al (2013:358), the maternal complication to be considered were caesarean section 
(C-section), pre-eclampsia, eclampsia, haemorrhage, gestational diabetes, maternal 
death, systemic infections and maternal near miss. 
 
1.2 BACKGROUND TO THE RESEARCH PROBLEM  
 
There has been an increase in fertility intention among HIV infected women following 
the expansion of ART in response to the HIV epidemic (Cooper, Moodley, Zweigenthal, 
Bekker, Gail, Shah, & Myer 2009:44; Finocchario-Kessler, Sweat, Dariotis, Trent, 
Kerrigan, Keller, & Anderson 2010:1106). Consequently, there are higher prevalence 
and incidence of pregnancy among HIV infected women (Kaida, Matthews, Kanters, 
Kabakyenga, Muzoora, Mocello, Martin, Hunt, Haberer, Hogg & Bangsberg 2013: 
e63411) and it is comparable with the general population (Kabami,Turyakira, Biraro and 
Bajunirwe 2014:81). On the contrary, there are evidences of reduced occurrence of 
pregnancy for HIV virus itself or ART can have a risk of infertility (FavotNgalula, Mgalla, 
Klokke, Gumodoka & Boerma 1997:414). A study conducted in Uganda shows that ART 
use did not affect pregnancy desire (Kipp, Heys, Jhangri,  Alibhai & Rubaale  2011:27). 
 
Maternal HIV infection in women who have not received anti-retroviral therapy (ART) is 
associated with preterm birth, low birth weight, small for gestational age and stillbirth in 
sub-Saharan Africa (Chekol 2011:10; Joseph, Biodun & Michael 2011:356; Wedi, 
Kirtley, Hopewell, Corrigan, Kennedy and Hemelaar 2016:E33). Though mother to child 
transmission (MTCT) is substantially reduced by ART, some of these pregnancies are 
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complicated by low birth weight (LBW)  and pre-term or premature deliveries (DOS 
REIS et al 2015:111; Kim et al 2012:1). DOS REIS et al (2015:111) further state that the 
complications are highly prevalent among women on ART before or in the first trimester 
of pregnancy and receiving protease inhibitors. 
 
Exposure to ART increases the incidence of DM (Isa, Oche, Kang'ombe, Okopi, Idoko, 
Cuevas and Gill 2016:ciw381; Karamchand, Leisegang, Schomaker, maartens, Walters, 
Hislop, Dave, Levitt & Cohen 2016; Tzur, Chowers, Agmon-Levin, Mekori & Hershko 
2015:620).  ART leads to an increase in metabolic dysfunction such as insulin 
resistance, dyslipidaemias and lip-dystrophy. High risk of DM also presents in patients 
with a high viral load and low CD4 (+) count, longer duration with HIV infection, 
advanced age, low socioeconomic status and the accumulation of visceral fats (Kalra et 
al 2011:1). DM is estimated to be four fold more in HIV infected patients on ART 
(Brown, Cole, Li, Kingsley, Palella, Riddler, Visscher, Margolick & Dobs 2005:1179). 
 
Both pre-gestational and gestational DM is increasing; mainly, driven by a sharp 
increase in Type II DM (Bell, Bailey, Cresswell, Hawthorne, Critchley & Lewis‐Barned 
2008: 445). A high glucose level impairs implantation and affects the level of hormones 
essential for pregnancy leading to infertility or reduced incidence of pregnancy (Livshits 
& Seidman 2009:701). High blood glucose can also damage embryonic cells and thus 
pregnancy in DM is associated with an increase rate of adverse outcome for both 
mother and fetus (Kinsley 2007: S153). These are macrosomia, stillbirth, infant death, 
hypertension during pregnancy, increased frequency of C-section and spontaneous 
abortion (Bell et al 2008:445; Fernandes, Simões, Figueiredo, Ribeiro, Aleixo, Aragüés 
& Amaral 2012:494; Kinsley 2007: S153; Middleton, Crowther, Simmonds & Muller 
2010:9; Verheijen, Critchley, Whitelaw & Tuffnell 2005:1500). Fetal congenital 
abnormalities and poor perinatal outcomes are related to glycaemic control in first 
trimester (Kinsley 2007: S153; Middleton et al 2010:9; Rowan, Gao, Hague & McIntyre 
2010:9) and optimized metabolic control can reduce these complications. However, 
McCance (2011:954) indicates that perinatal mortality and congenital malformation 
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rates remains several fold higher in pregnancy in DM irrespective of improved 
management of maternal hyperglycaemia. 
Therefore, HIV infection and its treatment increase the risk of DM. Conversely, a poorly 
controlled DM share immunosuppression state like HIV. Complications of DM and its 
treatment have challenged adherence in DM and HIV co-morbid patients (Young  et al 
2009:1).  
 
Because HIV and DM are related, impact on each other and affect the pregnancy 
outcomes in reproductive age women, linking and collaborating the program 
management and clinical services of HIV and DM with maternal health seems 
paramount to reduce their complications (Gounder &  Chaisson 2012: 1426). This is due 
to the fact that integration can improve coordination and service delivery by providing 
services together. Integration also ensures that services are managed and delivered 
together in an efficient and high quality service (Dudley & Garner 2011). In addition, 
integration addresses equitable access for people from different communities and 
socioeconomic backgrounds, a more convenient and satisfying service, and better 
health overall (Gounder & Chaisson 2012:1426). For instance, there is an integration 
experience between HIV and TB (World Health Organization (WHO) 2012), HIV and 
family planning (Baumgartner, Green, Weaver, Mpangile, Kohi, Mujaya and Lasway 
2014: 570), TB and DM (WHO 2011), maternal and child health (Matthews 2005) where 
it is shown that integration of services improve quality of care for patients. However, 
with integration of care, health providers might become overloaded and loss specialized 
skills to manage specific diseases, which could lead to poor quality services and poor 
health (Gounder & Chaisson 2012:1428).  
 
Experience from Cambodia (Janssens, Van Damme, Raleigh, Gupta, Khem,  Soy Ty, 
Vun, Ford &  Zachariah 2007:880) shows integrating HIV care with other chronic 
diseases such as DM and hypertension (HPN) is feasible, resulting in a satisfactory 
outcome for HIV patients and efficiency gains for the services. In Malawi (Gounder and 
Chaisson 2012) the need for integrated management of HPN and DM in HIV patients 
was assessed and suggested to develop initiatives for the integrated care for HIV with 
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HPN and DM. However, these studies did not consider the advantages of DM/HIV 
integration with pregnancy care. Irrespective of the presence of interactions between 
HIV and DM, impacting pregnancy and pregnancy outcomes, there has not been a 
practice of integration between HIV and DM in Ethiopia. 
 
1.3 STATEMENT OF THE RESEARCH PROBLEM  
 
Ethiopia is facing a rapidly emerging burden of DM, ranging within 0.5% to 1.2% 
(Misganaw, Mariam, Ali & Araya 2014:1). Simultaneously, the country is challenged with 
high HIV prevalence of 1.3% (FDRE 2014:6). HIV and its treatments are risk factors for 
DM, and HIV and DM can lead to clinical complications to the affected patients and can 
also impact pregnancy outcomes. In line with the emergence of DM as major diseases 
of public health importance among HIV infected patients in Ethiopia; however, DM and 
HIV service integration has got little attention. 
 
Diabetes Mellitus and HIV services are vertically implemented in Ethiopia and are less 
frequently tied together to deal with their complications. There seems a missed link 
between DM and HIV to reduce adverse pregnancy outcomes related to them. That is, 
there is no defined and well-established level of integration between the two programs 
to deal with HIV and DM related adverse pregnancy outcomes.  Therefore, it is high 
time to consider an integrated care of model linking HIV and DM to deal with adverse 
pregnancy outcomes in the affected women of child-rearing age. 
 
The integration of HIV, DM and pregnancy care service is not specific as well. It is 
necessary to clarify on what level of HIV and DM integration is required at health 
facilities and different program management levels to improve pregnancy outcome 
among HIV and DM patients. It is also noted that clinicians primarily work on linking, 
with a few elements of coordination. There is no routine active screening and testing of 
HIV patients for diabetic patients and vice versa. There are health facilities with 
pregnancy counselling and a few contraceptive services at the HIV clinic. Others 
provided the full package of family planning and pregnancy counselling and testing at 
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HIV clinics. The collaboration and coordination between HIV, DM and pregnancy care 
seem absent or uneven differing in different settings, but critical to improve maternal 
and perinatal health. 
 
In Addis Ababa city where this study is conducted, the rate of HIV prevalence declined 
from 8.5% in 2009 to 5.7% in 2011. However, the city is still one of the highest HIV 
prevalence in the country (CSA 2012:234). Besides, the burden of DM is high in the city 
and accounts for about 6.5 % of hospital admissions in Addis Ababa (Gizaw, Harries, 
Ade, Tayler-Smith, Ali, Firdu and Yifter  2015:74). Though HIV is decentralized to health 
centres, DM care is limited to hospitals and a few health centres. DM is integrated with 
other non-communicable diseases such as hypertension. 
 
There is little and non-uniform link or collaboration of HIV, DM and pregnancy service 
across health facilities. HIV counselling and testing services at diabetic clinic are limited. 
The practice of active screening of diabetes at HIV clinics is absent. There are health 
facilities that provide pregnancy counselling, condom and oral contraceptive pills at the 
HIV clinic. However, these activities are not routinely recorded and registered. HIV 
counselling, testing and treatment are being given at antenatal care (ANC) clinics. 
However, the focused ANC recommends only the urine test for ketones to screen 
diabetes mellitus in pregnant women. Diabetic mellitus screening algorithms and 
registers are not available at ANC clinic. Nevertheless, a standardized and integrated 
HIV, DM and pregnancy care model is essential to improve the clinical complications 
and adverse pregnancy outcome. 
 
Even though there is an established relationship between DM and HIV diseases and 
both are affecting pregnancy outcome among the reproductive age women, there has 
not been a theoretical framework or a model guiding an integrated service delivery in 
Ethiopia. Hence, the researcher in this study is interested in developing an integrated 
model addressing how a child-rearing age woman should obtain an integrated service 
inclusive of diabetes, HIV and pregnancy care in health facilities to prevent adverse 
pregnancy outcomes. To state in a sentence, during the period where maternal and 
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perinatal death is high in Ethiopia due to HIV and DM (Central Statistical 
Agency/CSA/Ethiopia and ICF. 2016), the authors aimed to develop an integrated 
model of care inclusive of HIV, DM and pregnancy care so as to guide a clinical care 
and policy of maternal care. 
1.4 PURPOSE OF THE STUDY 
 
The purpose of the study was to develop an DM/HIV integrated service delivery model 
to improve pregnancy outcomes for females in Addis Ababa, Ethiopia. 
  
1.4.1 Objectives of the study 
 
A research objective is a concrete, measurable end towards which effort or ambition is 
directed (Brink, Van der Walt & Van Rensburg 2018:85). The objectives of the study 
were listed under the two phases of the study. 
 
Objective of Phase I of the study was to 
• explore the functional, organizational and clinical integration of DM, HIV and 
pregnancy care service at federal, regional, sub city and health facility levels. 
 
Objectives of Phase II of the study were to 
•  describe pregnancy care, HIV and DM services at ANC, DM and HIV clinics in 
Addis Ababa health facilities, 
•  determine the prevalence rate of DM among HIV females of childbearing age 
enrolled in HIV care during 2011-2016 in Addis Ababa health facilities, 
•  determine prevalence rate of pregnancy among HIV and DM childbearing age 
females enrolled to care during 2011-2016 in Addis Ababa health facilities, and 
•  determine prevalence rate of adverse events in pregnancy among HIV and DM 
childbearing females enrolled to care during 2011-2016 in Addis Ababa health 
facilities. 
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 1.5 RESEARCH QUESTIONS 
 
The research questions were based on the objectives of the study and were stated as 
follows: 
• What is the level of integration of HIV, DM and pregnancy care services in Addis 
Ababa health facilities? 
• What is the magnitude of pregnancy and adverse pregnancy outcome among 
HIV and DM patients? 
 
1.6 SIGNIFICANCE AND CONTRIBUTION OF THE STUDY 
 
This study will unfold critical evidences on the impact of diabetes mellitus and HIV on 
pregnancy outcome and the integration level of HIV, diabetes mellitus and pregnancy 
care. The findings will therefore be applicable in the improvement of the practical 
knowledge regarding the provision of an integrated standard care for HIV and DM to 
prevent adverse pregnancy outcomes. It can also assist program managers and policy 
makers to consider the interaction between HIV and DM to reduce pregnancy outcomes 
of childbearing women. The DM/HIV care of model in this study could optimize the 
control of DM and HIV among reproductive age women from preconception through 
pregnancy and minimize the risk of maternal and foetal complication due to the DM and 
HIV.  
 
Understanding the interaction between HIV and DM and their impact on pregnancy 
outcome could assist in the planning programs of HIV and DM, and sexual and 
reproductive health policy formulation. The study assesses the prevalence rate of 
pregnancy and its adverse outcomes impacted by DM and HIV. This can help to 
improve counselling on fertility issues and strict antenatal care to avert adverse 
pregnancy outcome of mothers in Ethiopia. Recognizing the chronic nature of HIV and 
DM may also assist to come up with an integrated care of model, including routine 
screening of HIV and DM among pregnant women to deal with adverse outcomes due 
to DM and HIV. 
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1.7 DEFINITIONS OF KEY CONCEPTS  
 
A concept is an abstraction based on observations of behaviours or characteristics. A 
conceptual definition presents the abstract or the theoretical meaning of the concepts 
being studied (Polit & Beck 2017:47 & 722). It was important to define concepts so that 
their right meaning in the study is clearly understood. Hence, defining them gives the 
reader a clear understanding in the context. The following concepts are defined in the 
context of this study. 
 
1.7.1 Diabetes Mellitus 
 
Diabetes mellitus is a disease in which the body’s ability to produce or respond to the 
hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and 
elevated levels of glucose in the blood (Concise Oxford English Dictionary 2011, sv 
“diabetes”). It is also a chronic disease that occurs either when the pancreas does not 
produce enough insulin (Type 1 diabetes) or when the body cannot effectively use the 
insulin it produces (Type 2 diabetes) (WHO 2013b:2). In this research, the WHO 
diagnostic criterion for diabetes mellitus in women is used. It is when fasting plasma 
glucose ≥ 7.0mmol/l (126mg/dl) or 2–hour plasma glucose ≥ 11.1mmol/l (200mg/dl) 
(WHO 2006:1).  Gestational diabetes (GDM) is diagnosed at any time during pregnancy 
if one or more of the following criteria are met: fasting plasma glucose 5.1-6.9 mmol/l 
(92 -125 mg/dl), 2-hour plasma glucose 8.5-11.0 mmol/l (153 -199 mg/dl) following a 
75g oral glucose load (WHO 2013b:5). 
 
1.7.2 Diabetes mellitus care 
 
For the purpose of this study, screening for DM using urine or blood test of fasting or 
random sugar, treatment of DM and follow up are defining care of diabetes mellitus.  
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1.7.3 Human immunodeficiency virus  
 
Human immunodeficiency virus is the type of virus that enters the body through blood or 
sexual activity and can develop into acquired immune deficiency syndromes (AIDS) 
(Longman dictionary of contemporary English, 2009 sv “HIV”). It also refers to human 
immunodeficiency virus and infects cells of the immune system, impairing their function. 
HIV infection results in progressive deterioration of the immune system, leading to AIDS 
(Goldman & Ausiello 2008:403; World Health Organization 2013: xiv-xv). HIV infection 
is diagnosed by routine blood test detecting antibodies related to HIV within 6-12 month 
after infection (Suthar, Ford, Bachanas, Wong, Rajan, Saltzman, Ajose, Fakoya, 
Granich,  Negussie  &  Baggaley 2013: e1001496). In this study HIV infected women 
are those who are diagnosed and confirmed by routine blood test detecting antibodies 
related to HIV (Suthar, Ford, Bachanas, Wong, Rajan, Saltzman, Ajose, Fakoya, 
Granich, Negussie, and Baggaley 2013: e1001496).  
 
1.7.4 HIV clinic  
 
HIV clinic is a room or place where HIV infected people get care, adherence support 
and anti-retroviral therapy. 
 
1.7.5 HIV services 
 
In this study, HIV services include counselling on HIV prevention, testing of HIV, clinical 
and laboratory evaluations, adherence support, provision of ART and the follow-up care. 
 
1.7.6 Integration 
 
Based on Longman dictionary integration is “the combining of two or more things so that 
they work together effectively” (Longman dictionary of contemporary English, 2009 sv 
“integration”). Pike and Mongan (2014:7-8) defines integration as a search to connect 
the health care system with other human services to improve outcomes. Integration is a 
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concept which brings together inputs, delivery, management and organization related 
services of diagnosis, treatment, care, rehabilitation and health promotion as a means 
to improve access, quality, user satisfaction and efficiency (Pike & Mongan 2014:8). 
 
In this study, the definition by Kodner and Spreewenberg (2002:4) is used: “integration 
is a set of methods and models on the functional, organizational and service delivery or 
clinical levels designed to create connectivity alignment and collaboration within and 
between HIV, DM and pregnancy care to enhance quality of care, quality of life, and 
system efficiency for patients with HIV and DM problems cutting across multiple service 
provider and setting”. 
 
1.7.7 Pregnancy 
 
Pregnancy, according to Concise Oxford English Dictionary (2011, sv “pregnancy”) is 
the condition or period of being pregnant. It is the state of carrying a developing embryo 
or fetus within the female body. 
This condition can be indicated by positive results on an over-the-counter urine test, and 
confirmed through a blood test, ultrasound, detection of fetal heartbeat, or an X-ray 
(Ouyang et al 2013: 357).  
 
1.7.8 Pregnancy care 
 
This includes pregnancy counselling on conception/being pregnant, urine pregnancy 
test, provision of one of the modern family planning, all comprehensive antenatal care 
(ANC) and delivery service. 
 
1.7.9 Pregnancy prevalence 
 
This is defined as the number of pregnancies detected during 2011-2016.  
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1.7.10 Health care workers  (HCW) are health care providers or clinicians  at health 
facilities such as doctors, nurses and health officiers working actively  at HIV, NCD and 
ANC clinics. 
1.7.11 Program managers are the focal persons or team leaders for NCD, MCH and 
HIV programs and are responsible for the respective programs at FMOH, RHB and sub-
cities.The program managers could also be team leader. Therefore, team leader and 
program mananger could be used  interchangeably.  
1.7.12 Program officers are  health professionals who are supervised by the program 
managers and actively engaged in the planning, implementation, monitoring and 
evaluation.  
1.8 ASSUMPTIONS OF THE STUDY 
 
Assumptions are statements that are assumed to be true without necessitating proving 
them (Burns & Grove 2013:40). The assumptions for this study were as follows: 
 
1.8.1 Ontological assumptions 
 
Ontology means the nature of reality (Holloway & Wheeler 2010:21). According to 
Giacomini (2010:129), it is the examination of the nature of being real which is socially 
constructed by individuals involved in the research situation. In this study, integrating 
DM and HIV to improve pregnancy outcome is real and measurable. This means the 
level of DM/HIV integration can be observed, prevalence of adverse pregnancy 
outcome among HIV and DM patients is measurable as well. HCWs and program 
managers through in-depth interviews (IDI) and focus group discussion (FGD) can 
construct the level of DM and HIV integration. i.e., multiple realities about the integration 
of DM and HIV can be constructed. 
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1.8.2 Epistemological assumptions 
 
According to Longman dictionary of contemporary English, “Episteme” is a Greek word 
meaning knowledge. Epistemology is about what can be known (Longman dictionary of 
contemporary English, 2009 sv “episteme”). This is how the researcher understands 
knowledge and how it is obtained (Holloway & Galvin 2016:21). The epistemological 
assumption in the pragmatic paradigm claims that knowledge arises out of actions, 
situations and consequences, and is socially constructed by the processes of 
institutionalization and legitimization. Socialization places managerial characteristics 
and perceptions at the core of any inquiry that seeks to understand organizational life 
(Yefimov 2014:5). 
 
It was assumed that the integration of DM and HIV to improve adverse pregnancy 
outcomes could be studied and one could learn something useful about the DM/HIV 
integration. The DM and HIV integration was explored through capturing and 
documenting what HCWs and program managers had to say since they were the ones 
with experience of clinical service and program management of HIV and DM.  
 
1.8.3 Methodological assumptions 
 
Based on the above assumptions the researcher took certain methods that were 
workable for learning about integration of HIV and DM to improve adverse pregnancy 
outcome. 
 
A mixed method research was used to answer the research question of this study. 
Johnson, Onwuegbuzie and Turner (2007:112) state that mixed method research 
combines elements of qualitative and quantitative research approaches for the purpose 
of breadth and depth understanding and corroborating. According to Creswell, Klassen, 
Plano Clark and Smith (2011:5) mixed method research focuses on collecting, 
analysing, and mixing both quantitative and qualitative data in a single study or series of 
studies to investigate and understand the same phenomenon. Its central premise is that 
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the use of quantitative and qualitative approaches to provide a better understanding of 
the research problem than either approach alone. . 
 
The mixed method in this study assisted to obtain a more complete picture of HIV, DM 
and pregnancy care service integration of HCWs at health facilities and program 
managers working in the ministry of health, Addis Ababa region and sub-cities on 
maternal health, non-communicable diseases (NCD) and HIV. In this study data 
abstraction checklist for quantitative data, observation, in-depth face to face interview 
and focus group discussion with open ended question guide were utilized. This allowed 
obtaining a deep and rich understanding of what the program managers and health care 
providers were thinking and doing regarding HIV and DM  integration to prevent adverse 
pregnancy outcomes. 
1. 9 THOERETICAL FRAMEWORK  
 
Theory is the interpretive lens based on which one shape the study (National Institute of 
Health (NIH) 2005:4). This study was guided by an integration theory initially defined by 
Leutz (1999)  (cited in Pike & Mongan 2014:10). 
  
According Pike and Mongan (2014:10) integration has a sense of the ‘glue’ that holds 
the units together. In a health system, integration can occur in the policy, budgeting, 
organization, service and clinical delivery levels. Integration is also conceptualized as 
occurring on a continuum in which full integration anchors one end and full separation 
can chores the other. In between there is little structural arrangement (informal referral) 
to explicit formal structures, such as contractual agreements and formal referral 
protocols (Pike & Mongan 2014:11-12). 
 
The concept of integrated care was initially used by primary care and was promoted as 
a means to address access, quality and continuity of health care services in efficient 
way particularly for peoples with multiple morbidities. It was developed to deal with the 
health service fragmentation due to specialization and differentiation, which results in 
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suboptimal care, higher cost and poor quality of care (Dudely & Ganer 2011:2). Thus, in 
a developing country with a population with multiple morbidities, an integrated health 
system has been promoted as a means to improve access, quality and continuity of 
services in a more efficient way (WHO 2008:2).   
 
Accordingly, a conceptual framework is developed based on which this study is 
structured (figure 1.1). Its basis is the work of Shortell, Gilles and  Anderson (1994) and 
Van Deusen Lukas and Desai (1999) and used in South Africa for TB and HIV 
integration (Uyei, Coetzee, Macinko, Weinberg & Guttmacher 2014:42) and recently 
described by Pike and Mongan (2014:26-27). This HIV, DM and pregnancy care 
integration conceptual framework is operationalised by three domains; functional, 
organizational, clinical or service integration. 
1.9.1 Organizational Integration 
 
This is the extent to which non-clinical program components are incorporated at the 
point of care or clinics. In this study it was assessed for the co-location of HIV, DM and 
pregnancy care services, combined DM and HIV patient services, HIV and DM 
information management, and joint training for HIV and DM to prevent adverse 
pregnancy outcomes. 
 
1.9.2 Functional integration 
 
This is a mechanism by which financing, information and management modalities are 
linked to coordinate and support accountability and decision making between 
organization and professionals to add the greatest overall value to the system. 
Functional integration supports organizational and clinical integration to occur (Van 
deusen Lukas and Desai 1999). In this study, it was a description of the extent to which 
key administration, financial operations and activities are combined at the managerial 
and policy level, such as strategic planning, budgeting and setting operation guidelines 
for joint HIV, DM and pregnancy care programs. 
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1.9.3 Clinical integration 
 
Clinical integration is the extent to which diagnostic, treatment, care and health 
promotion are concurrently delivered to the patients. It ensures services do not fall 
between the cracks. It includes notions of continuity of care, coordination of care, 
disease management, good communication among caregivers, smooth transfer of 
information and records, elimination of duplicate testing and procedures (Pike &  
Mongan 2014:94). 
 
In the clinical integration, service can be integrated structurally where there is formal 
HIV and DM related guidelines and protocols regarding the practice of joint service 
delivery. The process of clinical integration includes behaviour and practice of HCWs 
regarding the DM, HIV and pregnancy service delivery. Clinical integration also helps to 
explore whether there is a culture of workplace and personal identification with HIV, DM 
and pregnancy care integrated service delivery (Axelsson & Axelssom 2006:78-79).  
 
The process in the service integration means to see whether there are HIV counselling 
and screening services at diabetes and ANC clinics. The process indicates whether 
there is screening of diabetes mellitus service in HIV and ANC clinics. The process also 
measures access and means of utilization. In the study, it meant the number of facilities 
with integrated DM, HIV and pregnancy counselling. 
The integrated service delivery influences both output and impact. Output is 
performance of service generated and in this research it is the number or proportion of 
reproductive age mothers at HIV and ANC clinics counselled and screened for diabetes 
mellitus, the proportion tested for HIV at DM and ANC  clinics and the number or 
proportion of mothers at ANC with DM and HIV screening and testing services. Impact 
on the integrated service models means patients’ outcomes. In this study it meant the 
magnitude of DM among HIV patients, the prevalence of pregnancy and pregnancy 
outcomes among HIV and DM patients.The co-variate, the potential determinants for 
the output and impact, are age and sex, sugar level and CD4 count of the participants. 
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The co-varaite are also used to describe the  contex of the study interms of the 
prevalence and burden of DM, pregnancy and adverde pregnacy oucomes (Figure 1.1). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1:  Integrated service delivery: conceptual framework  
(Adapted from Pike and Mongan (2014:26-27)) 
 
The integration conceptual frameworks used here is a high-level conceptual categories 
and relationships that may not explain DM/HIV/pregnancy care integration, but identify 
the types of concepts that are likely needed to provide an explanation (Pike & Mongan 
2014:25). In this study, the integrated theoretical framework developed based on theory 
of integration by Leutz (1999) (cited in Pike & Mongan 2014:10) was used to guide this 
study. In other words, the integration theory and the conceptual framework used in this 
study served as guidance for model development. 
 
 
Functional 
Integration: 
combined budget, joint 
strategic planning 
Organizational 
integration: co-
locations, combined 
patients records 
Clinical/services 
integration: structure 
process, culture 
Output: 
utilization 
Impact: patient 
health outcome 
Covariates: 
Patient’s characteristics: age, sex, blood sugar level, CD4 level 
Clinical level characteristic: patient value, age of the program 
Context: Prevalence of HIV,pregnancy and APO  rate, DM 
burden  
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1.10 RESEARCH PARADIGMS    
 
Paradigms is a ‘world-views’ that signal distinctive ontological, epistemological, and 
methodological perspectives. The paradigm of post-positivism emphasizes quantitative 
methods as opposed to interpretivists which focus on qualitative inquiry. Pragmatic 
paradigm embraces the two extremes normally espoused by post-positivism and 
interpretivist (Johnson et al 2007:112; Morgan 2007:48).  
 
Pragmatic paradigm is concerned with applications and puts the research problem as 
central and applies all approaches to understanding the problem (Creswell 2014:39). 
Creswell (2014:39) further argues that, instead of methods being important, the 
research problem is the most important issue and individual researchers have freedom 
of choice regarding the methods, techniques and procedures of research that best meet 
their purposes. Pragmatism paradigm rejects the scientific notion that social inquiry was 
able to access the truth about the real world solely by virtue of a single scientific method 
(Mertens 2007:212). Thus, it provides the underlying philosophical framework for mixed 
method research (Creswell 2014:39). Therefore, pragmatism or mixing paradigms was 
preferred in this study to obtain a more complete picture of HIV, pregnancy care and 
DM service integration to improve pregnancy outcomes. 
 
1.11 THE RESEARCH DESIGN  
 
The research design, according to Burns and Grove (2013:209), is the overall plan of 
action of the study. It dictates the type of study planned and methods to be employed to 
produce and analyse data (Bowling 2014:158). Creswell et al  (2011:72-73) classify 
mixed methods study designs into four; the convergent parallel design, the explanatory 
sequential design, the exploratory sequential design and the embedded design.  
 
This study applied an exploratory sequential mixed method study design, with an 
exploratory qualitative design followed by a descriptive quantitative design in two 
phases of the study period (see Figure 1.2). This was to achieve the understanding of 
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how women in the reproductive age group could be offered integrated services of DM, 
HIV and pregnancy care services to improve the pregnancy outcomes and then to come 
up with the service delivery model. The quantitative phase utilized the instrument 
refined using the phase I findings to further enrich the model, assess the level and 
domains of the integration service inclusive of DM, HIV and pregnancy care. 
 
 
 
 
 
 
 
 
Figure 1.2: A mixed method exploratory sequential study design  
(Adapted from Creswell et al (2011:2087) 
 
1.12 RESEARCH METHODS 
This study has two phases, phase I and phase II. In phase I, a qualitative data was 
collected using IDI, FGD and observation through video recording and field notes.The 
word was coded for theme anlysis. In phase II, a quantitative data was collected using 
the abstraction checklist.Descriptive analysis was carried out. Purposive sampling for 
qualitative, and simple random sampling for qauntitative phase were used. The 
research methodology is summarized in table 1.1 below. The detailed methods and 
data design quality are described and presented in chapter 3. 
 
 
 
 
 
 
Qualitative data 
collection and 
analysis  
Builds to 
Quantitative 
data collection 
and analysis  
Interpretation 
Point of 
interface 
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TABLE 1.1: SUMMARY OF STUDY OBJECTIVES, METHODS AND DATA ANALYSIS BY PHASES 
OF THE STUDY 
 
Phases of 
the study Objectives Approach Sample 
Sampling 
method Data collection Data analysis 
Phase-I 
To explore the functional, 
organizational and clinical 
integration of DM, HIV and 
pregnancy care service at federal, 
regional , sub city s and health 
facility levels 
 
Qualitative 
NCD, HIV and Maternal 
health program managers at 
federal, regional, sub city 
levels and health facilities 
Purposive 
In-depth interview, 
focused group 
discussion and 
observation: audio 
record and 
fiedlnote 
Transcription, 
categorizing, 
coding and 
theme-based  
Qualitative HCWs  working at NCD, HIV and ANC Purposive 
Focused group 
discussion, 
observation: audio 
record and fiedl 
note 
Transcription, 
categorizing, 
coding  and 
theme-based 
Phase-II 
To determine prevalence of DM 
among HIV patients among 
childbearing female registered 
during 2011-2016 in Addis Ababa 
health facilities 
Quantitative HIV infected  patients 
Sex based 
stratified Simple 
random 
sampling 
Data abstraction 
and patient 
interview: data 
abstraction 
chekclist/quesiton-
naires 
Prevalence rate  
To determine the prevalence  of 
pregnancy among HIV and DM 
childbearing female registered 
during 2011-2016 in Addis Ababa 
health facilities 
Quantitative HIV infected patients and DM patients 
Sex based 
stratified Simple 
random 
sampling  
Data abstraction 
and patient 
interview: data 
abstraction 
chekclist/quesiton-
naires 
Prevalence rate  
To determine the prevalence of 
adverse pregnancy outcomes 
among HIV and DM childbearing 
females registered during 2011-
2016 in Addis Ababa health 
facilities 
Quantitative HIV infected patients and DM patients 
Sex based 
stratified Simple 
random 
sampling 
Data abstraction 
and patient 
interview: data 
abstraction 
chekclist/quesiton-
naires 
Prevalence rate  
To describe mothers with a 
documented HIV and DM services 
at ANC clinics in Addis Ababa 
health facilities 
Quantitative Pregnant women with ANC follow up 
Simple random 
sampling 
Data abstraction 
and interview: 
data abstraction 
chekclist/quesiton-
naires 
Number and  
percentage 
To describe females with  a 
documented pregnancy care and 
HIV services at DM clinics in Addis 
Ababa health services  
Quantitative DM reproductive age women Simple random sampling 
Data abstraction 
and interview data 
abstraction 
chekclist/quesiton-
naires 
Number and  
percentage 
To describe females with a 
documented pregnancy care and 
DM services at HIV  in Addis Ababa 
health services  
Quantitative HIV infected childbearing women 
Simple random 
sampling 
Data abstraction 
and interview data 
abstraction 
chekclist/quesiton-
naires 
Number and  
percentage 
 
 
 
 
 
22 
 
1.13 LAYOUT OF THE STUDY 
 
The content of the thesis is organized into six interrelated chapters. The chapters in this 
study are as follows: 
Chapter 1: Introduction and orientation to the study  
Chapter 2: Literature review  
Chapter 3: Research design and methods  
Chapter 4: Description,analysis and triangulaiton  of the findings 
Chapter 5: Development of an integrated servcie delivery model for HIV, DM and 
pregnancy care 
Chapter 6: Conclusions, limitations and recommendations 
 
1.14 CONCLUSION  
 
Chapter 1 presented an orientation to the study. The problem statement was derived 
from the given background. The purpose and objectives were also outlined. The 
research questions and an overview of the theoretical framework, the research method, 
and the research design were also presented. Definitions of terms were listed. The next 
chapter is the literature review. 
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CHAPTER  2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
Literature review assists to summarize and understand the existing knowledge 
regarding the topic under study (Sadler, Burgin, McKinney & Ponjuan 2010:235). The 
literature review in this study serves to identify any gaps in the existing pool of 
knowledge on the topic under study. In this chapter the literature review covers the main 
concepts related to the research topic; specifically, diabetes mellitus, HIV, the 
relationship between HIV and DM, pregnancy care, effects of DM and HIV on 
pregnancy, and outcomes of pregnancy.The review was guided by the research 
questions. Google scholar, pubmed, UNISA electronic articles and books, national 
policy guides and reports on DM, HIV and maternal health were the source for the 
literature review. After thorough reading of these sources, summary notes were taken, 
similar themes were summarized and organized to fit to the reseach questions. 
 
2.1.1 Non-communicable and communicable diseases in developing countries 
 
The significant increase in non-communicable diseases death in the next decade is 
expected in Africa, where NCD is likely to become the leading cause of death by 2030 
(Dalal, Beunza, Volmink, Adebamowo, Bajunirwe, Njelekela, Mozaffarian, Fawzi, Willett, 
Adami & Holmes 2011:885). However, less attention has been paid to the extent to 
which NCD contributed to morbidity and mortality. The focus in sub-Saharan Africa 
region has been on communicable diseases and maternal, perinatal and nutritional 
causes of morbidity and mortality (Boutayeb 2006:191). These are countries where the 
burden of communicable diseases is still high. The convergence of NCD and 
communicable diseases in low and middle income countries has the potential to 
overstretch the already strained health systems. With some developing countries now 
focusing on major health system reforms, a unique opportunity is available to address 
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challenges by NCD and communicable disease with novel approaches. Therefore, 
integrating public health activities for communicable disease and NCD should extend 
beyond health care services to prevention (Remais, Zeng, Li, Tian & Engelgau 
2013:221). 
There are close relationships between communicable diseases and NCD in terms of 
causation, co-morbidity, and care. Oftentimes, both communicable diseases and NCD 
co-exist, and one can increase the risk or impact of the other (Norheim, Jha, Admasu, 
Godal, Hum, Kruk, Gómez-Dantés, Mathers, CD Pan, Sepúlveda and Suraweera. 
2015:239). Diabetes, for example, can interact with and complicate a number of 
communicable diseases. HIV-infected patients with access to anti-retroviral treatments 
can now expect prolonged survival and ageing and hence accompanied by the 
emergence of diabetes and lipid disorders (Lo, Chen, Sheng, Hsieh, Sun, Liu, Wu, Wu, 
Hung & Chang, 2009:302). 
 
Together, NCD and communicable disease can affect pregnancy outcomes. For 
instance, poor maternal nutrition before and during pregnancy together with smoking 
tobacco during pregnancy contribute to poor intrauterine growth, resulting in low birth 
weight which in turn predisposes to DM risk later in life.  The problem is compounded by 
HIV/AIDS. Low birth weight and malnutrition are more frequent in HIV-infected children 
(DOS REIS et al 2015:111; Kim et al 2012:1). In this chapter DM, as an accelerating 
NCD; and HIV, as an impacting communicable disease will be discussed regarding their 
relationship and their impact on adverse pregnancy outcomes.  
 
2.2 HUMAN IMMUNO-DEFICIENCY VIRUS 
 
HIV belongs to the family of retroviruses that targets and weakens the immune system. 
The virus destroys immune cells with the CD4 (+) marker, often called T cells. Over 
time, HIV can destroy many of these cells to an extent that the body cannot fight off 
infectious diseases (WHO 2013a: xiv). 
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The advanced stage of HIV infection is AIDS. AIDS is defined by the opportunistic 
infections or cancers that take advantage of a very weak immune system. It takes 
from 2 to 15 years to develop AIDS depending on the individual (Goldman & Ausiello 
2008:393). 
 
2.2.1 Transmission of HIV 
 
HIV can be transmitted via the exchange of a variety of body fluids. The infectious 
fluids are blood, breast milk, semen and vaginal secretions. Having unprotected anal 
or vaginal sex; sharing contaminated needles, syringes and other injecting equipment 
and drug solutions when injecting drugs; receiving unsafe injections, blood 
transfusions, tissue transplantation, medical procedures that involve unsterile cutting 
or piercing; and experiencing accidental needle stick injuries can lead to HIV infection 
(Goldman & Ausiello 2008:395). The transmission of HIV from an HIV-positive 
mother to her child during pregnancy, labour, delivery or breastfeeding is called 
mother-to-child transmission (MTCT). Without interventions, the rate of HIV 
transmission from mother-to-child can be between 15-45% (Tsague, Tsiouris, Carter, 
Mugisha, Tene, Nyankesha, Koblavi-Deme, Mugwaneza, Kayirangwa, Sahabo & 
Abrams 2010:753). 
 
2.2.2 Anti-retroviral medications 
 
HIV can be suppressed by anti-retroviral therapy (ART) consisting of a combination 
of three or more anti-retroviral (ARV) drugs. ART does not cure HIV infection, but 
controls viral replication within a person's body and allows an individual's immune 
system to strengthen and regain the capacity to fight off infections (Goldman & 
Ausiello 2008:396). 
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2.2.3 HIV/AIDS and Chronic illnesses 
 
The wide use and effectiveness of Highly Active Anti-retroviral Therapy (HAART) has 
allowed the HIV infected population to live a longer and healthier life. Thus, they are 
now exposed to the same amount of risk factors (increased age, obesity and lack of 
physical inactivity) for NCD such as DM and premature cardiovascular disease as the 
non-HIV infected population (Baker, Henry & Neaton 2009:176; Young et al 2009:9). 
The rate of NCD is becoming higher among HIV patients due to the high prevalence of 
traditional risk factors such as smoking, alcohol and substance abuse, adverse effects 
of certain ARV drugs such as Abacavir and some protease inhibitors and the direct 
effects of HIV itself (Alvarez, Salazar, Galindez, Rangel, Castañeda, Lopardo, Cuhna, 
Roldan, Sussman, Gutierrez & Cure-Bolt 2010:256). 
 
In people living with HIV (PLHIV), there is chronic activation of the innate immune 
system with excessive production of inflammatory markers that in turn are associated 
with an increased risk of atherosclerosis and coronary artery inflammation. HIV-
mediated breakdown of the integrity of the gut mucosa and chronic translocation of gut 
microbial products into the systemic circulation contribute to the chronic inflammatory 
state (Rajasuriar, Khoury, Kamarulzaman, French,Cameron & Lewin 2013:1199). These 
all pave a way to the development of chronic illnesses like DM among PLHIV. 
 
2.3. DIABETIS MELLITUS 
 
Diabetes is a serious, chronic disease that occurs either when the pancreas does not 
produce enough insulin; a hormone that regulates blood sugar or glucose, or when the 
body cannot effectively use the insulin it produces (Wiener, Fauci, Braunwald, Kasper, 
Hauser, Longo, Jameson, Loscalzo & Brown 2012:1145). 
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2.3.1 Classification of Diabetes Mellitus 
 
The WHO (2016:11) defines the following categories of diabetes mellitus: 
• Type 1 diabetes (T1DM) which is characterized by deficient insulin production in 
the body. Type 1 diabetes patients require daily administration of insulin to 
regulate the amount of glucose in their blood. Symptoms include excessive 
urination and thirst, constant hunger, weight loss, vision changes and fatigue. 
• Type 2 diabetes (T2DM) which is due to ineffective use of insulin. T2DM 
accounts for the vast majority of people with diabetes. It may go undiagnosed for 
several years, until complications have already arisen. For many years, T2DM 
was seen only in adults but it has begun to occur in children. 
• Impaired glucose tolerance (IGT) and impaired fasting glycaemia (IFG) which are 
intermediate conditions that occur in the transition between normal blood glucose 
levels and diabetes (especially type 2), though the transition is not inevitable. 
• Gestational diabetes mellitus (GDM) which occurs when a woman develops high 
blood sugar during pregnancy. It increases risk of infection and obstructed 
labour. If not properly treated, GDM can cause serious complications during 
pregnancy and childbirth. For instance, pre-eclampsia is three times more likely 
to occur in women with GDM (WHO 2016a:13). 
 
Since GDM is associated with an increased risk for Type 2 diabetes for both the woman 
and child, it can also lead to serious health problems later in life. This can initiate a 
vicious cycle where the child will go on to have an increased risk of DM. This child also 
may pass this risk onto another generation (WHO 2016a:1). 
 
2.3.2 Diabetes mellitus in Ethiopia 
 
In Ethiopia, the International Diabetes Federation (IDF) 2015 report indicated an 
estimated DM prevalence of 3.4 % (IDF 2015:70). However, DM prevalence of as high 
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as 8% has been reported in 2013 on HIV/AIDS patients taking HAART (Sachithanan, 
Loha &  Gose 2013:1). DM claimed 23,145 deaths in Ethiopia in 2015 (IDF 2015:70). 
 
A systemic review by Gebre (2013:249) in Ethiopia showed that Major DM related 
complications have increased; hypertension (12.1% to 34.1%), neuropathy (27.7% to 
34.1%), and DM foot disease (1.7% to 4.6%). However, the review did not look into the 
complication of HIV on DM, or DM and HIV on pregnancy outcome. Hence, the 
researchers concluded mentioning that no study has been conducted confirming 
whether DM increases infectious disease occurrences or vice versa. 
 
2.4 HIV AS A RISK FACTOR FOR DIABETES MELLITUS 
 
The chronic and repeated inflammatory reaction by HIV correlates with an increased 
risk for diabetes. Some HAART medications have either direct or indirect adverse 
actions to a patient’s glucose metabolism, which makes them more likely to develop 
diabetes. Additional medications such as steroids given to treat some HIV-associated 
illness can cause altered glucose metabolism in healthy individuals (Tebas 2008:S86). 
 
Another risk for insulin resistance in HIV-infected patients is Hepatitis C infection (White, 
Ratziu & El-Serag 2008:831). Due to the fact that both Hepatitis C and HIV are 
transmitted in the blood and risk factors for acquiring them are similar, some HIV-
patients may be co-infected with hepatitis C (Operskalski &  Kovacs 2011:12). Patients 
co-infected with both HCV and HIV had increased insulin resistance and higher 
diabetes rates versus HIV-infected patients without HCV infection after initiation of ART 
using a nucleoside reverse transcriptase inhibitor (NRTI) regimens with or without non-
nucleoside reverse transcriptase inhibitor (NNRTI) (Butt, McGinnis, Rodriguez-
Barradas, Crystal, Simberkoff, Goetz, Leaf & Justice 2009:1227). 
 
The incidence of medication related diabetes increases as the duration of therapy 
increases. Protease inhibitors (PI) have a direct effect on glucose metabolism 
(hyperglycaemia) and then diabetes. Indinavir, ritonavir, and amprenavir are the PI’s 
29 
 
commonly ascribed to diabetes (Ledergerber, Furrer, Rickenbach, Lehmann, Elzi, 
Hirschel, Cavassini, Bernasconi, Schmid, Egger & Weber 2007:111). Thus, the use of 
protease inhibitors has been associated with insulin resistance in pregnant and non-
pregnant women. However, an association was not found between PI and Gestational 
diabetes (Jao, Wong, Van Dyke, Geffner, Nshom, Palmer, Muffih, Abrams, Sperling & 
LeRoith 2013: e141). The NRTI such as stavudine increases the risk for developing 
diabetes indirectly as well (Ledergerber et al 2007:111; Young et al 2009:9). 
 
2.4.1 Incidence and risk factors of DM among HIV patients 
 
According to the population survey in America, DM prevalence among HIV-infected 
adults was 10.3% and this was 3.8% (95% confidence interval (95% CI): 1.8% to 5.8%) 
higher in HIV-infected adults compared with general population adults. The survey 
shows that DM among HIV-infected persons may develop at earlier ages in the absence 
of obesity. Among HIV-infected adults with diagnosed DM, 3.9% had DM type 1 and  
52.3% had DM type 2 and 43.9% had unspecified DM. Factors independently 
associated with DM among HIV-infected adults include increasing age, obesity, 
increasing time since HIV diagnosis, and geometric mean of CD4 (+) count.  ART 
prescription in the past year is not associated with prevalent DM in the survey 
(Hernandez-Romieu, Garg, Rosenberg, Thompson-Paul and Skarbinski 2017: 
e000304). 
 
In a prospective study by Putcharoen, Wattanachanya, Sophonphan,  Siwamogsatham, 
Sapsirisavat, Gatechompol, Phonphithak, Kerr, Chattranukulchai, Avihingsanon  and 
Ruxrungtham  (2017:1535), 123 patients developed new onset DM, resulting in an 
incidence rate of 7.6 (95%CI: 6.3-9) per 1000 per year follow up (PYFU). In this study, 
age >35 years, male sex, body mass index (BMI) ≥25 kg/m, family history of diabetes, 
abnormal waist circumference, lipodystrophy and exposure to didanosine (ddI) were 
significantly associated with incident DM.  A prospective study in Nigeria, which 
determined the incidence of type 2 DM at baseline and after 12 months of ART 
initiation, indicates that the baseline T2DM prevalence was 2.3%, and an additional 
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5.3% had developed T2DM after 12 months of ART. In this study, newly developed 
diabetes was associated with BMI but not with age, CD4 (+) count, viral load, or type of 
ART (Isa et al 2016:ciw381).  
 
In a study exploring the association between efavirenz exposure and incident diabetes, 
the crude incident of diabetes during the initiation of ART was 13.24 per 1000 PYFU. 
Treatment with efavirenz rather than nevirapine was associated with increased risk of 
developing diabetes (hazard ratio 1.27 (95% CI: 1.10-1.46)). Zidovudine and stavudine 
exposure were also associated with an increased risk of developing diabetes 
(Karamchand et al 2016: e2844). 
A cross-sectional study conducted in Cameroon showed that that overall rate of GDM 
was 6.3%. This was 6.6% among HIV infected women. Family history of DM, HIV, and 
pre-pregnancy body mass index (BMI), only age ≥30 years were significant predictors of 
GDM. A significant association between use of ART and GDM was indicated in this 
study (Jao et al 2013: e141). 
 
A systematic review done in Africa to investigate the incidence and prevalence of type 2 
diabetes mellitus (T2DM) in patients with HIV infection reported that the incidence rates 
ranged from 4 to 59 per 1000 person years. However, this meta-analysis shows no 
association between T2DM prevalence and HIV infection or antiretroviral therapy 
(Prioreschi, Munthali, Soepnel, Goldstein, Micklesfield, Aronoff & Norris 2017: 
e013953). 
 
2.4.2 Human immunodeficiency virus in Ethiopia 
 
In a 2012/2013 cross-sectional study conducted at Hawassa University referral hospital  
in southern Ethiopia  that aimed to determine the magnitude of metabolic syndrome, DM 
was diagnosed in 25% of patients receiving ART compared to 22.5% of the ART naïve 
group (OR: 1.14 CI: 0.71-1.84). Based on this study, patients receiving ART had 
significantly elevated Cholesterol, triglyceride, glucose and LDL-c levels, but lower CD4 
(+) cell counts than the pre-ART groups. Being a female, having a body mass index 
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(BMI) of at least 25, older age of ≥45 years and having total cholesterol of at least 
200mg/dl were significantly associated with the presence of metabolic syndrome. 
Taking stavudine (d4T) -lamivudine (3TC) - efaverinxze (EFV) regimen was significantly 
associated with higher odds of metabolic syndrome (Tesfaye, Kinde, Medhin, 
megerssa, Tadewos, Tadesse, and Shimelis, Kinde, Medhin, Megerssa, Tadewos, 
Tadesse  and Shimelis 2014:102). 
 
A retrospective study done in Israel among HIV+ve Ethiopian immigrants shows that the 
prevalence of DM was 31% compared to 4% in HIV-infected non-Ethiopians and 8% in 
non-HIV-infected Ethiopians. The relatively increased prevalence of DM was age 
independent, but most noticeable in those under the median age (< 42 years). BMI was 
a predictor for DM (OR 1.263, CI 1.104-1.444, P = 0.001), although its values did not 
vary between the two ethnic groups. The researcher concluded that HIV-infected 
Ethiopians are more likely to develop DM at lower BMI values compared to non-
Ethiopians (Tzur et al 2015:620). 
 
An institution-based cross-sectional study done at the Jimma University Specialized 
Hospital in south-western Ethiopia demonstrates that the overall prevalence of DM 
among HIV+ people was 6.4% and it was associated with age, duration of highly active 
antiretroviral therapy, hypertension, and low-density lipoprotein cholesterol 
(Mohammed, Shenkute & Gebisa 2015:197). A Hospital-based cross-sectional study in 
north-western Ethiopia at HIV clinic of the University of Gondar Hospital by Abebe, 
Getachew, Fasika, Bayisa, Demisse and Mesfin (2016: e011175) also indicates that the 
overall DM prevalence was high (8%), particularly among subjects in the pre-ART 
group. 
 
In short, studies in sub-Saharan African settings (Isa et al 2016: ciw381;Jao et al 2013: 
e141; Prioreschi et al 2017: e013953 & Karamchand et al 2016: e2844) including the 
studies among Ethiopian (Abebe et al 2016: e011175; Mohammed, Shenkute & Gebisa 
2015:197; Tesfaye et al 2014:102 & Tzur et al 2015:620) have  only look into the burden 
and  risk factors of DM in HIV patients. However, there is limited information on 
32 
 
integrating the DM and HIV services to deal with the impact of the co-morbidity of the 
two diseases on pregnancy outcomes. 
 
2.5 PREGNANCY AND MATERNAL HEALTH 
 
According to WHO (2017: [SA]), maternal health refers to the health of women during 
pregnancy, childbirth and the postpartum period. Maternal mortality is a key indicator for 
maternal health. Despite a 44% reduction in maternal deaths between 1990 and 2015 
(UNICEF 2014:3), about 830 women die each day due to complications in pregnancy 
and childbirth (WHO 2015a). In 2015, HIV/AIDS was the leading cause of death among 
women of reproductive age around the world (Abubakar, Tillmann & Banerjee 
2015:117). One fourth of the pregnancy-related deaths in sub-Saharan Africa is 
attributable to HIV (Zaba, Calvert, Marston, Isingo, Nakiyingi-Miiro, Lutalo, Crampin, ., 
Robertson, Herbst, Newell & Todd 2013:1763). Women living with HIV in sub-Saharan 
Africa are at 6-8 times greater risk of dying during pregnancy or postpartum than their 
HIV-negative peers (Abubakar, Tillmann & Banerjee 2015:117). 
 
The global sustainable development goal 3.1 is targeted to achieve less than 70 deaths 
for every 100,000 live births by 2030. This necessitates improving access to quality care 
before, during and after childbirth (Norheim et al 2015:239). 
 
2.5.1 Preconception care 
 
According to the WHO (2016:1) preconception care is one of the components of 
pregnancy care for women of childbearing age. It includes the clinical preventive 
services delivered to women during well woman visits. It is particularly essential to 
prevent complications of pregnancy due to chronic diseases such as HIV and DM. 
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2.5.2 Antenatal care 
 
The WHO (2016:1) defines antenatal care (ANC) as the care provided by skilled 
healthcare professionals to pregnant women and adolescent girls in order to ensure the 
best health conditions for both mother and baby during pregnancy. Risk identification; 
prevention and management of pregnancy-related or concurrent diseases; and health 
education and health promotion are the components of the ANC. High quality health 
care during pregnancy and childbirth can prevent deaths from pregnancy complications, 
perinatal deaths and stillbirths (WHO 2016c:1). 
 
According to the WHO (2016: xvi) indirect causes of maternal morbidity and mortality, 
such as HIV and DM, contribute to approximately 25% of maternal deaths and near-
misses. To detect and address preventable complications related to pregnancy and 
childbirth such as HIV and DM, the WHO recommends an ANC model with a minimum 
of eight contacts. However, less than two-thirds of women receive antenatal care at 
least four times throughout their pregnancy in the world (Alkema, Chou, Hogan, Zhang, 
Moller, Gemmill, Fat,Boerma,Temmerman, Mathers & Say 2016:462). 
 
The recommendation by the WHO (2016:1) is that pregnant women should receive 
comprehensive care at each of the contacts with the health provider. These include 
counselling on healthy diet and optimal nutrition, physical activity, tobacco and 
substance use; malaria and HIV prevention; blood tests and tetanus vaccination; foetal 
measurements including the use of ultrasound. The recommendation also advices to 
dealing with common physiological symptoms such as nausea, back pain and 
constipation. 
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2.5.3 Fertility, conception and HIV 
 
Amongst others, an effect of HIV/AIDS on women is a change in fertility or conception 
levels. HIV/AIDS is related to conception or fertility due to behavioural change or 
biological mechanisms (Kushnir & Lewis 2011: 546). 
 
Thackway et al (1997), and Stephenson and Griffioen (1996) (cited in Kushnir & Lewis 
2011:548) describe that a new diagnosis of HIV is often followed by a decrease of 
sexual activity behaviour reducing pregnancy and birth rates among HIV infected 
women. This is because HIV-infected women terminate pregnancies in light of the 
challenges of pregnancy, birth, and parenting in the context of HIV infection (Kushnir & 
Lewis 2011:548).  On the contrary, other behavioural influences may lead to higher 
fertility rates. In societies with high HIV/AIDS rates, some couples may desire larger 
families to ensure survival of children, though others limit family size due to concerns 
about leaving orphans behind after an early death (Loutfy, Hart, Mohammed, Su, Ralph, 
Walmsley, Soje, Muchenje, Rachlis, Smaill & Angel 2009: e7925). In countries where 
HIV/AIDS treatment is widely available, such as South Africa, positive parenting is on 
the rise. The risk of mother-to-child transmission is as low as 2% in these areas, and 
treatment with ART medication has prolonged life expectancy for many potential 
parents with HIV (Myer, Carter, Katyal, Toro, El-Sadr and Abrams 2010: e1000229). 
This has resulted in the increase of fertility rate (Maier, Andia, Emenyonu, Guzman, 
Kaida, Pepper, Hogg & Bangsberg 2009:28). For instance, study from seven African 
countries demonstrates that the rate of new pregnancies was significantly higher among 
women receiving ART (9.0/100 PY) compared to women not on ART (6.5/100 PY) 
(Myer et al. 2010: e1000229). Nevertheless, Houle, Pantazis, Kabudula, Tollman, and 
Clark (2016:10) show that fertility patterns are not homogenous among different setting 
and countries.  
 
Biological mechanisms also influence fertility rates in HIV-positive women. Research 
has shown that women with HIV may find it more difficult to conceive than their HIV-
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negative counterparts due to ART–induced mitochondrial toxicity to embryo (Kushnir & 
Lewis 2011:550-51), hence reducing pregnancy rates. For example, HIV sero-
conversion was associated with a 0.02 (95% CI: 0.01-0.03) relative decreases in fertility 
for HIV- positive women (Marston, Nakiyingi-Miiro, Kusemererwa, Urassa, Michael, 
Nyamukapa, Gregson, Zaba, Eaton, & ALPHA network 2017:S69). HIV/AIDS may 
induce sterility, increase foetal mortality, decrease production of spermatozoa, all 
contributing to a declining fertility (Ombelet, Cooke, Dyer, Serour & Devroey 2008:605). 
HIV also affects the placenta by interfering with the transfer of important nutrients to the 
foetus. The virus causes abnormal development of the embryo. These can lead to 
spontaneous abortion (Myer et al 2010: e100022).  
 
Complications of HIV, such as increased risk of cervical abnormalities, early 
menopause, pelvic inflammatory disease-causing scarring of the Fallopian tubes, and 
severe wasting may also contribute to infertility in HIV infected women (Juhn, Kalemli-
Ozcan & Turan  2008: w14248). 
 
Since advanced HIV infection tends to decrease fertility, starting HAART can improve 
the likelihood of pregnancy. However, there are also indications that the drugs can have 
negative effects on fertility. Researchers from Uganda find out that the use of anti-
retroviral therapy increased fertility in HIV-positive women (Maier et al 2009:28). On the 
other hand, women on HAART are less likely to conceive because of the use of some 
anti-retroviral, particularly zidovudine and other NRTIs that may affect fertility in women. 
These can damage the mitochondria in eggs leading to infertility (Kushnir & Lewis 2011: 
546). 
 
2.5.4 Fertility, conception and diabetes mellitus 
 
There is a relationship between diabetes and fertility as well. Poorly controlled diabetes 
is associated with lower rates of fertility due to obesity, being underweight, having 
diabetic complications, having polycystic ovarian syndrome (PCOS) and having an 
autoimmune disease (Basmatzou & Konstantinos 2016:371; Livshits & Seidman 
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2009:701). The reproductive period of diabetic women may be reduced due to delayed 
menarche and premature menopause. During the reproductive years, diabetes has 
been associated with menstrual abnormalities, such as oligomenorrhea and secondary 
amenorrhea (Basmatzou & Konstantinos 2016:371). 
 
High glucose levels are reported to increase a woman’s chance of miscarriage by 30-
60%. Even when implantation does occur, there is an increased risk of birth defects due 
to damage caused to embryonic cells form the high levels of glucose in the blood. A big 
baby (macrosomia) resulting in a C-section, which increases a mother’s chance of 
infection is also another effect of hyperglycaemia in pregnancy (Gunatilake & Perlow 
2011:106). 
 
Young women with diabetes, either T1DM or T2DM, tend to start their menarche a little 
bit later in life than women without diabetes. On the other end of the spectrum, women 
with diabetes tend to go through menopause slightly earlier. This provides a slightly 
smaller window of fertility for women with diabetes (Livshits & Seidman 2009:703). In 
addition, many women with T2DM have an underlying syndrome called polycystic 
ovarian syndrome (PCOS). PCOS is associated with insulin resistance, which is a major 
player in type 2 diabetes. Because of the effects of PCOS on the ovaries, women with 
T2DM and PCOS may find a harder time with conception than women without diabetes 
(Basmatzou & Konstantinos 2016:371). 
 
Women with T1DM were approximately twice as likely to have experienced menopause 
earlier than similar non-diabetic women. In particular, patients with early menopause 
were younger at T1DM onset (Livshits & Seidman 2009:703).  In the same study, the 
age of menarche was found to be significantly older for Type 1 diabetic women 
compared with non-diabetic women. Taken together with premature menopause, this 
therefore reduces the reproductive period in T1DM women by 6 years. Premature 
menopause in women may also be related to the autoimmunity aspects of T1DM 
(Livshits & Seidman 2009:701).  
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2.6 ADVERSE PREGNANCY OUTCOMES 
 
In 2015, at the start of the Sustainable Development Goals (SDGs) era, pregnancy-
related preventable morbidity and mortality remains unacceptably high. In 2015, about 
303 000 women and adolescent girls died as a result of pregnancy and childbirth-
related complications (Alkema et al 2016:462). Around 99% of maternal deaths occur in 
low-resource settings and most can be prevented (WHO 2014:2014). Similarly, 
approximately 2.6 million babies were stillborn in 2015 mainly in the low-resource 
settings (Blencowe, Cousens, Jassir, Say, Chou, Mathers,  Hogan, Shiekh, Qureshi,  
You & Lawn 2016: e98). 
 
A survey data collected in 23 developing countries by WHO shows that women with an 
adverse outcome (i.e. stillbirth, neonatal death, infant with low birth weight and/or infant 
with very low birth weight) in their first pregnancy were found to be at increased risk of 
the adverse outcome in their second pregnancies. That is, a first pregnancy that ended 
in a stillbirth still appeared to be at increased risk of stillbirth at the end of their second 
pregnancy; women who had seen their first children die as neonates were at increased 
risk of seeing early neonatal death in their second pregnancies (Ouyang et al 
2013:315). An analysis using facility-based cross-sectional data of the WHO Multi-
country Survey on Maternal and Newborn Health in 29 countries demonstrates that  
adolescent pregnancy was associated with higher risks of adverse pregnancy outcomes 
(eclampsia, puerperal endometritis, systemic infections, low birth weight, preterm 
delivery and severe neonatal conditions) compared with mothers aged 20–24 years 
(Ganchimeg, Ota, Morisaki,  Laopaiboon, Lumbiganon, Zhang,  Yamdamsuren,  
Temmerman,  Say, Tunçalp & Vogel 2014:40). 
 
Pre-term labour, still birth, abortion, big baby are some of the adverse pregnancy 
outcome in diabetic mothers (Wendland, Torloni, Falavigna, Trujillo, Dode, Campos, 
Duncan & Schmidt 2012:32).HIV infected mothers could have abortion, still birth, IUFD, 
HIV infected neonates (Alemu,  Yalew, Fantahun & Ashu 2015:31; Joseph, Biodun &  
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Michael 2011:356). In short,  in patinets with poorley controlled DM  or  HIV infeciton, 
there could be adverse pregnancy out comes. 
 
2.6.1 Risk factors for adverse pregnancy outcome 
 
The risks factors of adverse pregnancy outcome include diabetes, hypertension, 
obesity, smoking, HIV/AIDS, heavy alcohol use, stress and depression. Unintended 
pregnancy and closely spaced births are also associated with adverse pregnancy 
outcome (WHO 2016c:xi). Hence, the WHO (2016:xiii) recommends the screening and 
testing of diabetes, HIV, tobacco smoking, substance use during preconception and ant-
natal care (ANC). In a Multi-country Survey on Maternal and New-born Health 
Laopaiboon, Lumbiganon, Intarut, Mori, Ganchimeg, Vogel, Souza and Gülmezoglu 
(2014:49) indicate that the prevalence of pregnant women with advanced maternal age 
of more than 35 year was 12.3% which significantly increased the risk of maternal 
adverse outcomes such as maternal near miss, maternal death, stillbirths and perinatal 
mortalities. A matched case control study conducted in Nigeria shows that a 
commencement of ANC attendance <4months  and number of pregnancies ≥4  months 
were found to be associated with adverse pregnancy outcomes (Sadiq, Poggensee, 
Nguku, Sabitu, Abubakar & Puone 2016:1).  
There are evidences indicating HIV and DM are key risk factors for adverse pregnancy 
outcome. For instance, the prospective case record analysis of 212 HIV-infected women 
in India showed that HIV-infected women were more likely to have pre-term birth, 
intrauterine growth retardation, and anemia compared to uninfected women. Mean birth 
weight was significantly lower in neonates of HIV-infected women than HIV-uninfected 
women. The study also indicated that HIV-infected women on ART had decreased 
incidence of PTB and IUGR (Dadhwal, Sharma, Khoiwal, Deka, Sarkar, and Vanamail  
2017:75). In addition, the survey in the Asian population reveals that pregnant women 
with type 1 diabetes are at increased risk of developing many adverse maternal and 
fetal outcomes such as preeclampsia, eclampsia, cesarean delivery, sepsis, and shock 
as compared  to the pregnant women without the disease (Lin, Kuo, Chiou, and Chang 
2017: 80679). 
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2.6.2 Pregnancy outcome in Ethiopia 
Prevalence of adverse birth outcomes (still birth, preterm birth and low birth weight) is 
high and still a major public health problem in Ethiopian. For instance, study by Adane, 
Ayele, Ararsa, Bitew, and Zeleke (2014:90) at Gondar University Hospital, Northwest 
Ethiopia shows that about 23% of women had adverse birth outcomes (14.3% preterm, 
11.2% low birth weight and 7.1% stillbirths). 
 
Ethiopian women had a less favourable intra-partum outcome, according to the 
retrospective study by Salim, Mfra, Garmi and Shalev (2012:161). They had a higher 
incidence of pre-eclampsia (6.8% versus 4.0%, P=0.01) and early postpartum 
haemorrhage (4.3% versus 1.6%, P=0.003) than the control women, the general 
obstetric population in Israel. The incidence of vacuum or caesarean delivery was 
significantly higher among Ethiopian than among control women (odds ratio, 1.68; 95% 
CI: 1.28-2.20; P=0.002). Besides, Worku, Yalew and Afework (2014:1336) in northern 
Ethiopia indicate that skilled maternal care has reduced adverse pregnancy outcomes 
but the associations were not significant. Nevertheless, neither of these studies 
stratified the adverse pregnancy outcome by the status of DM or HIV status. 
 
A descriptive study comparing birth outcomes of Ethiopian in Israel and non-Ethiopian 
women showed that Ethiopian women had about twice the incidence of very and 
extremely preterm births, compared with non-Ethiopians. In this study it was found that 
Ethiopian women had twice the odds for neonates who were either small for gestational 
age or had low 5-minute Apgar scores. Ethiopian women had about threefold increased 
risk of stillbirths (OR 2.9 [95% CI 1.87-4.49]) (Calderon‐Margalit, Sherman, Manor & 
Kurzweil 2015:125).  
2.6.3 Incidence of pregnancy and pregnancy outcomes among HIV infected 
patients 
 
According to a retrospective cohort study among PLHIV in South Africa, the overall rate 
of pregnancy was 5.2 per 100 person-years and a cumulative incidence of first 
pregnancy was 22.9%. This indicates that women experience high rates of incident 
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pregnancy after HAART initiation. Also the study states that the strongest predictor of 
incidence of pregnancy was age, with women 18–25 having 13.2 times the rate of 
pregnancy of women ages 40–45 in adjusted analysis. CD4 (+) counts below 100 and 
worse adherence to HAART were associated with lower rates of incident pregnancy 
(Westreich, Maskew, Rubel, MacDonald, Jaffray and Majuba  2012:1). 
 
Calvert and Ronsmans (2013:1631) indicates that an HIV-infected women has eight 
times the risk of a pregnancy-related death compared with HIV-uninfected women. The 
excess mortality attributable to HIV among HIV-infected pregnant and postpartum 
women is 994 per 100,000 pregnant women. It is also predicted that 12% of all deaths 
during pregnancy and up to 1-year postpartum are attributable to HIV/AIDS in regions 
with a prevalence of HIV among pregnant women of 2%. Another meta-analysis 
indicates that HIV-infected women has over three times the risk of a puerperal sepsis 
compared with HIV-uninfected women and this is increased to nearly six amongst 
studies only including women who delivered by caesarean (Calvert &  Ronsmans 2013: 
e74848). 
 
On the contrary, a retrospective cohort study in South Africa by Gibb, Kizito, Russell, 
Chidziva, Zalwango, Nalumenya, Spyer, Tumukunde, Nathoo, Munderi and 
Kyomugisha (2012: e1001217) indicates that ART or HIV infection does not have an 
adverse effect on pregnancy outcome. Gibb et al (2012:e1001217) further demonstrate 
that there is no significant difference in the occurrence of low birth weight and pre-term 
birth in pregnancies that occurred before and after ART. The consumption of illicit drug 
does not have any effect on the adverse effect of pregnancy as well. 
 
A systematic review in developing countries shows that frequently observed ART 
related adverse birth outcomes included low birth weight (LBW), preterm Birth (PB), 
Small for Gestational Age (SGA), while still birth and congenital anomalies were 
infrequent.  In the review, it is also indicated that type of regimen such as Protease 
Inhibitor (PI) based regimens and timing of initiation of ART are some of the factors 
associated with adverse pregnancy outcomes (Alemu et al 2015:31). A study conducted 
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in a teaching hospital in Nigeria indicates that untreated maternal HIV-infection in 
pregnancy may be associated with adverse pregnancy outcome such as intrauterine 
growth restriction (IUGR), pre-term birth, higher frequency of birth weight less than 
2500g and caesarean delivery as compared with women who received HAART from 
early pregnancy  (Joseph et al 2011:356). 
 
The overlap between pregnancy and HIV is even more striking in Ethiopia, with very 
high rates of both HIV and pregnancy incidence reported among young women (Central 
Statistical Agency [Ethiopia] and ICF International 2012: 69,234). With a growing 
interest in “treatment-as-prevention” (Montaner, Hogg, Wood &Kerr 2006:531), an 
increasing incidence of pregnancy among women receiving HAART seems inevitable, 
especially in Addis Ababa, where there is wide access to HAART and a very large at-
risk population of reproductive-age women. For instance, a facility based retrospective 
follow-up study in Addis Ababa in 661 women’s charts demonstrates that the incidence 
of pregnancy among women who enrolled in HIV care comprised of 21 incident 
pregnancies with the rate of 3.9 per 100 person-years in the pre-ART period and 67 
incident pregnancies with the rate of 8.02 per 100 person years in the ART period. A 
facility based retrospective cohort study in northwest Ethiopia conducted over 4 years 
involving 1,239 women on ART indicates even a higher incidence of pregnancy, 49.2 
per 1,000 person-years (Meseret, Shimeka & Bekele 2017:1). A facility based 
retrospective cohort study  conducted in Gondar University hospital in northwest 
Ethiopia shows that adverse pregnancy outcome is also common among HIV –infected 
mothers. Accordingly, the prevalence of LBW and pre-term delivery were 89 (21.4%) 
and 69 (16.6%), respectively. The baseline maternal CD4 (+) counts below 200 
cells/mm3, maternal body mass index (BMI) below 18.5 and maternal exposure to 
HAART were factors significantly associated with both LBW and preterm delivery 
(Kebede, Andargie & Gebeyehu 2013:254). 
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2.6.4 Pregnancy outcome and Diabetes Mellitus 
 
A systematic review by WHO (Wendland et al 2012:32) find out that macrosomia, large 
for gestational age, perinatal mortality, preeclampsia and caesarean delivery are related 
to DM. The Indian study by Ellerbe, Gebregziabher, Korte, Mauldin and Hunt (2013: 
e65017) also demonstrates the association between maternal DM with increased weight 
in new-borns. However, a study done in Tanzania shows that DM doesn’t significantly 
relate to low birth weight (Mitao, Philemon, Obure, Mmbaga, Msuya and Mahande 
2016:75).  
 
High serum blood glucose is a key cause of maternal and fetal complications in 
pregnancies of women with any type of diabetes. The review of adverse pregnancy 
outcome in Negrato, Mattar and Gomes (2012:41) indicates that fetal adverse outcomes 
found in pregnancies of women with diabetes are fetal and neonatal loss, congenital 
abnormalities and malformations, premature delivery, fetal growth acceleration. Women 
with type 1 diabetes have a four- to fivefold increase in perinatal death, and a four to 
six-fold in stillbirth compared to the general population. It is also shown that C-section, 
hypoglycemia and the worsening of any degree of a pre-existing renal insufficiency and 
retinopathy can be complications of DM among women. Rates of pre-eclampsia 
(12.7%), C-section (44.3%) and maternal mortality (0.6%) found among women with 
type 1 diabetes are considerably higher than in the background population.  
 
2.7 CONCLUSION 
 
This chapter provided a detailed literature review on DM and HIV as related to adverse 
pregnancy outcomes. It was shown that HIV and ART are risk factors for DM. 
Pregnancies among HIV infected or diabetic mothers could be complicated with adverse 
pregnancy outcomes impacting both meternal and child health. The next chapter will 
discuss the design and methodology used in this research. 
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CHAPTER 3 
RESEARCH DESIGN AND METHOD 
 
3.1 INTRODUCTION 
 
This chapter presents details of the types of study design utilized to conduct the 
research. It also addresses the method used to collect data, means of analysing data 
and the ethical considerations in the study. The research’s validity and trustworthiness 
are discussed as well. 
3.2 RESEARCH DESIGN 
 
Burns and Grove (2013:195) describe research design as ‘’a blueprint for conducting 
the study that maximizes control over factors that could interfere with the validity of the 
findings’’. A research design is also defined as a comprehensive plan to answer 
research questions. It is a strategy adapted to develop accurate and meaningful 
evidence (Polit & Beck 2017:183).  
 
This study applied a mixed method approach with exploratory and descriptive research 
design to achieve the aim and specific objectives of the study. Phase I of the study used 
the exploratory design as a part of qualitative approach, while phase II applied the 
descriptive design as part of the quantitative approach. 
3.3 A MIXED METHOD APPROACH 
 
Mixed methodology is a design for collecting, analysing, and mixing both qualitative and 
quantitative data in a single study to understand a problem (Clark & Creswell 2015:386). 
A key assumption in the use of the mixed methods is that neither quantitative nor 
qualitative research by itself is sufficient to understand a complex research problem. 
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Drawing on the strengths of quantitative and qualitative research adds up to a better 
understanding of the research problem (Creswell 2014:266). 
 
Mixed method is also helpful to obtain different, multiple perspectives, validation, build 
comprehensive understanding, have better contextualised measures, whenever there is 
a need to explore and to further understand experimental results, process and outcome 
(Clark & Creswell 2015:386). It also helps to get a more comprehensive account of 
what’s going on within the research. When used together as a mixed method, both 
qualitative and quantitative approaches enhance the integrity of the findings (Creswell 
2014:267).  
3.3.1 Application of mixed method in this study 
 
In the HIV, DM and pregnancy outcome study, the researcher wanted to determine the 
level of integration of DM and HIV to deal with adverse pregnancy outcome, where 
descriptive design as part of quantitative research was applied. To find out the domains 
of the integration, the qualitative research was used to have a perspective of peoples 
working on the HIV and DM services and officers working on maternal health. Besides, 
the clinicians at health facilities were interviewed to know how they were delivering the 
service of DM testing and treatment at HIV and ANC clinics, HIV counselling and testing 
services at DM and ANC clinic and services of pregnancy care at DM and HIV clinics. 
Hence, these people were questioned to explore how they rendered the integrated 
services of DM, HIV and pregnancy care. The researcher tried to come up with an 
integrated model of care for DM, HIV and pregnancy care services which was 
augmented by the descriptive part of a quantitative design.  
 
Moreover, to have in-depth understanding of the pregnancy care among HIV and DM 
patients, using qualitative approaches was critical. Also, this study needed to answer 
the question of the magnitude of pregnancy and adverse pregnancy outcomes among 
HIV and DM patients. The prevalence of DM among HIV patients was also determined. 
This warranted a quantitative study design. To further refine the model of care 
45 
 
developed in phase I from qualitative approach, it was also important to describe the 
level and domains of integration of HIV, DM and pregnancy care services. 
3.3.2 Types of mixed methods 
 
The classification of mixed method designs depends on timing, emphasis and mixing. 
Based on the timing, it is grouped as sequential where one built on the other and 
concurrent where both are collected at the same time.(Clark & Creswell 2015:389). In 
this study a sequential mixed methods; that is, an exploratory sequential mixed method 
was used (Clark and Creswell 2015:391; Creswell et al 2011:2108).  
3.3.2.1 Sequential exploratory mixed method research 
 
A sequential exploratory mixed method is characterized by an initial phase of qualitative 
data collection and analysis followed by a phase of quantitative data collection and 
analysis. Exploratory sequential design, meant for the exploration of a phenomenon, is 
aimed to generalize qualitative findings to a larger sample (Creswell  et al 2011:2086). 
In this method the qualitative part is given a higher emphasizes than the quantitative 
(Clark & Creswell 2015:389). Basically, it is a two-phase research where qualitative 
results can help and inform the second quantitative method (Creswell et al 2011: 2086-
87). 
 
Using the sequential exploratory mixed method in this study, the phase one or 
exploratory section of the study had two key purposes; 1) to explore the integration of 
DM, HIV and pregnancy care services and to develop a servcie delivery model inclusive 
of DM, HIV and pregnancy care services, and 2) to modify or refine a draft instrument to 
be used for the phase II quantitative research. The second phase of the study not only 
descried the level of DM, HIV and pregnancy care service integration, it substantiated 
the finding during the phase II and enriched the developed a servcie delivery model of 
integrated DM, HIV and pregnancy care service delivery. 
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3.3.2.2 A rationale for applying the sequential exploratory method in this study 
 
There was no data collection instrument which assisted to collate information regarding 
the level and domains of integration regarding DM, HIV and pregnancy care. Hence, it 
was important to explore the levels and domains of the integration and come up with a 
structured questionnaire and abstraction checklist to objectively investigate the level 
and the domains related to DM, HIV and pregnancy care in Ethiopia. Therefore, the 
sequential exploratory method was applicable, as this method helps to refine the data 
collection instrument. 
 
The researcher used this study design because there was no model inclusive of DM, 
HIV and pregnancy care as a guide, though there is a relationship among the three 
health entities. Therefore, the researcher intended to explore what is on the ground and 
the potential suggestion from the experts and patients. Hence, a sequential exploratory 
type of mixed study design was used (Creswell  et al 2011:2087).  
3.4 QUALITATIVE RESEARCH APPROACH 
 
Qualitative research is underpinned by interpretivism, constructivism, and critical theory 
research paradigms (Terrell 2012:257). The qualitative research is a holistic and striving 
for an understanding of the 'whole' part of the phenomenon being studied. It helped to 
develop a model based upon the data collected (Polit & Beck 2017:463). In a qualitative 
design, an inductive approach is used and unstructured interviews, focus groups, and 
participant observation are applied to collect data (Clark & Creswell 2015:54). 
 
Therefore, in phase I of this study, qualitative study provided the opportunity to explore 
the level and domain of integration existed among HIV, DM and pregnancy care 
services from the perspective of HCWs and experts on HIV, DM and maternal health. 
The qualitative approach was utilized to develop an integrated model of care by 
interviewing the program officers and experts working on HIV, DM and pregnancy care.  
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3.4.1 Exploratory research design  
 
Polit and Beck (2017:15) describe explorative research as a valuable way to yield new 
insights into a topic for research. According to Deforge (2010:1254), exploratory study is 
conducted when little is known about the phenomenon of interest with the goal to 
assess a relationship among variables within this little known phenomenon. The 
researcher in this study understands that DM and HIV can affect pregnancy outcomes. 
Nevertheless, the key question the researcher wanted to answer is, “How can DM, HIV 
and pregnancy care service among reproductive age women in Ethiopia be coordinated 
or integrated to improve pregnancy outcomes?”. That is, the researcher wanted to come 
up with an integrated model of service delivery linking HIV and DM to improve a 
pregnancy care. Thus, in phase I of this research, the researcher viewed the broader 
understanding of level and domain of integration of DM, HIV and pregnancy care which 
had not been explored so far. This assisted to come up with the HIV and DM service 
integration level that could address adverse pregnancy outcomes .i.e. services related 
to DM among HIV patients given at the HIV clinic, services related to HIV among  DM 
patients given at DM clinic and HIV and DM services among pregnant women that are 
being given at ANC unit. 
 
3.5 QUANTITATIVE RESEARCH APPROACH  
 
Quantitative research is underpinned by positivist or post-positivist research paradigms. 
It is regarded as the traditions of the natural science which claims that knowledge is 
only created by following scientific methods of observation and testing (Terrell 
2012:257). During phase II of this study, the quantitative approach was utilized to 
describe the DM, HIV and pregnancy care services at the study health facilities. It was 
further used to describe the number of pregnancies and pregnancy outcome occurred 
among HIV and DM patients. There is no information so far as to which level of 
DM/HIV/pregnancy service integration leads to a better pregnancy outcome and 
feasible for reproductive age mothers.  
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In phase II of this study, the findings in phase I were enriched to refine and develop data 
abstraction and questionnaire. 
3.5.1 Descriptive research design 
 
In descriptive research design a situation, a phenomenon, and events are observed by 
the researcher who focuses on what is happening or how much has happened rather 
than why it is occurring (Polit & Beck 2017:15; Tappen 2015:81). Descriptive designs 
can simply intend to report what is observed (Gratton & Jones 2010:7; Tappen 
2015:78). In phase II of this research, the researcher’s intent was to assess the level of 
DM, HIV and pregnancy care services in the study health facilities. In this study, the 
researcher wanted to describe burden of DM among HIV infected females, and to 
determine the prevalence of pregnancy and pregnancy outcomes among HIV and DM 
mothers using the descriptive quantitative design.  
3.6 RESEARCH METHOD 
 
Research method refers to the techniques the researcher uses to structure the 
study. It includes using a set of orderly disciplined procedures to obtain information to 
meet the objectives of a study (Polit & Beck 2017:11). In this section, the methods are 
outlined based on qualitative and quantitative approaches by referring to sampling 
techniques, data collection, data management and data analysis. 
3.6.1 Research methods for qualitative approach (Phase I) 
 
3.6.1.1 Setting and population 
  
The settings for phase I study were federal ministry of health (FMOH), health bureau, 
sub-cities and public health facilities in Addis Ababa. The target population were experts 
at NCD, HIV and maternal and child health (MCH) at the federal ministry of health, 
regional health bureau, sub-cities and HCWs working at the study health facilities. That 
is, relevant information was obtained from experts and health care providers. Experts, 
program managers and officers, were those who are working on DM, HIV and maternal 
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health at different administrative levels (federal, region, and sub-cities in the Addis 
Ababa city). The health care providers were those from public health facilities working at 
HIV, DM and ANC units. 
3.6.1.2 Sampling techniques 
 
Purposive sampling entails selecting a particular subset of a population rather than 
making a random selection (Tappen 2015:115). The purpose of the study in phase I of 
this study was to gain an in-depth understanding of the level and domains of DM, HIV 
and pregnancy care (Burns & Grove 2013:352), hence purposive sampling was applied.  
 
In a homogeneous type of purposive sampling, units are selected based on their having 
similar characteristics because such characteristics are of particular interest to the 
researcher (Clark & Creswell 2015:333). According to Clark and Creswell (2015:334), a 
homogeneous sample is often chosen when the research question being addressed is 
specific to the characteristics of the particular group of interest, which is subsequently 
examined in detail. Therefore, in phase I of this study, health providers and officers with 
similar experience of HIV, DM and maternal health were selected using a homogeneous 
purposive sampling. They were intentionally approached and selected to get a rich data 
on HIV and DM integration at federal, regional, sub-cities and facility level. Besides, 
during the IDI and FGD, the interview was started with small number of experts, and the 
selection of further participants was on the basis of the information gathered from earlier 
interviews, i.e. a theoretical sampling (Thornberg  & Charmaz 2014:153). 
3.6.1.3 Eligibility criteria 
 
HCWs,  program managers and officers working on DM, HIV and pregnancy care who 
gave their consent to participate in the study, were part of the study. To be a candidate 
for the study, HCWs and program managers and officers should have worked on DM, 
HIV and pregnancy care for at least 06 months.  
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3.6.1.4 Sample Size 
 
Boddy (2016:432) states that an adequate sample size in qualitative research is one 
that permits the deep, case-oriented analysis that is a hallmark of all qualitative inquiry, 
and that result in a new and richly textured understanding of experience. Provided that a 
researcher remains faithful to the principles of qualitative research, sample size should 
follow the concept of saturation (Mason 2010 [Sa]). Saturation is when the collection of 
new data does not shed any further light on the issue under investigation. However, the 
objectives of the study are the ultimate driver of the sample size (Malterud, Siersma and 
Guassora 2016:1753). In this study, the sample size was 7 FGDs, 11 IDIs and 13 
observations, after which the researcher could not appreciate new information. 
3.6.1.5 Approach to data collection 
 
The researcher was the data collector, who used the interview guide, audio record and 
also took notes of the observation. The study participants were informed about the IDI 
and FGD earlier to arrange the appropriate time for the interview. IDIs and FGDs were 
conducted at the places convenient for the study participants. IDIs were conducted in 
offices and clinics where there were no clients or patients. The FGD was carried out in 
mini-halls accomodating at least 10 individuals at a time. Also, there were times where 
FGD was  perfomred inside the office of the health center, sub-cities, RHBs and FMOH. 
Amharic was the language of communication during the IDI, FGD and informal interview 
in the observaitons. Before the tape recording, verbal consent was obtained from the 
study participants. IDIs were mainly for program managers where as FGDs was among 
the program officer  and HCWs. 
 
• Pre-testing the data collection instrument  
 
The advantage of conducting a pretest as described by Polit and Beck (2017: 57 & 268) 
is to assess the appropriateness of data collection instrument, and method, potential 
problems that will be encountered, and identify confounding variables to control.  
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In this study, 2 IDIs and 01 FGD were conducted prior to the main study in order to 
determine whether the interview guide would bring the intended information or not. The 
study pretest helped to identify weakness, ambiguity or lack of clarity of the questions in 
the interview guide.  Questions that were not clear during the pretest study were 
clarified, rephrased, and modified before the main data collection process. Questions in 
the question guide were rearranged: the sequence of the questions was ordered in a 
logical way. Probing questions modified, addressed and added.  However, there were 
no changes to the methodology. The results of the pretest were not included in the final 
findings of the study. 
3.6.1.6 Method of data collection 
 
An interview guide for IDI and FGD was developed and used in phase I of the study 
(see Annexure H). Polit and Beck (2017:732) defined interview as ‘’ the data collection 
method in which an interviewer asks a question(s), either face-to-face or by telephone’’.  
Interviews are designed to generate participant perspectives about ideas, opinions, and 
experiences (Polit & Beck 2017:506).  
 
The interview guide for IDI and FGD was drafted based on the integration theory and 
was modified based on the finding during the interviews. The drafted interview guide 
depended on the domains of integration such as organizational, financial, 
administrative, functional, and clinical and service integration. The functional, financial 
and administrative integration section was utilized while interviewing experts at the 
ministry of health, regions and sub-cites in the Addis Ababa. It was also applied during 
the FGD of HCWs at DM, HIV and ANC clinics. The organizational and clinical 
integration part was asked for HCWs working at DM, HIV and ANC clinics. In short, the 
interview guide was an initial draft and was further refined and developed based on the 
subsequent IDI and FGDs (see Annexure H). 
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• In-depth interview 
 
An IDI is a technique designed to elicit a vivid picture of the participant’s perspective on 
the research topic. IDIs are usually conducted face-to-face and involve one interviewer 
and one participant. Interview data consists of tape recordings, typed transcripts of tape 
recordings, and the interviewer’s notes (Mack, Woodsong, MacQueen, Guest and 
Namey 2005:29-30). A classical IDI was utilized in this study. It was particularly useful 
for exploring a topic broadly; in this case, the integration status of DM,HIV, and 
pregnancy care. It also helped to understand details of services of DM, HIV and 
pregnancy care being carried out at the respective service outlets and also explored the 
domains and level of integration of HIV, DM and pregnancy care in the Addis Ababa 
city. Field notes were kept as well. 
 
• Focus group discussion 
 
FGD is one component of unstructured interview and it was an interaction of study 
participants and the interviewer to explore specific issues and develop a better idea as a 
group (Tappen 2010:240). Similarly, Polit and Beck (2017:729) argue that FGD is a kind 
of group interview intended to explore information taking the advantage of group 
dynamic. It can be used for many topics, however, it is believed very good for sensitive 
topics. The FGD sessions were tape recorded in this study. A principal advantage of 
focus groups was that they yielded a large amount of information over a relatively short 
period of time. FGD assisted to encourage the participants to share views and 
experiences and also to debate issues  
 
In phase I of this study, FGDs were chosen as a data collection approach to obtain an 
opinion deeper as one capitalized others’ ideas or assistive on information recall. In this 
study, the researcher obtained a detailed opinion regarding the relationship between 
DM and HIV, their impact on adverse pregnancy outcome and the status of HIV and DM  
integration to address pregnancy outcome in Addis Ababa. The FGDs were facilitated 
by the researcher. 
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• Observation 
 
The researcher  observed how HIV, DM and pregnancy care were being rendered in the 
06 public health facilities during the real clinical practice. The observation was done at 
DM, HIV and ANC clinics. Participants’ observation was also done at FMOH at NCD, 
MCH and HAPCO units. The observations focussed on the linkage, coordination or 
collaboration of these services. It also looked into the interactions among patients and 
HCWs, and the communication among the HCWs working at DM, HIV and pregnancy 
care while serving their patients. The researcher took notes during the observation. 
 
Therefore, the IDIs, FGDs and the observations assisted to explore organizational and 
functional integration of DM, HIV and pregnancy programs and services at the ministry 
of health, Addis Ababa regional health bureau, sub-cities and the study health facilities 
during the phase I of this research. There were a total of   11 IDIs, 7 FGDs and 13 
observation carried out in this study. IDIs included 11 study participants. Each FGD 
involved 6-8 participants. The observation was carried out at the 6 health facilities, three 
sub-city, at the Addis Ababa region and 3 units in FMOH. The interviews and the 
observations were stopped when no new dominant issues emerged in the dataset. Data 
saturation reached after 11IDIs, 7 FGDs and 13 observations (See chapter 4, table 4.1). 
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3.6.1.7  The process of data collection 
 
• Sources of data 
 
As there was little information regarding the formal integration of these three items (DM, 
HIV and pregnancy care), the researcher in this study collected a primary information 
using interviews and focus groups involving the experts, HCWs and the patients 
themselves. Hence, the recorded IDI & FGD, the field notes from the observations and 
the written memos were the sources of data. 
 
•  Phase I data collection 
 
Data were collected by the researcher using IDI and FGD. The HIV, DM or ANC 
programs managers took part in the face-to-face IDI while other program officer and 
other clinicians were brought together for the FGD. The introductory statement during 
the IDI and FGD was; 
“I am Zewdu Gashu Dememew. I am a student at UNISA. Thank you for taking 
your time to take part in FGD/IDI. I am a principal investigator of this study. This 
is a discussion on the integration service related to HIV, DM and pregnancy care. 
There is no right or wrong answer. You are free to withdraw from interview any 
time in the middle of the interview should there is any inconvenience. Is that 
clear? So, I will start the interview.” 
 
The study participants were interviewed through the local language, Amharic. The 
interviews were recorded, except in one case where consent was refused and the 
researcher only took notes.  
• Topic guide 
 
The interview guide was drafted for both the IDI and FGD based on the integrated 
theoretical framework. After 2 IDIs and 1 FGD, it was modified especially the sequence 
and the probing questions (Annexure H). 
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• Data collection at the federal ministry of health (FMOH) 
 
Participant observation and interview were carried out. The researcher undertook an 
interview with the team leader and the officer of NCD unit. Both of them were males. 
The same visit was paid to HIV/AIDS prevention and control office (HAPCO) and MCH 
unit and observation was done where a female officer gave information on the 
collaboration and coordination activities. Field notes were taken after the visit to these 
units at FMOH.  
 
Key Notes: 
1. HAPCO is the office at federal ministry level that is responsible for the national 
prevention, care, treatment and support of HIV/AIDS. At the region and sub-cities, 
the structure that can handle HIV/AIDS is under disease promotion and disease 
prevention (DPDP) core process. There are also sub-cities that has standalone HIV 
unit focusing on the prevention while the care and treatment of HIV is under the core 
process of medical service. 
2. Family health is the unit at federal, region and sub-cities that addresses MCH. 
PMTCT, ant-natal care and family planning are under this unit. 
3. Non-communicable diseases unit at federal regional and sub-cities is a unit that 
concerns with all kinds of cancers, DM, HPN, cardiac illnesses, chronic renal 
problems, liver diseases and other similar disease. NCD is under the medical 
service core process with a focal person at regional health bureaus and some cities. 
However, there are sub-cities where NCD is under the disease promotion and 
disease prevention core process. 
• Data collection at Addis Ababa regional health bureau 
 
Three IDIs were conducted with participants each from the HIV, NCD and pregnancy 
care in the family health unit. Two of the participants were females; aged 37 years and 
45 years; and were a family health officer and the HIV focal person respectively. The 
third was a 38 years old male who was a  program manager of the NCD unit in the 
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RHB. The IDIs took approximately 30-45 minutes. One FGD was udertaken with 6 
experts, 2 each from the three units. 
• Data collection at the sub-cities 
 
Three sub-cities were involved to conduct IDIs and FGDs. Three IDIs were conducted 
with a 45 years old female HIV focal person, 50 years old female family health officer, 
and a 46 years old female NCD focal person. One FGD was conducted with a group 
containing 6 members; two from HIV unit (male 35 years and female 36 years), two 
from family health unit (36 years old female team leader, 35 years male officer) and 
another two from NCD (29 years female  team leader and 37 male NCD officer).The 
IDIs took approximately 25- 40 minutes while the FGD took 45 - 60 minutes. 
• Data collection at health facilities 
 
Five IDIs and 05 FGDs were conducted at six health facilities. The IDIs was conducted 
with officers from HIV (Female, 46 years; and male 23 years), NCD (Two females, 26 
years; 40 years) and ANC unit (Male, 25years; female 35 years) . The IDIs took 25-45 
minutes. The FGDs took 45-85 minutes each, with 6-8 individuals involved. 
• Participant observation 
 
Prior to the appointment for the IDIs and FGDs, observation was performed at regions, 
sub-cities and health facilities. Memo and field notes were captured. During the 
observation the coordination, collaboration and referral linkage among NCD, HIV and 
maternal health  or ANC, integration behaviors of the HCWs were the focus area. The 
observation tried to address the administrative structure where HIV, DM and pregnancy 
care were included. An example of observation was done where a young female officer 
was giving information on the collaboration and coordination activities. Observation field 
notes were written after the visit to these units.An observation took a duration of 20-35 
minutes.  
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TABLE 3.1: SUMMARY OF DATA COLLECTION LEVELS AND METHODS USED 
Level of 
data 
collection 
FGD IDI  
Observation ( and 
Informal interview/ 
participant observation) 
 
Checklist/Questionaries’ 
(Quantitative: ANC, 
DM, HIV/ART data) 
Health 
facilities 
 Summit 
health center 
(HC) (6#) 
 Woreda 19 
Kolfe keranio  
HC (7) 
 Goro HC (8):  
 GMH (6), 
 ZMH (7) 
 Lafto HC W-12, 
HIV (1) 
 Woreda-12 nefas 
silk Lafto HC, ANC 
(1) 
 Woreda-9 Kolfe 
Keranio HC, HIV 
(1) 
 GMH, MCH (1) 
 ZMH, NCD (1) 
 
5 Observations 
 
 Gandi memorial 
hospital (GMH), 
 Zewditu Memorial 
Hospital (ZMH), 
 Woreda -19 kolfe 
keranio  health 
centre (HC), 
 Woreda-12 Nefas-
silk,  
 Goro HC, and  
 Summit HC 
Sub-cities  Nefas silk 
Lafto sub-city 
(6) 
 Bole-HIV (1), 
 Bole-MCH (1), 
 Kolfe keranio-MCH (1) 
3  observations 
 
 
RHB  AACHB (6)  NCD/DM (1) 
 MCH (1) 
 HIV officer (1) 
1 observation 
 
 
FMOH 
 
  Done  at 
 HAPCO (once) 
 MCH (once) 
 NCD/DM (once) 
 
 
Total  7 FGD 11 IDI 13 observations  
 
# Numbers in the brackets after the name of study health facility, region or sub-city show the number of participants involved in the IDI and FGD. 
• Concerns and challenges during the data colleciton  
 
During the conducts of interview and discussions, the following issues and challenges 
were encountered: 
1. The need to have FGD at sub-cities and the region was noted to be vital to 
appreciate the group dynamics. This was done accordingly. The initial proposal 
was to carry out only IDIs at sub-cities and region and FGD at health facilities. 
2. A fewer numbers of FGD participants due to working hours, 6-8 participants per 
FGD. The discussion was carried out during the “free and non-rushing hours”, 
after 3:00 pm in the afternoon yet a fewer clinicians were involved.  The 
interviews were also made at the end of the mornings before lunch where the 
participants might be exhaustive to fully show their ideas.   
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3. The interview was done in the office, at ART, ANC or NCD. The interview in the 
afternoon was with the assumption of little workload. Nevertheless, there were 
occasions where clients in need of the service were knocking or opening the door 
interrupting the interview. Other staff member in need of the interviewer were 
also interrupting the interview process                                                
4. The challenge of getting enough time, HCW and patients in private health 
facilities due to the working nature of the facility (profit making) where they 
wanted to keep the privacy of the their clients. It was also difficult to get a room 
or an office for the IDI and FGD, and the difficulty of appointing the busy HCW 
and experts working in the private health facilities. Hence, the private health 
facilities were left out. To compensate for the left out private health facilities, 
three public health facilities were added after re-requesting the IRB’s of Addis 
Ababa ethical clearance committee. 
5. At the federal ministry level, data collection using formal IDI and FGD could not 
be carried out. This is because the Addis Ababa city IRB could not write a 
support letter to the federal ministry of health. This is because; structurally, 
FMOH is not accountable for Addis Ababa. However, informal observation and 
interviews were carried out regarding the coordination, collaboration and the 
structure regarding the DM, HIV and pregnancy care services at federal level. 
                      
6. The researcher used the mobile phone to record the interview. In one FGD and 
two IDIs, the sound of the incoming calls interrupted the recording and affected 
the discussion or interviews. 
3.6.1.8  Coding and analysis 
 
Coding is attaching labels to segment of data that depicts what each segment means 
(Thornberg & Charmaz 2014:159). During the coding process, according to Thornberg 
and Charmaz (2014:160), the researcher interrogated the data to identify units of 
analysis (categories). Interviews and discussions were made using the widely spoken 
Amharic langauge. However, the translation was done while transcribing the audio 
recorded data.  Initially, the researcher familiarized himself with the data through 
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listening to all audio records; then reading and rereading of transcripts before coding 
and categorizing.The researchers used an iterative approach to analyse IDI  and FGD.  
Field noted for observation was written using English langauge.The field noted and 
memo of the obsrevation were coded, categirized and put to similar theme This allowed 
pursuing emergent themes in subsequent data collection. In this study, key points in 
each interview were highlighted. The researcher gave each key point a code to describe 
the data. The codes  revealed patterns across the data and then grouped the patterns 
into categories. Each category was given a title. New codes and sub-categories 
emerged as themes.  
3.6.1.9 Rigor in qualitative research 
 
In qualitative research, rigor is associated with openness, adherence to a philosophical 
perspective, thoroughness in collecting data and thoroughness in the consideration of 
all the data. Evaluation of the rigor of a qualitative study is based upon the logic of the 
emerging theory and the clarity with which it sheds light on the phenomenon under 
investigation (Polit & Beck 2017: 557 & 747). To enhance the trustworthiness of the 
qualitative part of this study, the researcher used the criteria formulated by Lincoln and 
Guba (1986:73) namely, credibility, transferability, dependability and confirmability. 
 
• Credibility 
 
The credibility of the research can be improved through triangulation. Triangulation 
enriches understanding of a phenomenon by viewing from different perspectives. It 
ensures that different sources and mixed methods lead to similar results. Triangulation 
ensures credibility through cross-checking two or more sources and methods (Lincoln 
and Guba 1986:73-74). In this study, findings from observation, IDI and FGD were 
triangulated and interpreted. Member checks were used to address credibility by asking 
the HCWs and program managers of DM, HIV and maternal health to review the 
researchers' interpretation of that interview and observation. 
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Additionally, DeForge (2010:125-126) describes triangulation as the use of multiple 
references to draw conclusions about what constitutes the truth. Triangulation can 
involve the use of different data collection tools with the same sample of participants, 
different qualitative methodologies to answer the same research question (Clark and 
Creswell 2015:490). As applied to this study, to describe and explore about the level 
and domain of HIV, DM and pregnancy care integration, both observation and interview 
were applied. At the end, findings from observation and interview were triangulated, 
interpreted and discussed together. 
 
Data triangulation - involves the use of multiple data sources in the study in order to get 
diverse views to aid in validating the conclusions (Creswell et al 2011:2103; Mateo and 
Foreman 2013:293). HIV, DM or pregnant women, and health providers and program 
managers of DM, HIV and maternal health were different data sources used in the 
qualitative part of this research. 
 
• Transferability 
 
This is the degree of similarity between the original situation and the situation to which it 
is transferred. According to Lincoln and Guba (1986:74-75), purposive sampling helps 
to ensure transferability. In this research, transferability was addressed by using 
purposive sampling of HCWs and program managers. In purposive sampling, specific 
information is maximized in relation to the context in which the data collection occurs. 
The aim of this study was not generalizing the finding to another setting as it was 
carried out in only 06 health care facilities. The transferability of this study depends on 
the future studies in similar contexts.  
 
• Dependability 
 
Dependability examines both the process and the product of the research for 
consistence (Mateo &Foreman 2013:193). In this research, dependability was ensured 
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by the employment of “overlapping methods”. That is, the level of DM/HIV integration 
with pregnancy care was looked into during the qualitative data collection. 
 
• Confirmability 
 
This relies on interpretation and is admitted value-bound. It reduces the influence of the 
researcher’s thoughts, hence reduces a degree of bias (Polit & Beck 2017:723). To 
reduce the distance between the interviewee and interviewer, the finding of this study 
were supported by evidence from different literature. In addition to the extensive 
literature review, confirmability was ensured by the seeking a critic from experts in the 
field of DM, HIV and maternal health during the evaluation of the model developed. 
3.6.2 Research methods for quantitative approach (phase II) 
 
3.6.2.1 The study setting 
 
According to Streubert and Carpenter (2011:27), setting is a place where the 
phenomenon of interest actually exists. The setting can be homes, health facility, 
community or sites selected (Streubert & Carpenter 2011:28).   
• Addis Ababa 
 
Addis Ababa is a dominant political, economic, cultural and historical city of the country 
established in 1887 by emperor Menilik II. It has the status of both city and state. It is 
the capital of the federal government of Ethiopia. The African Union is based in Addis 
Ababa. The city also hosts the headquarters of the United Nations Economic 
Commission for Africa (UNECA) and other continental and international organizations. 
The city is divided into ten sub-cities which are the second administrative units next to 
city administration. 
According to Central Statistical Agency of Ethiopia (CSA) (2007:17), Addis Ababa 
harbours about 3 million people. Altogether, there are 52 hospitals in the metropolis of 
which 6 are owned by Addis Ababa City Administration Health Bureau (AACAHB), 5 by 
the federal ministry of health, 2 by non-governmetal organizations (NGOs), 3 by 
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Defence and Police and the remaining 36 by the private owners. There are also 100 
health centres owned by the city administration. Furthermore, there are an estimated 
760 private clinics in the city (Addis Health 2013:32). 
 
A total of 82 health facilities is providing ART services in Addis Ababa, of which 60 are 
public, 16 private and 6 are non-governmental facilities (FDRE 2014:43-44). In these 
facilities 124,983 people living with HIV/AIDS were enrolled into care. About 76,035 
patients started ART of which only 49,807 are currently on ART (Addis Health 2013:32). 
During the current research, the researcher obtained the list of all public health facilities 
in Addis Ababa. Then, the health facilities were stratified as health centers and  
hospitals providing HIV, DM and ANC services. Of these, 04 health centers and 02 
public hospitals were randomly selected.  
3.6.2.2 Research population 
 
A population refers to the entire individuals in the certain group that has common 
binding characteristics to be studied (Babbie 2008:211). It is from this large population 
that a sample is drawn to make an inference about the population. LoBiondo-Wood and 
Haber (2014:232) described a population as an entire aggregate of care in which a 
research is interested. In this study, these were individuals with HIV, DM and ANC care 
and follow up in Addis Ababa. 
 
• Target population 
 
These are parts of cases about which an investigator wants to generalize (LoBiondo-
Woodand & Haber 2014:233). Target population is also known as theoretical 
population. According to Polit and Beck (2017:250), it’s an entire group of individuals or 
objects to which researchers are interested in generalizing the conclusion. In this 
research, diabetes and HIV infected female patients with a childbearing age on care in 
public health facilities of Addis Ababa city, and those mothers on ANC follow up were 
the population of interest. 
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• Accessible population 
 
They are also called study or source population and are the subset of target population 
to which the researchers can apply their conclusion. It is from here that one draws a 
sample (LoBiondo-Wood and Haber 2014:233). Diabetic and HIV infected patients 
within reproductive age groups and those attending ANC at a selected 06 health 
facilities in Addis Ababa were approached to obtain information during the period of 
data collection. 
3.6.2.3 Sample and Sampling Techniques 
 
In the HIV, DM and pregnancy care study a random sampling applied after stratifying 
the diabetic and HIV infected patients based on their gender where only the female 
patients in the reproductive age group were select as the study participants. Random 
sample relates to a randomly selected sample from a population.  A random sample is 
assumed to be a representative of the larger population. Therefore, every member of 
the study participants in this study was independently chosen and has equal non-zero 
chance of being selected into the sample (Babbie 2008:212).  
 
• Sampling frame 
 
Polit and Beck (2017: 334) defined sampling frame as ‘’a list of all the elements in the 
population from which the sample is drawn’’. In this study the framework was all lists of 
HIV infected, diabetic and pregnant mothers in care who fulfil the eligibility criteria in the 
study health facilities. 
 
A sampling frame was prepared from patients’ list that was appointed to care on the 
dates of data collection. The date of appointment for each patient was electronically 
registered in the computer at HIV clinic and manually documented at DM and ANC 
units. It was from patients’ appointment list that random table was produced. Study 
participants were selected randomly from the table using the lottery methods in the Exel 
after stratifying based on their gender. Therefore, a probability sampling was used. The 
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probability sampling forms a basis of random sampling (Babbie 2008:224). In this case, 
individuals in sampling frame would have an equal chance of being chosen (Bonita, 
Beaglehole and Kjellström 2006: 51). 
• Eligibility criteria 
 
Eligibility criteria are criteria set by the researcher to define the target population 
included in the study. Inclusion criteria are the characteristics of a person to include in 
the study based on specific criteria (LoBiondo-Wood & Haber 2014:233). Those criteria 
that ruled out certain population not to be participated in the study because of they do 
not possess or meet the inclusion criteria are called exclusion criteria (Polit & Beck 
2017:231). 
 
Inclusion criteria: Health facilities with ART, DM and anti-natal care (ANC) services 
since 2011 were part of the study site. Study participants were females, in a 
childbearing age of 18-49 years, who have already enrolled to DM and HIV care during 
2011-2016 and those in ANC care during the data collection. They should have 
confirmed HIV and DM have at least one visit in the last three months before data 
collection. Only data of documented and confirmed pregnant mothers was abstracted at 
ANC.  
 
Exclusion criteria: Severely sick patients who cannot give consent during interviewing 
and patient with incomplete information in the register were excluded from the study. 
Women with age over 49 years, in whom pregnancy is rare, were excluded.  
 
• Sample Size 
 
The sample size determination for HIV infected mothers was based on the assumption 
of the prevalence rate of diabetes mellitus and the pregnancy rate among HIV positives 
in the previous studies (see table 3.2). The sample size determination for diabetes 
mellitus was based on the 10% pregnancy rate among diabetes mellitus women. These 
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assumptions are with a 5% margin of error and 95% confidence interval (alpha=0.05). A 
non-response rate was assumed to be 20%. It was also assumed that the population of 
DM and HIV infected is large and unknown. Thus, the actual sample size for each 
objective was determined using a formula for a single population proportion (Daniel 
2009:192). 
 
N= (Z /2) 2 p (1-p) 
d2 
Where: 
N=the required sample size 
Z= standard score corresponding to 95% CI 
p= Assumed proportion of DM, pregnancy outcome 
d= the margin of error 5% 
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TABLE 3.2: SAMPLE SIZE CALCULATION BASED ON THE OBJECTIVES OF PHASE II STUDY 
Ser.  
No 
Objectives 
Assumed 
power and 
confidence 
level 
Assumed 
prevalence 
rates 
Computed 
sample 
size 
20% non- 
respondent 
rate 
Total sample 
size for 
prevalence 
rate  study  
1 
To determine prevalence of DM among 
HIV patients among childbearing female 
registered during 2011-1016 in Addis 
Ababa health facilities 
Power=90%, 
Confidence 
level=. 95 
0.34 (IDF 
2015:70) 
345 69 
414 HIV 
+mothers 
2 
To determine the prevalence of 
pregnancy among HIV childbearing 
female registered during  2011-1016 in 
Addis Ababa health facilities 
Power=90%, 
Confidence 
level=. 96 
0.32 (Degife 
et al 
2013:S34) 
334 67 
401 HIV+ 
mothers 
3 
To determine the prevalence of 
pregnancy among DM childbearing 
female registered during  2011-1016 in 
Addis Ababa health facilities 
Power=90%, 
Confidence 
level=. 97 
0.1 138 28 
166 diabetic 
mothers 
4 
To determine the prevalence of adverse 
pregnancy outcomes among HIV  
childbearing females registered during 
2011-1016 in Addis Ababa health 
facilities 
Power=90%, 
Confidence 
level=. 98 
0.68  
(Adaneet al 
2014:90) 
334 67 
401 HIV+ 
mothers 
5 
To determine the prevalence of adverse 
pregnancy outcomes among DM 
childbearing females registered during 
2011-1016 in Addis Ababa health 
facilities 
Power=90%, 
Confidence 
level=. 99 
0.1 138 28 
166 diabetic 
mothers 
6 
To describe mothers with a documented 
HIV and DM services at ANC clinics in 
Addis Ababa health facilities 
Power=90%, 
Confidence 
level=. 99 
0.2 300 57 
357 pregnant 
ANC 
attendants 
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3.6.2.4 Procedure of enrollment and sampling  
 
The sampling frame was prepared from the appointed clients on the specified date of 
data collection. In the study health facilities, there was a register database installed on 
the computer. All the patients’ information is available from this registration database, 
including the date of the appointment of the patients. Thus, those clients who would be 
coming on a certain date could easily be listed early in the morning of the date of 
appointment. This is a routine activity of every ART clinic. However, this was manually 
done at the ANC and DM clinics. In all clinics, the list was made based on their medical 
registration number and sex. It was from this sample frame that the participants were 
randomly selected using excel in the computer. The randomly selected DM, HIV 
infected and pregnant mothers on ANC follow up were approached till the intended 
amount of sample was selected. 
3.6.2.5 Development of data collection instruments and data collection 
procedures 
 
According to Polit and Beck (2017:266) data collection refers to ways to which 
information can be obtained systematically to answer the research question. According 
to LoBiondo-Wood and Haber (2014:273), data collection is a crucial stage in the 
planning as well as during conducting the study. Data collection tools in pragmatic 
paradigm use both from post-positivist and interpretivism paradigm (Polit & Beck 
2017:577). In this research, the draft data abstraction checklist and questionnaire was 
developed based on the integration theoretical frame with its different levels of domains; 
functional, organizational, and service or clinical integration (Uyei et al 2014:42).  
 
• Development of data collection instruments 
 
Babbie (2008:272) described data abstraction questionnaire as a document containing 
the questions and other types of items designed to solicit information appropriate for 
analysis. Though producing a high quality structured data collection instrument is 
challenging and time taking, research requirements must be analysed, related construct 
68 
 
needs to be clustered into a separate area of questions and the instruments must be 
done to reduce bias (Polit & Beck 2017:302). In this research, data abstraction and the 
questionnaire was drafted based on relevant literature on the phenomenon under study 
with due consideration of the research problem and the research question. It was further 
refined and enriched after the qualitative study finding in phase II of this study.  To 
ensure the reliability and full capture of information, thorough conceptualization and 
operationalization of the construct was carried out.  
 
The conceptualization in this study mainly came from the exhaustive literature review, 
specifically the integrated theory by Leutz (1999) and systemic review of TB/HIV 
integration study in South Africa by Uyei et al (2014). The data abstraction and 
questionnaire was prepared in English and then translated to the Amharic. Prior to data 
collection, the data abstraction and questionnaire was reviewed by experts that were 
epidemiologists, statcians, researchers and program officers who had at least mater 
level of educational levels. It was also pretested on a total of 15 participants (5 HIV, 4 
DM and 6 ANC attendant females) who did not form part of the sample for this study. 
Redundant items were avoided. For instance, items used to determine the level of 
integration was supposed to be the fourth section of the data collection part. This 
information was also part of the other section of the data abstraction and questionnaire 
and was not used (see Annexure F). 
• Characteristics of the data collection instrument 
 
The data abstraction and questionnaire was close-ended. Close-ended questions 
provide a greater uniformity of responses and are more easily processed than open-
ended ones (Babbie 2008:272). To ensure the standardized recording, accuracy and 
usefulness of the data for data analysis (Polit & Beck 2017:314), each category on the 
instrument was assigned a numeric value and responses were coded. The data 
collection tool was named ‘data abstraction checklist and questionnaire’ because one 
data collection tool was used to obtain data from patients medical file and register and 
from the interview of patients’ themselves. There were medical data, such as clinical 
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complications and pregnancy outcomes, which needed to be extracted from their files 
and register. The patients’ current information, such as socio-demographic and family 
history of DM, should have obtained from the patients themselves. Hence, this is one 
tool serving as abstraction and questionnaire and hence the name ‘data abstraction 
checklist and questionnaire’. Three data collecting tools were prepared for HIV infected, 
diabetic and ANC attendant females (see Annexure E) 
 
• Methods of data collection 
 
The structured data collection is obtaining data by formal instruments and protocols that 
dictate what to collect and how to collect and record the needed information (Babbie 
2008:278; Polit & Beck 2017:297).  In phase II of the study, structured data abstraction 
checklist was utilized to collect data on pregnancy, adverse pregnancy outcomes, 
documented HIV, diabetes and pregnancy counselling and testing services. The tool 
was refined based on the findings from a phase I study. Diabetic and HIV infected 
female patients were approached and interviewed to obtain additional information from 
the study participants and to countercheck key information from the abstraction 
checklist. This helped to have an accurate, valid and interpretable data, responding to 
the research question (Polit & Beck 2017:297). The structured data collection was 
applied to collect very precise information. (Burns & Grove 2013:507; Polit & Beck 
2017:298). In this study, numerical data were collected with the same structured plan 
implemented in all study health facilities. By doing so, all data were collected in similar 
way (Polit & Beck 2017:301). The quantitative data was collected by the trained 
clinicians at the health facilities and the researcher himslef. It took 5-10 minutes per the 
clients and  upto 30-40 mintures incldung the abstraction of the clients’ files. It was 
structured and face –to-face interview that was performed. 
 
• Data collection procedures  
  
The researcher served as the data collector. The following is the summary of procedure 
that was followed during the data collection. 
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a) After the UNISA and Addis Ababa city administrative ethical committee 
approved the research protocol, a support letter was sought and written to the 
health facilities requesting permission to conduct the study. The letter indicated 
the need to access HIV, DM and ANC attendants’ files and registers, and to 
interview the patients as part of the study. 
b) Each HIVor DM patients and mothers having a follow up at ANC was 
approached and asked for a written consent for the interview and to access to 
their files and clinical information. 
c) Data abstraction of the clinical information from the files of those patients who 
gave the written consent and fulfilled the inclusion and exclusion criteria was 
conducted. 
d) The data were obtained from DM, HIV and ANC attendants’ files. DM, ART, 
delivery and ANC registers were looked into for the abstraction. 
e) A structured interview was conducted to counter-check some information 
during data abstraction and to obtain additional data.  
3.6.2.6 Validity and reliability of measurement in quantitative research 
 
Validity and reliability are the two important technical considerations used to evaluate a 
research instrument in terms of adequacy and quality (Babbie 2008:157; Burns & Grove 
2013:393 & 394). 
 
• Reliability of a measurement 
 
LoBiondo-Wood and Haber (2014:290) describes reliability, as the ability of an 
instrument to measure the attributes of a variable or construct consistently. As stated by 
Burns and Grove (213:389) reliable instrument enhances the power of a study to detect 
a significant difference or relationship occurring in the study population. Thus, 
responses to a question would give same data in repeated observations (Babbie 
2008:157).  
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LoBiondo-Wood and Haber (2014:291) mentioned the following techniques for 
increasing the reliabilities of a measurement and reducing the likelihood of 
measurement error or bias due to random factors. 
 
i). Administration of standardized instruments: this allows the occurrence of 
measurements consistently across all participants. In this research a uniform data 
abstraction was conducted all over (Burn & Grove 2013:390). HIV and DM patients 
themselves were interviewed to counter check some information with data extraction 
checklist for the purpose of consistency. Also, quality assurance checks for outliers, 
consistency and duplicates were carried out before data analysis. 
ii). Making sure that the instructions and the content of the instrument are well 
understood. This would easily avoid bias. In this research, clarity on the questions in the 
data abstraction and the questionnaire were dealt with during the orientation of the 
research, pre-testing and data collection process. The specificity was given an 
emphasis to each question. 
iii). Training of researchers or data collectors in the use of the instruments. Ample 
practice and repeated training over the course of the study to maintain consistency is 
critical. The researcher practiced the data collection process before the real data 
collection. That means, the data extraction checklist was pretested prior to the study. 
The supervision was done by the researcher. Though the researcher was also collecting 
data, assistant data collectors were recruited in the health facilities after orienting on the 
purpose of the researcher and the data collection instruments for the quantitative data. 
iv). Ensuring that data are recoded, compiled and analysed accurately. Data entry 
should be closely monitored and audits should be conducted regularly (Babbie 
2008:159). In this study, there was a continual monitoring and supervision during data 
abstraction and face-to-face interview during the quantitative data collection to ensure 
that the researcher coded data accurately and in a timely manner. 
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• Validity of a measurement 
 
Validity is what the test or measurement strategy measures and how well it does so 
(Burns & Grove 2013:393). The same authors indicate that validity seeks to answer the 
question: “Does the instrument or measurement approach measure what it is supposed 
to measure?” The concept addresses the appropriateness, meaningfulness and 
usefulness of the specific inference made from instrument scores (Burns & Grove 
2013:394). Validity has to do with truth, strength and value. It can be inferred that if the 
measurement of the concepts improves then validity also improves by reducing 
systematic error. 
 
According to LoBiondo-Wood and Haber (2014:292) content validity starts with the 
development of questionnaires where experts have to review for appropriateness, 
accuracy and representativeness. The experts were epidemiologist , statistician and 
three program managers with masters level of education. Based on the 4 scale rating of 
the experts (or likert scale), the instrument could be 1 not relevant, 2 need 
modifications, 3 relevant, but need minor modification, or 4 very relevant and succinct. 
As the determination of content validity starts with operationalization of the construct of 
instrument (LoBiondo-Wood & Haber 2014:292); the DM, HIV & pregnancy care study 
had both conceptual and operational definitions based on the literature review and 
integration theory. That is, the study variables are operationalized so that the underlying 
theme of the study should have a strong conceptual basis and well validated constructs 
(Burns & Grove 2013:217-219). Thus, it accurately captures the content from the 
construct. 
 
In this study, the development of the data abstraction and the questionnaire wase 
preceded by extensive literature review, and further revised by experts who gave their 
comments by rating and modified per their comment. The data abstraction and 
questionnaires was translated to Amharic and back to English with the assistance of 
language experts. 
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3.6.2.7 Data analysis 
 
Babbie (2008:443) defined a quantitative analysis as ‘’the numeric representation and 
manipulation of observation for the purpose of describing and exploring the phenomena 
that those observations reflect’’. According to Marczyk, DeMatteo and Festinger 
(2005:198) the process of data analysis involves data preparation and management; 
analysis of the data; and interpreting the data; testing the research hypothesis and 
drawing valid inference. 
 
• Data preparation and management 
 
In addition to ensuring the confidentiality and security of personal data, Tappen 
(2015:283-284) suggests that the researcher should able to track and enter the data, 
and organize the data into a database. Setting up a data, recruitment and tracking 
system on a computer database provides with up to date information throughout the 
study, saves time and easily be ready for analysis (Tappen 2015:288). Data checking or 
screening can be done manually or electronically (Marczyk,et al 2005: 200) to ensure 
data accuracy and completeness (Tappen 2015:297). In this study manual data 
checking was done soon after the data was abstracted to screen for plausible ranges; 
for instance of age, implausible codes for gestational age.  In case of inaccuracy, 
medical records were re-abstracted or study participants were contacted again. Further 
data screening was done in the DM, HIV & pregnancy care study to ensure that 
responses were legible and understandable; within acceptable ranges, complete and 
accurate. 
 
After corrections were made through data screening, data were entered into a well-
structured database. In this study, the Epi-info version 3.5.3 of 2011 was used to 
prepare the data entry format from pre-tested data abstraction and questionnaires. With 
the inclusion of names, descriptions and abbreviations of the variables codebook was 
developed before initiation of data collection.  To ensure the accuracy of data entry, 
double entry was applied. Here, data were entered into the database twice and then 
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compared to determine whether there were any discrepancies. Two data entry clerks 
were recruited and involved in the data entry and cleaning. One carried out the primary 
data entry and the second person did the second data entry and cleaning 
 
After this double data entry, each abstracted data and questionnaire were stored in 
folders per the name of the health facility. The data were stored in a personal computer. 
Second copy of data  were filed as a backup data on CD-ROM. At the end of the data 
entry, the original data were coded for safeguard, as recommended by Burns and Grove 
(2013:452). Epi –info statistical package of 2011 was used which assisted in ignoring 
cases in which variables are missing. Before analysis, variables were checked for 
normal distribution in order to avoid overestimation (Type I error) by examining 
skewness (Marczyk, et al  2005:205). 
 
• Analysis of data analysis 
 
Once the data were screened, entered, cleaned and coded; it was easy for analysis. 
Frequency distribution in a frequency tables were used to describe variables in this 
study. Categorical variables were summarized by numbers and percentage. Numerical 
variables such as age and  number of births etc. were summarized using means, 
median and mode based on the symmetry of the data (Polit & Beck 2017:721). Means, 
ranges, quintiles, variance and standard deviations were used for variables such as 
gestational age. In addition to table, graphic displays of the variables were applied for 
description in this study. The proportion test (with p-value less than 0.05 as significant) 
was also used to compare two proporitons such as prevalence of pregnancy and 
pregnancy outcome between DM and HIV, ANC attendant pregnant mothers and DM, 
and HIV and ANC attendant pregnant mothers. The findings are presented in chapter 4. 
 
3.7 ETHICAL CONSIDERATION  
 
Research ethics is associated with morality governing research from inception to 
completion and publication of results (Babbie 2008:66-67). The trust in research results 
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in the trust in the integrity of researchers and the reliability of the result of their scientific 
works. Thus, if science is to remain trustworthy, researchers must observe basic moral 
principles (Rivera & Borasky 2009: 5-6). 
3.7.1 Fundamental Principles of Human Research Ethics 
 
There are three basic ethical principles that guide all research involving human subject. 
These are respect for person, beneficence and justice (Rivera & Borasky 2009: 5-9). 
3.7.1.1 Respect for person 
 
Respect for person involves autonomy and privacy, self-determination, confidentiality, 
the capacity to decide, make a choice, the dignity of people and the individuals (Rivera 
& Borasky 2009: 5). Sigh (2007:32) described the two moral requirements of respect for 
persons; the need to acknowledge autonomy and the requirement to protect those with 
diminished autonomy. Autonomy person, cited by Sigh (2007:32), is an individual 
capable of deliberating about personal goals and acting under the direction of such 
deliberation.  
 
To show respect is to give weight to autonomous persons’ opinions and choices. To 
deny individual respect is to show a lack of the freedom to act on considered judgments 
and withhold information necessary to make judgments when there is no reason to do 
so, according to Sigh (2007:32). In this study, it was with respect that study participants 
were approached. It was with their self –decision that they were part of the study. That 
means, the participants were made clear about the aim of the study and procedure of 
the data collection so that it was with their self-determination that they became part of 
the study. 
3.7.1.2 Privacy and anonymity 
 
There was a reasonable expectation of guaranteeing the privacy of study participants. 
So, there was no identifying information of individuals participating in this study that 
would be revealed in written or other means of communication. The interview questions 
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were coded with numbers rather than names. The information for the study was meant 
for academic purposes only, and therefore the information was shared with the 
supervisor of the study only. 
3.7.1.3 Confidentiality 
 
Information that would be given by interviewees was treated in a confidential manner so 
that the study participants were entitled to privacy of information. The information of the 
study participants was kept in the private or locked (with code) database. 
3.7.1.4 Beneficence 
 
Rivera & Borasky (2009:7) indicate that beneficence is risks reduced (non-mal-
efficiency) to ensure physical, mental and social well-being. As complementary 
expressions of beneficence, Sigh (2007:32) formulates two general rules of 
beneficence; maximizing possible benefits and minimizing possible harms. As this was 
an non-experimental study there was no risk of intervention to the study participants. 
The way the outcome of the study could be beneficial for HIV infected and DM patients 
and pregnant mothers was explained to them before the interview. 
3.7.1.5 Justice 
 
According to this principle, all research participants should be treated equitably (Sigh 
2007:33). Justice is also a fair recruitment of research participants and distribution of 
risks and benefits (Rivera & Borasky 2009: 9). This offers special protection for 
vulnerable groups. As this was not an intervention or experimental study, there was no 
major expected risk to study participants. However, as the disease entities were socially 
sensitive; specifically, HIV, stigma issue was potentially expected to deal with. Yet, all 
the ethical principles were strictly adhered to while approaching HCWs, program 
managers, officers,patients, accessing their files and conducting interviews. 
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3.7.1.6 Obtaining informed consent 
 
One of the foundations of research ethics is the idea of informed consent. Council for 
International Organizations of Medical Sciences and  World Health Organization 
(CIOMS/WHO) (2002) Guideline 4 stated the informed consent as: ‘’… for all biomedical 
research involving humans the investigator must obtain the voluntary informed consent 
of the prospective subject. A waiver of informed consent is to be regarded as 
uncommon and exceptional, and must in all cases be approved by an ethical review 
committee.’’ Accordingly, both UNISA and Addis Ababa ethical review comittees 
approved the written conscent form for this study. 
 
The individual has to receive the necessary information and should understand the 
information adequately and ought to arrive at a decision. S/he ought not to be subjected 
to coercion, undue influence or inducement or intimidation (Rivera & Borasky 2009:26; 
Sigh 2007:35).  In this study, essential information was addressed during the process of 
informed consent. These include the purpose of the research, the methods being used, 
the possible outcomes of the research, confidentiality, voluntary participation, 
associated demands, discomforts, inconveniences  as well as  risks that the participants 
may face (Nuffield Council on Bioethics 2005:11-15; Sigh  2007:35).  
Another component of informed consent is the principle that participants should be 
volunteers, taking part without having been coerced and deceived. (Nuffield Council on 
Bioethics 2005 11-15). During the interview process, in this research, the interviewees 
explicitly explained a person who may have access to the information. They were told 
that there was no penalty for refusal to participate. Rather, it was absolutely voluntary, 
with the right to discontinue at any time (Nuffield Council on Bioethics 2005 11-15; 
Rivera & Borasky 2009:37). 
 
In summary, during the interview and FGD, study participants’ informed written consent 
was sought and obtained for the interview, and to access to their medical record. 
The confidentiality of personal medical information was kept (Nufflied Council on 
Bioethics 2005:11-15; Sigh 2007:35). The study participants were explained to about 
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study purpose and significance. They were informed that it was their right to refuse to 
participate in the study any time (Nuffield Council Bioethics 2005:11-15; Rivera & 
Borasky 2009: 37). 
 
In this study the informed consent form was translated into local language, Amharic. It 
was pre-tested. Subjects were made to participate in the study only after they had read 
the statement for them and signed on it (Babbie 2008:47). 
3.7.1.7 The institution/site 
 
Guideline 2 of CIOMS/WHO (2002) states: ‘’ All proposals to conduct research involving 
human subjects must be submitted for review of their scientific merit and ethical 
acceptability to one or more scientific review and ethical review committees’’. The 
review committees must be independent of the research team, and any direct financial 
or other material benefit they may derive from the research should not be contingent on 
the outcome of their review. The investigator must obtain their approval or clearance 
before undertaking the research. The ethical review committee should conduct further 
reviews as necessary in the course of the research, including monitoring of the progress 
of the study.’’ Scientific review must consider the study design, including the provisions 
for avoiding or minimizing risk and for monitoring safety (Rivera & Borasky 2009:52). 
 
The initial review of research protocol was obtained from the Health Studies Research 
Ethics Committee (HSREC) of the Department of Health Studies at UNISA (REC-
012714-039). The committee approved the protocol after reviewing informed consent 
documentation and data collection instruments in addition to the research protocol (see 
Annexure J1).  
 
The approved protocol of this study was submitted to Institutes of Review Board (IRB) 
of the Addis Ababa Health Bureau for a complementary local scientific review and 
permission to conduct the study (see Annexure J2-J4). After ethical review was 
obtained from Addis Ababa IRB, then, permission letter to conduct letter from the 
regional health bureaus was obtained to communicate with the experts (DM, HIV & 
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maternal health) at regional health bureaus and sub-cities. The letter was written to the 
heads of study health facilities to observe the service delivery of HIV,DM and ANC and 
to access to records and registers of patients’ files as well as to interview the HCWs(see 
Annexure J3 & J4). In addition, study participants’ informed written consent was sought 
and obtained to access to their medical files, to participate in the interview and focus 
group discussion (see Annexure C & D). Throughout the process of the study, the 
supervisor of the study and the IRB committee monitored and confirmed that the 
protocol was followed as approved (Rivera & Borasky 2009:53). To effect this, the 
researcher reported and updated the progress and the process of the study every 
month until the end of the study. 
3.7.1.8 Scientific integrity of the research 
 
Research results might be influenced by conflict of interests and the publication of 
fabricated data (Bonita, et al 2006:59). To maintain scientific integrity and eliminate the 
possibility of scientific misconduct and plagiarism, the researcher in the HIV, DM and 
pregnancy care study followed the steps mentioned in Rivera & Borasky (2009:61). 
Hence, the researcher preserved primary data and documentation during the study. 
When citing ideas, words, processes, findings and results obtained by other authors, a 
clear reference was made to the respective sources. Important results which were 
contrary to the researchers’ results and conclusions were cited and discussed. Besides, 
the limitation of the research methods were recognized and properly documented and 
reported in chapter 6. 
 
• Scientific integrity on the part of the researchers 
 
Rivera and Borasky (2009:61) indicates that researchers are responsible for ensuring 
that no participant will be involved in the research before getting informed consent. The 
CIOMS guideline also states that the researcher has the duty to communicate to the 
prospective subject all the information necessary for adequate informed consent. Above 
all, the researcher had an obligation to protect the confidentiality of the study 
participants (Rivera & Borasky 2009:61). In this study, the researcher was honest to 
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accomplish the integrity of the research by adhering to study procedures, and by being 
transparent in the identification and management of conflict of interest (Rivera & 
Borasky 2009:60). 
3.8 CONCLUSION 
 
In this chapter, the study design and methods were discussed. The chapter also 
addressed ethical issues related to sampling and data collection. Study rigor and validity 
were dealt with as related to the study design. The next chapter, chapter 4, deals with 
description, triangulation and idscussion of the study findings. 
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  CHAPTER 4 
 
PRESENTATION, DESCRIPTION AND TRIANGULATION OF THE 
FINDINGS 
 
4.1 INTRODUCTION 
 
This chapter presents and describes the details of the findings in phase I and phase II . 
At end, the triangulation of the two findings is summarized and discussed. 
 
4.2 PHASE I 
 
The objectives of the phase I was to explore the functional, organizational and clinical 
integration of DM, HIV and pregnancy care service at  regional, sub city levels and 
health facility levels.  
In phase I of the study, the collection and analysis of qualitative data was carried out 
simultaneously. The data collection using IDI, FGD and observations was carried out at 
the administrative level (sub-cities, regional health bureau and FMOH). Also, the phase 
I undertook the IDI, FGD and observation at the selected health facilities of Addis Ababa 
city. 
 
4.3 PHASE II 
 
The objectives of the phase II were to: 
• describe pregnancy care and DM services at HIV, DM and HIV services at ANC, 
and pregnancy care and HIV services at DM clinics in Addis Ababa health 
facilities, 
• determine the prevalence rate of DM among HIV females of childbearing age 
enrolled in HIV care during 2011-2016 in Addis Ababa health facilities, 
• determine prevalence rate of pregnancy among HIV and DM childbearing age 
females enrolled to care during 2011-2016 in Addis Ababa health facilities 
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• determine prevalence rate of adverse events in pregnancy among HIV and DM 
childbearing females enrolled to care during 2011-2016 in Addis Ababa health 
facilities. 
 
Phase II dealt with the data collection using checklist and questionnaires. The data were 
collected from females in reproductive age groups attending ANC, HIV and NCD or DM 
(NCD/DM) clinics at the study health facilities. 
4.4 COMBINED FIDINGS OF FGDs, IDIs AND OBSERVATIONS 
 
Based on the aforementioned analysis, a total of seven themes were merged from the 
combined codes and categories from IDI, FGD and observation. Hence, guided by the 
domains of the integrated service, similar themes and categories were summarized in 
the table below (Table 4.1).  
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TABLE 4.1: SUMMARIZED FINDINGS FROM THE COMBINED FGDs, IDIs, AND ONSERVATION 
BASED ON THE DOMAINS OF INTGRAITON 
Domains Themes Category: FGD Category: IDI 
Category: 
Observation/field 
notes  
Functional 
1.Plan 
1. 1 One plan document  from higher level 
1.1 One  plan  document from 
FMOH and RHB 
1.3 Isolated planning 
process at FMOH  for 
HIV, MCH and NCD 
1.2 Woreda/District  based planning 
1.2 Woreda/District  based 
planning  
2. Budget 
  
2.1 A separate budget at core process  
2.1 The budget is for the core 
processes; of DPDP, medical 
service and family health.  
2.1 Isolate budgeting 
process 
2.2 No program based budget 
2.2 No earmarked budget for 
each program-for TB, HIV, 
NCD  
Organizational 
3.0 Monitoring 
system and 
information 
management 
 
 
 
 
 
3.1 A separate supportive supervision 
3.1 No program based 
supportive supervision 
3.1 A separate 
supportive supervision 
and monitoring. 
3.2 different supervision checklist 
3.2 Different supervision 
checklist  
  
3.3 Monitored intra-referral 
linkage  
3.4. HIV result registration at NCD clinic & 
ANC 
3.4 Separate  recording and 
reporting for NCD 
 
3.7 The NCD register 
does not have HIV 
screening or 
pregnancy testing 
result column 
3,5 s FP registration at HIV, not for DM 
screening/testing registration 
3.6 Absent   registration and reporting of 
DM at HIV  and ANC 
  
4.0 The structure 
and location of 
services 
4.2 Separate DM, HIV and pregnancy care 
service outlets 
4.2 Stand-alone HIV, ANC 
and NCD 
4.1 The structure of 
HIV, DM and 
pregnancy care   
Clinical integration-
structural integration 
5.Policy 
guideline, 
training manuals, 
protocols and 
algorisms  
5.1 Policy guidelines, protocols and 
algorism of joint service delivery 
5.1 Policy guidelines, 
protocols and algorism of joint 
service delivery 
5.1 Policy guidelines, 
protocols and algorism 
of joint service delivery 
5.2 Absent training manual 
combining DM, HIV and 
maternal care 
5.2  No training manual combining DM, HIV 
and maternal care 
Clinical integration-
process integration 
6.0 Integrated 
practice of  DM, 
HIV and 
pregnancy care 
service  
6.1 PMTCT (HIV service at ANC) 6.2 HIV service at DM 6.2 HIV service at DM 
6.3 Pregnancy care service  at HIV clinic  6.4 Pregnancy care at ANC  
6.5 DM service at HIV 6.5 DM services at HIV 6.5 DM service at HIV 
6.6  DM services at ANC 6.6  DM services at ANC 
6.6  DM services at 
ANC 
6.4  Pregnancy care at DM 
 6.7  Health care providers 
collaboration/linkage 
6.3 pregnancy care at 
DM 
clinical integration-
service delivery 
7.0 Suggested  
service 
7.1 Routine DM screening and diagnosis at 
HIV 
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(Suggestions) 
 
integrated 
approaches  7.2 Pregnancy care and FP service at HIV 
clinic    
7.3 Related service integration (One-stop-
shopping for related services) 7.4 One-stop-shop mentality  
7.5Policy  guideline and training manual 
7.5 Policy  guideline and 
training manual of integrated 
service 
 
 
  
7.4 Integration mentality of 
HCWs (One-stop shopping 
mentality) 
 
7.6Integrated monitoring: Joint supportive 
supervision, the feedback and supervision  
checklist  
7.6 Integrated monitoring 
system 
 
7.5 Policy guideline 
and training manual of 
integrated service 
 
Hence, under the four main domains of integration, seven main themes were identified. 
These are: 
Theme 1: Joint plan 
Theme 2: Shared budget 
Theme 3: Monitoring system and information management 
Theme 4: The structure and location of services 
Theme 5: Policy guideline, training manuals, protocols and algorisms  
Theme 6: The practice of an integrated DM, HIV and pregnancy care service delivery 
Theme 7: Suggested service integrated approaches  
 
The following section presents the themes and the categories. The description of each 
theme and categories is also supported by the field notes captured during the data 
collection and observations. This is again justified by the relevant quotes from the study 
participants. 
 
Theme 1: Joint plan 
 
Category 1.1: An integrated and joint plan  
A framework plan for all core process (Medical care, DPDP, family health, HPACO etc) 
comes from FMOH or RHB. The officers and the heads of each core process usually 
cascade their plan based on what has come from the higher up. The plan is a common 
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and comprehensive plan out of which the heads of the core process would take their 
own for the detailed plan related to family health (pregnancy care), DM & HIV. Though 
there is a joint planning, each program focuses on its own program related activities 
rather than the interrelated issues. During the interview one of the participants indicated: 
35, F, FGD, NCD unit:  “As an office, there is one planning… all core process 
will meet and there will be one joint and common planning. Then after, each core 
process will come up with their activities … Otherwise, as a health office (sub-city 
health office), there is one plan’’. 
 
Category 1.2 Woreda or district based planning 
 
The health offices in regions and sub-cities have one health plan. All core process meet 
for a common and comprehensive planning related to family health, DM & HIV, 
Tuberculosis, Malaria and others. The meeting is prepared at district level and it is 
named as a district or woreda based planning. The 34 years old HIV officer during the 
IDI in the Addis Ababa city health bureau (AACRHB) mentioned: 
34, F, IDI, HIV officer: “Yes, joint planning is done; there is what we call woreda 
based planning. This is a joint planning…ehee… (interrupted).” 
 
Similar to the federal or regional planning, each core process at sub-cities or districts 
focuses on the program based activities. It was observed that pregnancy care or DM 
team give an emphasis on the pregnancy care or DM. Issues binding HIV with DM or 
pregnancy care with DM are given little attention. It is named joint or common planning 
because the forum of planning is planned and cascaded simultaneously. Otherwise, 
there is little attention paid to the planning of cross-cutting issues among the programs 
or the units. 
 
In short, it was noted that at federal level, HIV, NCD and MCH unit are working 
differently. There was no integration of the plan at least in the cross cutting issues. Even 
though FMOH has one annual plan document for all units or program, the related 
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services are not put together during the planning process. For instance, NCD unit do 
plan on the DM, HPN, cancers and etc. It does not consider the related issue such as 
HIV or maternal health as related to DM.  
Theme 2: Budget allocation at federal level 
Category 2.1: A separate budget at core process 
At federal level, the budgeting exercise is done separately for HIV, NCD and MCH. 
There is no common budgeting. In fact, the ministry has one budget from where 
earmarked budget is allocated for each directorate or unit. For instance, the DPDP has 
its own budget where it allocates the earmarked budget for NCD unit, TB program, and 
malaria programs. In addition, the ministry allocates a budget for MCH unit or 
directorate where the unit assigns earmarked budget for maternal or child care. HAPCO 
is standalone office with its own plan and budget for one program, that is, HIV. 
The interviewers at the regions and sub cities mentioned that every core process has its 
own budget. Hence, the budget is allocated for the core process of DPDP core process 
(HIV), medical service (DM/NCD) core process and for family health (pregnancy care) 
core process. During the interview in a sub-city, this was described as: 
32, F, FGD, NCD officer:  “Regarding the budget, every core process has its 
own budget…The core process can utilize its own budget for any activity 
planned…” 
 
Category 2.2: No program based budget at regions and sub-cities  
There is no program based budget. That is, there was no mentioning of earmarked 
budget for each program of pregnancy care or ANC, HIV and DM or NCD. The 34 years 
old NCD focal person from AACRHB said: 
34, M, IDI, NCD team lead: “There is no a program budget. No assigned budget 
for each program;  for TB, HIV, NCD etc.The budget is for the core process of 
DPDP, curative and medical core process… for family planning. Otherwise, no 
budget …emhee…not for the program”. 
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However, it was noted that in sub-cities where HIV is an independent unit or core 
process, there is HIV related budget on HIV prevention actives. In others where HIV 
prevention is under DPDP and medical care of HIV/ADIS is under medical care core 
process, the budget allocation is for all activities under the core process, not only for 
HIV/AIDS care and support. 
 
One of the key challenges to integration of DM, HIV and pregnancy care services lies in 
the fact that both international funding and local government health structures still tend 
to be siloed separately (Kiersten, Varallyay and Ametepi 2012:09-10). For instance, 
PEPFAR, USAID and Global fund are the main source of budget for HIV; whereas, 
government budget are the financial source for NCD or maternal health. Besides, 
Malinda gate and Save the Children or UNICEF is the other financial source for 
maternal health.  Hence, such different source of fund need alignment for the success 
of integrative DM, HIV and pregnancy care services. The donor institutions have been 
equally slow to relinquish the vertical orientation of funding mechanisms for HIV and 
maternal health that may impede the efforts to integrate these services (Kiersten et al 
2012:10). 
 
Theme 3: Monitoring system and information management 
Category 3.1: No program based supportive supervision 
At the level of ministry, there was no joint supportive supervision (JSS) and joint 
mentoring. That is, there noted an isolated supportive supervision and monitoring. 
Besides, supervision and mentoring are vertical; HAPCO to HIV program, MCH unit to 
ANC and NCD unit to DM care and support units. 
The interviewers at the region and sub cities also reported a separate supportive 
supervision (SS). Each core process is doing the supportive supervision separately. The 
integrated supervision is undertaken occasionally when there is activity in need of joint 
monitoring. Otherwise, each core process does the monitoring of its own program. The 
feedback of the SS is also a discrete. The interviewers reported: 
88 
 
35, M, FGD, HIV officer: “During the supportive supervision, all the core 
processes are doing it separately…”  
35, F, FGD, FP officer: “Emee… feedback is given in separate. It is a separate 
feedback system.” 
The thinking that the core process under which HIV, DM and pregnancy care are 
assigned is different contributed for non-integrated and an isolated supportive 
supervision and monitoring. Same is true of the reporting system of these programs. 
This was supported by the following quotes during interview: 
F, 26, IDI, NCD officer: “I (NCD/DM officer) am under the medical service core 
process…HIV is standalone under the HIV/AIDS core process… Yes, we (NCD 
and HIV team lead or officers) are not going together (for supervision)” 
35, M, FGD,HIV Officer: “Yes, ehee…HIV has its own core process… same is 
true with reporting. Similarly, the unit reporting to me is the one that I am going 
to… (Door knocking)…. (silent)… and supervise”. 
35, F, FGD, family health officer: “There is a unit which is mainly dealing with 
pregnant mothers…that is, emee…regarding the mother it is up to the family 
health core process”. 
According to the officers and team leads, as long as the FMOH or RHB does not direct 
to do joint supportive supervision, they are not doing so. Hence, the officers or team 
leads at sub-cities and RHB were not mentoring or doing the supervision together.  
Category 3.2: Different supervision checklists  
The officers and team leads at all levels mentioned that not only is the supervision 
carried out separately, but also the supportive supervision checklist does not 
incorporate the related services of HIV, DM and pregnancy care. Pregnancy care or DM 
related item does not exist in the HIV supervision checklist. The supervision checklist of 
NCD does not have HIV or pregnancy care items. One of the interviewees indicated: 
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 45, F, IDI, HIV officer: “… there is no checklist alignment here…. at supportive 
supervision… eh?” 
Category 3.3: Monitored intra-referral linkage 
Even though there was rarely a joint supportive supervision, the study participants 
reported that the referral of patients from NCD to ANC, from NCD to HIV and from ANC 
to HIV is monitored during the assessment or the outreach joint activity using the 
internal referral forms. They looked at the referral papers to ensure the internal referral 
linkage. One of the officers explained: 
40, F, IDI, NCD officer: “We check… the internal referral …we looked at these 
papers (internal referral forms) what is being done at reproductive health on a 
mother. When we look at the referral papers we can assess how much we 
worked together.” 
Category 3.4: HIV service and pregnancy test result registration at NCD clinic  
The NCD register is prepared and being used in some selected hospitals. The register 
does not have HIV screening or pregnancy testing result recording column. However, 
there is HIV test result register at NCD clinic but registration for pregnancy care service. 
One of the interviewee described: 
46, F, FGD, NCD officer: “We might make a line (a column) by ourselves (on 
NCD register); otherwise, we do not have an isolated register (for pregnancy 
test)”. 
Category 3.5: Pregnancy care service registration at HIV  
There were pregnancy counseling, testing and FP service registration at HIV clinic. The 
registration is not available for DM screening or testing. This was described by the FGD 
participants as: 
37, F, FGD, ART officer:  “Yes, I do have register (for pregnancy care including 
family planning service at ART)”.  
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25, M, FGD, PMTCT officer: “Yes, regarding pregnancy testing and... 
ehee…inclusive of family planning, we make a report monthly (with ART clinic).”  
Category 3.6: Registration and reporting of DM at HIV or ANC 
It was generally observed that there is no registration or reporting on the screening 
/testing of DM at HIV or ANC. 
Health information systems or monitoring and evaluation, infrastructure, referral 
systems, are important in determining the success of integration efforts (Adamchak, 
Janowitz , Liku and Munyambanza l 2010:6). This is also mentioned by the study 
participants as the details of recording and reporting and joint mentoring and 
supervision are essential. However, this is challenged by; the increased burden of 
collecting and reporting on additional indicators for the integrated services; addressing 
need for increased supportive supervision to ensure quality of integrated services, 
establishing functional referral systems that can handle integrated services,  
establishing adequate monitoring and evaluation systems, as there are no standard 
indicators for integration, addressing the need for interlinked patient monitoring systems 
and  data quality (Kiersten et al 2012:09). Hence, as indicated by the study participants, 
there were no recording or reporting systems established for the related services of HIV, 
DM and pregnancy care. 
Theme 4: The structure, organization and location of HIV, DM and pregnancy care 
services 
Category 4.1 The structure and organization of HIV, DM and pregnancy care 
services at administrative levels 
At federal level, HIV care and treatment is a unit under DPDP; whereas, the HIV 
prevention activity is under the unit of HAPCO. HAPCO has its own president. It is the 
responsibilities of HAPCO concerning HIV prevention in the country. DM is one of the 
programs in the NCD unit. At federal level, NCD is a unit under the DPDP directorate. It 
is thus accountable for DPDP directorate in the ministry. NCD is well established with 
the policy and guideline, together with the commonest NCDs in Ethiopia such as DM, 
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HPN, breast cancer, cervical cancer and etc. Team leader of the NCD is assigned. The 
officers of DM, HPN and different cancers have already been employed. The health 
extension workers (HEW) are also included in the community awareness of DM, HPN, 
cervical cancer and etc. MCH is another directorate in the ministry. The pregnancy care 
is in the family health or MCH directorate. The maternal care, neonatal and child care 
are all the responsibilities of MCH. There are officers for child health, family planning, 
community care of mother and children. 
 
NCD is young program in regions and sub-cities. There is a team lead for NCD at region 
under the medical care core process. In these administrative levels, the MCH or family 
health unit addresses PMTCT and FP while HIV is under the DPDP core process. 
 
Nevertheless, there is an inconsistence structure and assignment of HIV, NCD and 
maternal health in different sub-cities. At some sub-sites, the structural organization of 
DM, HIV and ANC is that all are located in the same building and in the same floor. In 
other sub-cities the NCD is under the medical service - the unit that is responsible for all 
the health services at health facilities- while in other sub-cities the NCD unit is under the 
DPDP. HIV or ART is under the DPDP in almost all sub-cities. The family health unit 
which deals with pregnancy care is under the medical service while the PMTCT is under 
the HIV program. In the other sub-cities, HIV related prevention activities are under the 
DPDP while HIV care and treatment is under the medical service. This uneven 
arrangement can pose the risk to integrative service provision, planning, budgeting, 
monitoring and evaluation activities of these related programs. 
Category 4.2: Standalone HIV, ANC and NCD clinics at health facilities 
It was noted that ANC/PMTC, HIV or ART clinics are located separately in all health 
facilities during the study period. NCD is also stand-alone clinic. There are also officers 
for NCD. One of the interviewee described: 
30, F, FGD, NCD officer:  “Yes, like other clinics (for HIV and ANC), there is an 
isolated room for it (NCD). That is, standalone clinic (NCD). It is an OPD but only 
DM, HPN and other chronic illness together…” 
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Theme 5: Policy guideline, training manuals, protocols and algorisms 
Category 5.1:  Policy guidelines, protocols and algorism of joint service delivery 
Guideline, policy direction and algorisms on HIV and DM related pregnancy care are not 
in place and considered in the country. Also, the officers at all levels do not have an 
awareness to practice an integration of DM, HIV and pregnancy care services. The 
study officers and team leads confirmed that there is no guideline thus far that 
addresses DM, HIV and pregnancy care services all together.  
 
Pregnancy counseling and testing, and family planning provision guidelines and 
algorism are available at ART and ANC/PMNTCT clinics. However, there was no 
guideline or algorism that is comprehensive enough to contain DM, HIV, and pregnancy 
care services. The interviewees and the discussants said that: 
45, F, FGD, ART officer: “No, not at all (combined guideline or protocol)”. 
30, F, FGD, PMTCT officer:  “No direction from sub-city or FMOH regarding 
guidelines/algorism of DM/HIV”. 
35, M, IDI, NCD focal person: “No, this guideline (NCD guideline) is for the 
general population. No specific group (HIV or pregnant women) is addressed. 
The DM/ANC, DM/HIV etc… are not addresses in the NCD guideline” 
45, F, FGD, NCD officer: “No guideline or algorithm related to HIV and DM.” 
However, it was noted that the guideline & algorism for HIV testing and counseling is 
available in all service outlets including ANC and NCD.  Also, the pregnancy counseling 
and family planning provision guidelines and algorism are available at ART and ANC 
clinics. This was described as: 
35, F, IDI, NCD, officer: “PITC (provider initiated HIV testing and counseling) is 
common algorithm. One can get PITC algorithm at NCD, HIV, ANC…You also 
get PITC algorism”. 
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50, F, FGD, NCD officer: “I have (guideline & algorism) for HIV... but not for 
DM”. 
Category 5.2: Training manual combining DM, HIV and pregnancy care 
Trainings at federal levels are not designed in such a way to addresses HIV or 
pregnancy care with NCD. This was justified as: 
40, F, FGD, HIV officer:   “No, there is no (training manual combining DM, HIV 
and maternal   care), but PMTCT (HIV with pregnancy care and family planning)”. 
26, M, IDI, NCD officer:  “No, not at all (No direction from RHB, sub-city or 
FMOH) regarding the joint  training of DM/HIV”. 
 40,F, FGD, ART officer:  “No, I have not trained (on DM/HIV)”. 
The need of the policy guide and training manuals as well as the practice of integrated 
HIV and family planning has been widely implemented in countries hard-hit by HIV in 
sub-Saharan Africa including Ethiopia (Kiersten et al 2012:xi). Hence, as stated by the 
study participants there are a need of policy guidance and development of training 
manuals from FMOH so that the integration will be successful. 
 
It was also stated by Kiersten et al (2012:4) that renewed attention of policy makers and 
politicians is critical on the potential for integration to save money or achieve better, 
more cost-effective outcomes with existing resources. The existence of clear targeted 
national policies outlining guidance and strategies are required for implementation of 
integration efforts particularly in contexts where vertical approaches are still pervasive 
throughout the health sector. Therefore, that need of direction from higher up (FMOH 
and RHB) is paramount for the effective implementation of DM/HIV/pregnancy care 
integration at the sub-city, district or health facility levels. Nevertheless, the 
development of integrative police guideline can be challenged by the revisions to update 
service delivery guidelines and norms. 
Theme 6: The practice of integrated HIV, DM and pregnancy care services  
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Category 6.1 HIV screening, care and treatment at ANC   
Pregnant mothers are one of the priority groups in Ethiopia for HIV testing and 
counseling. That is, a universal HIV testing and counseling for pregnant women is a 
police in Ethiopia where all pregnant mothers visiting ANC are offered free and 
confidential HIV counseling and testing. The HIV testing service is inclusive of their 
partners. In addition, after the adoption of option B+ PMTCT, a pregnant mother with 
HIV infection will have a preventive ART for her and her newborn until one and half year 
after birth . The study participants have described: 
M, 25, FGD, PMTCT Officer: “We do PITC for all pregnant mothers and their 
partners”.  
F, 30, FGD, ANC Officer:  “…after they get pregnant, they will stay at PMTCT for 
1 and ½ years”. 
50, F, IDI, family health officer: “If the mother is HIV+, we offer full PMTCT 
service to have HIV free child”. 
Category 6.2: HIV service at NCD clinic 
The researcher also noted that PITC is offered should the DM patients show signs and 
symptoms of immunodeficiency. HIV counseling and testing is not routinely done for 
every clients visiting NCD clinic. The following were the reflections during IDI and FGD: 
 
IDI 29, F, NCD officer: “Here PITC can be done at NCD clinic if they (clinicians) 
suspect HIV. If positive at DM, they will be linked to HIV clinic.” 
F, 50, FGD, NCD officer: “Like other OPD, here (at NCD) PITC is done.” 
 
Category 6.3: Pregnancy care at HIV clinic  
Pregnancy counseling was reported to be a routine advice in HIV clinics. HIV infected 
females are told not to get pregnant though on ART. This is because the chance of 
MTCT is not nil. If HIV infected clients want to be pregnant, the HIV officer advice to 
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have unprotected sexual intercourse during a high risk period of getting pregnant. This 
was justified as: 
30, F, FGD, PMCT officer: “We cannot prevent them from getting pregnant. 
With very low CD4, they might want to get pregnant. Here, we tell them it is a 
problem both for their mother and fetus”.  
25, M, FGD, ART officer: “We tell that there are cases where they can give HIV 
infected child … ehee….I mean…even with follow up due to high viral load”. 
45, F, FGD, ART officer: “They want to get pregnant. We advise them to do 
mating during the ovulation rather than doing sex all over the month… We advise 
them on the timing of sexual intercourse”. 
It was noted that clients were routinely provided with dual family planning, hormonal and 
a barrier (condom) methods. Short-term family planning such as pills and injections 
were provided in all HIV clinics. However, the long term family planning service 
including Implanon had just been started at HIV clinics of a few health facilities. 
Otherwise, it was observed that it is a routine practice to refer clients for long term 
family panning to FP unit. The study participants said: 
35, M, FGD, HIV officer: ”We counsel and advice on the use of family planning 
and it is integrated with HIV”. 
45, F, FGD, ART officer: “We give short term FP in this (HIV) clinic...When they 
need a long term FP, we link to FP clinic”. 
45, F, FGD, ART officer: “….. Condom and DEPO, we will give them here (at 
HIV clinic)”. 
45, F, IDI, ART officer: “For Implanon and IUCD we refer them to FP clinic”. 
35, F, FGD, Family health officer: “At HIV, we render FP including long term 
FP…just started…Our clinicians have trained recently”. 
46, F, IDI, ART officer: “In this clinic (HIV); mainly, mother uses dual FP”. 
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35, F, FGD, Family health officer: “We have a plan to start the long term (FP), 
just trained health care providers a month back”. 
Pregnancy test using a urine sample is another service at HIV clinic. This is provided 
when mothers complain about the sign and symptoms of pregnancy or delayed mensus. 
The pregnancy test is also provided whenever the females in the reproductive age are 
enrolled to HIV clinic and started ART. If mothers are confirmed to be pregnant, they will 
be linked to PMTCT. The interviewees reported: 
36, F, IDI, ART officer: “Depends on the women complaint (if she has signs of 
pregnancy, morning sicknesses, and if she reported the monthly mensus is 
absent), I will send (for pregnant test); specially, if she is amenuric…. (Long 
silence). Emhhee…ehhee… If it is confirmed, I will link to PMTCT”.  
Category 6.4: Pregnancy care at NCD clinic 
The pregnancy test at DM is rarely entertained. It is only when the patients requested 
the  test that  it is offered.. Whenever they need the service of pregnancy care, they are 
referred to family planning. However, for a diabetic pregnant mother, her pregnancy and 
DM is taken care of at hospital setting. The study participates described: 
F, 46, FGD, NCD officer: “If the young girl/women come, of age 18 or 19, we will 
give her the detail counseling and advice (regarding pregnancy)…” 
29, FGD, NCD officer: “As an institute, based on the symptoms by the DM 
mother, we can do an investigation (pregnancy test (PT))”. 
F, 50, FGD, NCD officer: “… we ask for amenuria (absence of menses) and if 
we suspect for pregnancy, we send for pregnancy test”. 
 
Category 6.5: DM service at HIV  
Unlike the routine HIV test for all pregnant mothers at ANC clinic, there was no routine 
DM screening at HIV clinic. The DM screening and investigation is based on the 
symptoms and signs reported by the clients. 
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M, 30, FGD, HIV officer: “Regarding DM…ehee… if the symptoms of DM are 
detected, we will investigate the clients (laboratory tests)”. 
45, F, FGD, ART officer: “We ask about feeling thirst, weakness, fatigue, dry 
mouth, urine in the night; then, we do laboratory tests (fasting blood sugar)”. 
50, F, FGD, ART officer: “Based on the symptoms (of DM), random blood sugar 
(RBS) may be done. Otherwise, like HIV, there is no emphasis… or routine test 
for DM.” 
 
The HCW are not also well aware of how HIV or ART are a risk factor for DM.  
Therefore, the practice of routine DM screening at HIV is absent. The active and routine 
DM screening for HIV infected patients was not noted during the observation or 
interview as well. The HCWs justified this as: 
28, M, participant’s observation/ informal interview: “…no convincing 
evidence that HIV or ART is a risk factor for DM”. 
It was also noted that there were some HIV clinics that order FBS before the initiation of 
ART and reported as: 
46, F, IDI, ART officer: “Before putting our clients of ART, we usually do 
baseline investigation such as FBS, hemoglobin, CD4 …” 
M, 30, FGD, HIV officer: “DM test (is done) per the complaints on the follow up, 
monthly. In fact, we assess for any new event… including DM, in the follow up”. 
Whenever HIV infected females are confirmed to be diabetic, they are linked to NCD for 
treatment and follow up. One of the participants said: 
35, F, IDI, HIV officer: “If HIV+ infected clients of ours becomes diabetic, this will 
be linked to DM clinic”. 
It was observed that DM screening and evaluation is done based on the patient’s 
complain at the study health facilities. DM is usually diagnosed at the general OPDs. 
DM suspects at ANC or HIV clinics are usually referred to OPD or DM/NCD clinicians 
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for confirmation. If DM is diagnosed, referral is made to chronic care. At DM clinic, if HIV 
is confirmed, s/he is sent to ART using the intra-facility referral form. 
Category 6.6: DM services at ANC 
 
During the initial visits of pregnant mothers to ANC, a urine dipstick is done. When 
glucose 2 or 3 plus results are found, FBS or RBS is sent to confirm DM, in addition to 
the clinical evaluation. If no glucose is detected, active screening of DM is not a practice 
in the subsequent visits or ANC follow up. It is only when the pregnant mothers come up 
with the signs and symptom of DM that DM evaluation is done. The interviewees said: 
30, F, FGD, PMTCT officer: “In the initial visit, we will send urine dip stick, if plus 
2 or 3, that is the indication for DM, we will send for FBS, then after”.  
45, F, FGD, PMTCT officer: “If she (pregnant mother) comes up with… 
dehydration, frequent urination…in the subsequent ANC follow up…that we will 
do FBS…otherwise, DM testing is not a routine service for pregnant mother”. 
 
The knowledge of the effect of poorly controlled DM on pregnancy outcome was not 
optimal among the study participants. Besides, the focused ANC is not emphasizing the 
DM screening at ANC. The participants indicated: 
30, F, FGD, PMTCT officer: “If we see ANC, DM screening is not in the focused 
ANC, or not implemented.” 
50, F, IDI, Family health officer: “As far as I am concerned…no risk factors 
related to DM (on pregnancy) are considered at ANC”. 
 
Therefore, HCWs were not thinking of the need of the routine DM screening at ANC. 
One of the interviewee’s confirmed: 
25, M, FGD, PMTCT officer: “No routine screening service of DM in ANC… No 
pregnant mother is specifically screened for HPN or DM”. 
 
Mothers with DM and pregnancy have a follow up at hospitals. The DM mothers without 
pregnancy or other comorbid illnesses can have follow up at health centre (HC). There 
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is a focal person at health facilities who can decide whether mothers can have a follow 
up at HC or Hospitals. They can be started on medication at hospitals and then referred 
back to health centre for follow up. This is because there could be birth complications 
during a labour or then after. These are supported by the interviewees as: 
 
50, F, FGD, NCD officer: “Pregnant mother with DM are having a follow up at 
Hospital”. 
30, F, FGD, NCD officer: “If she has both HIV and DM, she will be linked to 
hospitals, especially for DM and potential birth complication…may be to control 
the sugar”.  
29, F, IDIs, NCD officer: “Yes, after birth she (DM and pregnant mother) will be 
having a follow up here (at health centre)”. 
 
Category 6.7: Health care providers’ collaboration 
 
It was observed that there are occasional shared forums where the NCD is collaborating 
with HIV or MCH unit. Neither the pregnant women are screened for DM or are offered 
a routine DM testing at ANC and HIV, nor do they get a combined ART treatment with 
diabetic medications. Hence, if a mother has both HIV+ and DM, they (health care 
providers) talk together and decide whether the patients should be treated here or 
should be referred to better health facility. An NCD officer during the IDI described: 
F, 29, IDI, NCD officer: “For diabetic pregnant mother, the clinicians 
communicate and discuss together and might refer to hospital for better follow up 
and treatment...” 
In some health facilities, there is no capacity of diagnosing DM at ANC and ART clinics. 
There is a thinking that the diagnosis of DM is a work of clinicians at DM or OPD. So 
there is usually a referral of DM suspects to OPD, NCD clinics or other health facilities 
with NCD clinics or NCD experts. 
Theme 7: Suggested Service Integrated Approaches 
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The key guiding question asked to explore the possible and feasible level of integration 
was, “How do you think should HIV and DM be integrated to prevent adverse 
pregnancy problems?” 
Sub category 7.1 DM service at ANC 
 
NCD officers commented that the pregnancy counseling and advice before conception 
for female in the reproductive age group can be beneficial. In addition, building the 
capacity of clinicians working at DM clinics to enable them give a follow up care for 
diabetic and pregnant women at health centers could be feasible. The officers said: 
50, F, FGD, NCD officer:  “… there is a limited capacity of HCWs and the health 
center…but mothers can have a follow up at health center to take care of diabetic 
and HIV infected mothers without other complication… emhee… [silent]… this 
can be beneficial for mothers…Also, a routine pregnancy counseling and 
provision of at least short term family planning is essential at chronic care unit”. 
35, F, FGD, Family health officer: “At ANC it is also important to have a routine 
FBS/RBS, like a routine HIV testing and counseling at ANC. It could be practiced. 
However, this has to come to health facilities in the form of … direction or 
guideline from FMOH”. 
Subcategory 7.2:  Routine DM screening and diagnosis at HIV 
  
The clinicians at health facilities suggested creating the awareness of clinicians on the 
fact that HIV infected individual on ART could potentially develop DM and hence the 
need to make the routine DM screening practice for PLHIV. However, they emphasized 
the need to have the direction from higher level that convinces the importance of active 
DM screening and diagnosis at HIV clinic. Diabetic mother can be linked to NCD clinics 
for treatment and follow up using the standardized referral form. Mentioning the existing 
threat for the suggested activities, the HIV officers commented: 
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50, F, FGD, HIV officer: “That is sound and preferable, the routine (of DM 
screening at HIV clinic) is important, but the supply (reagents or supplies for DM 
testing such as glucometer) is challenging”. 
 
35, F, IDI, HIV focal person: “That (the routine DM screening) is good, but 
clients are not comfortable to give blood repeatedly (in every follow up 
period)…ehee… may be at interval at a time…” 
 
Subcategory 7.3 Pregnancy care HIV clinic  
 
In addition to the counseling and the advice on the family planning and period of 
conception, all kinds of family planning were commented to be rendered at HIV clinic. 
This is because the long term FP has already been initiated in some health centers and 
they suggested that it should be scaled up to other health facilities. In fact, this warrants 
the training of HCWs and revision of the guidline and protocols/algorisms on pregnancy  
and HIV care and support. The intervireew’s at region and sub-cities described: 
 
37, F, IDI, family health team leader: “Health care provider should be trained in 
short and long term (on FP methods)… So, they could give all methods (of FP) at 
ART clinic (HIV clinic)”.  
 
50, F, IDI, MCH officer: “…referral to FP for long term might be stigmatizing. 
[mobile calling and interrupted the IDI)… (Silent)…It is better to finalize and give 
all FP service at ART clinics”. 
45, F, IDI, ART officer: “On ART (HIV) training, this (pregnancy care and 
including all methods of FP) can be integrated so that they could be given by 
HCW at ART (HIV clinic)”. 
 
Subcategory 7.4 Related service integration (One-stop-shopping mentality for 
related services) 
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The program team leaders and officers said that it is better to serve  a patient with 
multiple problems at a time and give all related service. As much as possible, in terms 
of time, resource and human power, the combined approach of giving a comprehensive 
service that are related together can be cost effective. Moreover, this is beneficial for 
the patients. The approach of screening and evaluating a single patient for HIV at ART 
clinic, for DM at NCD clinic and for pregnancy at ANC creates inconvenience for the 
patient. Advanced and complicated care of HIV, DM or pregnant problem might warrant 
referral to relevant clinic or it might need consultation of the expertise. Otherwise, the 
active and routine screening and diagnosis of HIV at ANC and NCD, or DM at HIV or 
ANC and pregnancy testing and counseling at HIV or NCD is feasible and practical to 
do. This necessitates the revision of policy guide or development of protocols and 
algorisms. The comprehensive service packages of interlinked items (DM, HIV, 
pregnancy care) for a patient was reflected by the study participants as follow: 
 
35, M, FGD, family health team leader: “All programs that are related should be 
integrated…ahaa…ehee…such services should be interlinked”. 
 
50, F, IDI, family health officer: “A mother coming for ANC can be screened for 
both (DM & HIV)”. 
 
37, F, FGD, family health team leader: “Though there is a (issue of) resource, 
cost and times, if that happens (DM screening at HIV and ANC clinics), early 
detection of these diseases is possible”. 
 
35, M, FGD, HIV team lead: “Only disease consideration needs to be left 
out….We needs to treat patients…the patient centered approach. Just think of 
patient, not disease entity… Better if managed (related problems of a patient) 
once… sound for patient satisfaction,”  
 
50, F, FGD, HIV officer: “Like ANC with HIV (i.e., PMTCT) similar guideline for 
similar services can be prepared to render similar service at a time”. 
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45, F, IDI, HIV officer: “HCWs at ART can be trained and can give a 
comprehensive pregnancy care & DM services at ART (HIV clinic)”. 
 
37, F, FGD, family health team leader: “Whenever you deal with health, a 
separate disease entity approach is not useful…Because NCD cases can have 
HIV, pregnant females can have DM or HIV…” 
 
In order to overcome problems of low coverage of active HIV screening and pregnancy 
care at DM clinic in Ethiopia, ministry of health may practice community based 
DM/pregnancy/HIV health services integration at primary health care (PHC) level. There 
are several advantages to treating related diseases like HIV, DM and pregnancy 
problems in primary care and other priority health care programs. Integrated treatment 
programs in which medical providers are supported to treat related health problems 
offer a chance to treat ‘the whole patient’, an approach that is more patient-centered 
and often more effective than an approach in which mental health, acute and chronic 
physical health, reproductive health, and chronic pain problems are each addressed in a 
different ‘silo’ without effective communication between providers.  This was also well 
described in the mental health integration into PHCU in Ethiopia (Ayano 2016:1) 
 
Category 7.5 Policy guideline and training manual of integrated service 
  
It was suggested that the practice of DM screening and diagnosis at HIV and 
ANC/PMCTC, pregnancy care and family planning provision including long term FP at 
HIV and DM clinics can be included in the policy guideline, training manuals, protocols 
and algorisms. The FMOH or RHB are expected to prepare such policy guideline, 
training manual, algorism or protocols so that sub-cities and health facilities will make 
use of it. Direction or guidance that is not coming from the higher administrative could 
not be implemented at lower administrative level. These issues were explained as: 
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30, F, FGD, family health team leader: “HIV guideline when prepared, it should 
include other related burden like DM at the same time”. 
 
 35, M, IDI, NCD team leader:  “The guideline should clearly state what to do if     
a diseases entity occurred with HIV…Guideline should be standardized &    
comprehensive”. 
 
36, F, FGD, family health team leader “Police or guideline should guide a full 
and a comprehensive health service for a client.” 
 
29, M, IDI, NCD team leader: “The integration should be started from higher up 
(FMOH and RHB)… Things from federal should have an integrated service 
delivery approaches”. 
 
30, F, FGD, family health team leader: “… So, rather than… these things 
(related item like DM, HIV and pregnancy) come in separate, it is better as one 
together… Hence, works from higher administrative level (FMOH and RHB) 
should come down together”. 
 
Though such kinds of integration are suggested, the study participants emphasized that 
there should be bold evidences indicating that integration is efficient, cost effective and 
useful for patients. Otherwise, activities should be prioritized. That is, HIV screening and 
diagnosis has already been prioritized among pregnant women. Similarly, for there is a 
hidden but accelerating DM burden in Ethiopia, the screening and diagnosis of DM 
should be prioritized among the population with high risk such as HIV or patients on 
ART where poorly controlled DM could cause harmful events among the pregnant 
women.  
 
Category 7.6 Integrated monitoring: Joint supportive supervision, the feedback 
and supervision checklist 
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The supportive supervision can be integrated and the supervision checklist could 
include the content of DM, HIV and pregnancy care. The register and reporting of DM 
can include HIV and pregnancy care services. Same is with ANC/PMCTC register 
where DM screening and diagnosis could be included. 
 
45, F, FGD, HIV officer:” DM symptoms can be one question in the HIV  intake 
form…  Had it been incorporated into intake form, HIV mentors could have 
mentored the testing of DM for HIV infacted patients…” 
 
45, F, IDI, HIV officer: “Mentors can see whether the DM being also screened at 
HIV care”. 
 
29, F, FGD, family health team leader: “Feedback is given in separate…It 
would have been better to do together and give the feedback at the same time on 
one paper”. 
 
29, F, IDI, NCD team leader: “It could have been better to organize the checklist 
together and do the feedback simultaneously”. 
 35, M, FGD, HIV team leader: “Disease prevention, medical service and HIV 
should have done it (SS) in common, including the preparation of the supervision 
template”. 
4.5 LEVEL OF DM, HIV AND PREGNANCY CARE INTEGRATION 
 
As described in Chapter One, there are three degrees or levels of health service 
integration. These are linkage, collaboration and full integration. Linkage focuses on 
improving the link between providers. Collaboration is more structured referral linkage 
than only linkage. In collaboration reports are defined and provided and there is a formal 
arrangement such as protocols, but are difficult to sustain. Full integration has the 
ideology of one-stop-shopping where a client obtains all health services in a clinic. In 
this section, the findings from the observation, IDIs and FGDs are used to determine the 
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degree of integration among DM, HIV and pregnancy care services at administrative 
(FMOH, RHB and sub-city) and health facility levels. 
 
 Kiersten et al (2012:3) indicate that the integration can occur at the levels of 
adminisration or health facility down to community. The services can be co-located at 
the individual service provider, the consultation room, other facility levels. The 
integrated servcie can also be provided through referral services to other providers or 
separate facilities, which often provide more specialized or standalone services. In this 
study, the degree or the intensity of integration at FMOH, RHB and sub-cities or districts 
is described as administrative level of integration. This is because these levels are 
playing a role of management, program monitoring and evaluation. The level or intensity 
of integration at the hospital, health center or community level is assigned as facility 
level integration. It is also noted that the mere coexistence of services in the same 
facility does not constitute integrated services (Kiersten et al 2012:3). Accordingly, the 
degree or intensity of integration at administrative and facility level is described in this 
section. 
4.5.1 Level of DM, HIV and pregnancy care integration at administrative levels 
(FMOH, RHB and sub-cities) 
 
According to theme 1-5, at administrative level, there was an isolated maternal and child 
health (ANC), HIV and NCD supportive supervisions, registrations and reporting 
system. There are occasional joint and integrated SS, financing and planning inclusive 
of all programs. However, the family planning and HIV has an integrated registration 
and reporting system. 
 
Supervision and mentoring from federal, region or sub-cities are vertical, so HCWs do 
not belief it is important to give routine DM screening testing at ANC and HIV. However, 
they are well aware of the accelerating burden of DM in Ethiopia. They think that DM 
program, NCD in general, is not well funded, recognized and decentralized. That might 
hide the need for efficient and effective integration of related service such as DM, HIV 
and pregnancy care. 
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During the planning or budgeting process at FMOH, RHB and sub-cities, there is no 
issue of HIV related activities at DM, no issue of DM related duties in HIV or PMCTC 
and no comprehensive pregnancy related issues on HIV or DM.  There existed the 
policy or guideline or training manuals regarding the integration of HIV care with 
pregnancy care. Otherwise, there is no policy guideline or training manuals addressing 
DM in HIV, DM in pregnancy care or the three items all together. Therefore, at 
administrative levels the collaboration type of integration was witnessed between HIV 
(HAPCO) and pregnancy care (MCH). The level of integration between HIV (HAPCO) 
and NCD and between NCD and family health or MCH is a linkage. 
 
4.5.2 Degree of DM, HIV and pregnancy care integration at health facilities 
 
The responses to address the level or intensity of DM/HIV/pregnancy care at health 
facilities were the one described under the themes 6 and 7 above. The table below 
(Table 4.2) summarizes the degree of integration based on the themes.  
 
At ANC clinic, HIV infected mothers and the newborn get full care and treatment of HIV.  
Hence, full integration of maternal and newborn care, and HIV care and treatment are 
provided at least during the pregnancy and two years after giving birth.  
 
Nevertheless, HIV testing is provided at NCD clinic for clients who shows symptoms 
and signs indicating HIV or AIDS. If an HIV infection is detected, the clients are referred 
to ART HIV clinic. There are no standard protocol for the referral linkages between NCD 
and HIV clinic. Therefore, the type of linkage between NCD and HIV program is taken 
as a linkage. HIV testing and counseling algorism was available in all service outlets 
including ANC and NCD. However, no protocol or algorism includes DM with HIV or DM 
with pregnancy care and family planning. 
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TABLE 4.2: SUMMARY OF EXPLORED LEVEL OF INTEGRATION AMONG HIV, DM, AND 
PREGNANCY CARE AT HEALTH FACILITIES OF ADDIS ABABA, 2018 
 
 
 
 
In addition to the signs and symptoms, it is mentioned that dipstick test, FBS and RBS 
are the commonly used methods of screening DM patients. At HIV clinic, DM screening 
is done only when the clients reported the signs and symptoms indicative of DM. 
Otherwise, there was no active and routine DM screening for HIV infected patients. 
 
Besides, there is no direction or policy guideline recommending that routine and active 
DM screening for HIV infected individual. Hence, during the study period, linkage is the 
type of integration practiced between NCD and HIV clinics. The linkage degree of 
integration is noted between NCD and ANC. This is because the DM screening for 
pregnant mothers’ depends on the report from the clients and linkage to NCD clinic is 
done for diabetic mothers. 
 
Service outlets NCD clinic HIV   clinic ANC clinic 
HIV service • PITC 
• Symptom based testing 
and counseling 
• Referral of the confirmed  
HIV infected female to 
HIV clinic  
= LINKAGE 
 • Routine HIV testing and 
counseling 
• ART for 1 &1/2 years at 
ANC/PMTCT 
• Register and reporting 
available 
• Guideline and algorims 
on HIV, pregnancy care,  
• FP available 
=FULL INTGRATION 
DM service  • Symptom based evaluation 
and treatment 
• Referral for the treatment 
and follow up to HIV clinic 
=LINKAGE 
• Symptom based 
evaluation 
• Referral for treatment 
and follow-up 
=LINKAGE 
Pregnancy 
care 
Pregnancy test(PT) si available 
and refer PT positive to ANC 
and referral for FP 
=LINKAGE 
 
Pregnancy counseling and advice 
available 
PT available and positive PT 
referred to ANC. Short term FP and 
pregnancy counseling available 
=COORDINATION 
Pregnancy counseling and 
advice available. Referral for FP 
=COORDINATION 
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The pregnancy counseling and testing service as well as family planning counseling and 
family planning service provision are routinely given at HIV clinic. The long term family 
planning was just started to be given at a few health facilities. There is a formal 
registration and reporting of pregnancy care and family planning service at HIV clinic. 
However, pregnant mothers are referred to ANC. In addition, females with the need of 
long term family planning are linked to family planning unit. At ANC/PMCT, counseling 
on family planning and future pregnancy is also given. Hence, the level of integration 
between pregnancy care service and HIV clinic and between pregnancy care and 
PMCTC/ANC is coordination.  
 
At NCD clinic, DM female patients are rarely given pregnancy counseling while they are 
referred to FP unit for the all kinds of family planning services. If they show the signs 
and symptoms of pregnancy, pregnancy test service is given. If they are positive for 
pregnancy test, they will be referred to ANC/PMCT. If it is at the health center level that 
pregnant and diabetic mothers are sent to hospital for better follow up. Hence, at NCD 
clinic, the DM and pregnancy care service has a linkage level of integration. 
 
4.5.3 Suggested integrated approaches of HIV, DM and pregnancy care at 
administrative levels 
 
According to the theme 8, at administrative levels the integration between HIV and ANC 
is full integration; between HIV and DM and between DM and ANC is collaboration. 
 
4.5.4 Suggested integration approaches of HIV, DM and pregnancy care at Health 
facility level 
 
Theme 8 is also the theme that indicated the suggested integration level at health 
facilities. Accordingly, table 4.3 summarizes the suggested integration level at health 
facilities among pregnancy care, HIV and DM to address the adverse pregnancy 
outcome among the reproductive age mothers. Therefore, it seems feasible to have a 
routine HIV testing at DM clinic, supported by the DM and HIV care SOPs and 
guideline. These SOP and the guideline should direct the key activities which can be 
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practiced at DM clinic that is related to HIV. Hence, the coordination level of integration 
is feasible and practical. However, the full packages of integration where HIV testing 
and comprehensive HIV treatment follow up can be implemented at ANC clinic. This 
has got an already developed guidelines and algorisms in favor of full integration where 
clinicians at ANC room are trained on HIV care and treatment, pregnancy care and 
family planning services for reproductive age women.  
 
For HIV clinicians working at HIV clinic, the DM/HIV integrated guidelines, algorism and 
SOP are suggested to be prepared addressing routine and active DM screening among 
HIV infacted mothers, treatment follow up for the DM/HIV comorbidity, counseling on 
the preventive methods of DM (dietary practice, exercise and smoking), and a formal 
referral and consultation services between HIV clinicians and DM expert. Therefore, 
almost all services relates to DM at HIV clinic could be addressed so that DM/HIV 
comorbid patients can obtain all services for both, except the referral or consultation for 
complex cases at health centers. In fact, the clinicians should be trained on the 
integrated HIV and DM care to address adverse pregnancy outcome in the females. 
Similarly, these full packages of DM preventive and treatment service could be offered 
at ANC by revising the PMCTC guideline and SOPs where DM is addresses clearly in 
pregnant mothers with HIV infected or otherwise. Here, counseling, testing, treatment 
and follow up services of both DM and HIV could be rendered for mothers at ANC as far 
as they are at ANC clinics—full integration. 
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TABLE 4.3: SUMMARY OF FEASIBLE AND PRACTICAL LEVEL OF INTEGRATION AS SUGGESTED 
DURING THE IDI AND FGD FOR ADDIS ABABA HEALTH FACILITIES, 2018 
 
However, the coordination level was suggested per the current health facility structure in 
Addis Ababa for pregnancy care at NCD clinic. This is because; at DM clinics females 
could be routinely counseled on the pregnancy care including the family planning. 
Pregnancy care can be offered whenever the clinician suspects or the clients requested. 
Short term FP services could also be offered and referral could be practical for long 
family panning service to FP clinic. Hence, the pregnancy care and DM SOPs and 
Service Chronic/DM care ART/HIV care ANC/PMTC 
HIV services • Routine HIV testing and 
counseling 
• HIV testing algorism can 
be availed 
• HIV and DM care guideline 
or SOP is possible 
=COORDINATION 
 Option B+ is already available 
=FULL INTGRATIONB 
DM services  • Routine FBS 
• Health education (HE) on 
preventive measures 
• Treatment and follow up of 
DM/HIV co-morbidity 
• DM/HIV guideline, algorism 
• Referral/consultation for 
complicated and specialty care 
to chronic care 
=FULL INTGRATION 
• HE on preventive 
measures 
• Routine 
FBS/RBS/DIPSTICK 
• Treatment and follow ay 
ANC/PMTC till post-
partum period and refer 
to chronic clinic 
• Referral consultation to 
chronic care if 
complications 
• DM screening, 
diagnostic algorism can 
be available at ANC 
clinic 
=FULL INTEGRATION 
Pregnancy 
care 
• Counseling and HE on 
pregnancy care 
• PT available 
• FP: Short term 
• Referral for long term FP 
• DM + Pregnancy acre 
=COORDINATION 
=FULL integration   
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algorism could be prepared considering these feasible and practical services related to 
pregnancy care at DM; thus, the coordination level of integration. 
 
Therefore, the level of integration at health facility level could be full integration among 
DM, pregnancy care and HIV at ANC; coordination among DM, HIV and pregnancy care 
at DM clinic. Table 4.4 summarizes the explored level of integration and the suggested 
level of integration for the HIV, DM and pregnancy care services at the three service 
outlets.  
 
TABLE 4.4: LEVEL OF INTEGRATION AMONG DM, HIV AND PREGNANCY CARE SO FAR AND 
THE SUGGESTED APPROACHES AT HEALTH FACILITIES OF ADDIS ABABA, 2018 
 
According to Leutz (1999) (Cited in WHO 2008:112-13), one size of integrated care 
does not fit all’. It is therefore vital to consider the context; that is, different care settings 
and perspectives in which a specific integrated care initiative develops. In other words, 
one can integrate all of the services for some of the people, some of the services for all 
of the people, but one cannot integrate all of the services for all of the people. That is 
could be why different degree or intensity of integration were noted and suggested. 
 
 A comprehensive approach towards the integration of DM, HIV and pregnancy care 
can shape the whole health system and allow for services to be integrated at various 
Ser No. Integration between Intensity of integration so far Suggested level integration 
1 HIV  service at DM LINKAGE COORDINATION 
2 HIV  service at and ANC FULL INTEGRATION FULL INTEGRATION 
3 DM service at ANC LINKAGE FULL INTGERATION 
4 DM service at HIV LINKAGE FULL INTEGRATION 
5 Pregnancy care at DM LINKAGE COORDINATION 
6 Pregnancy care at HIV COORDINATION COORDINATION 
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levels of intensity depending upon the different needs of services users. For instance, 
though DM is one of the NCDs considered in this study other related NCDs such as 
HPN could be part of the NCD, HIV and pregnancy care integration, provided that there 
is a good evidence that HPN can also affect pregnancy and common among HIV 
infected females. 
  
Vertical integration in the health system is the ownership of the various stages of the 
production process (Kodner 2009:13). For instance, HIV or NCD and MCH are vertical 
program in Ethiopia. Daily integrated maternal health services where the record cards, 
registers, procedures and training courses of the separate 'vertically' organized services  
(of HIV, DM and pregnancy care) need to be brought together to enable the 
development of the model  fully integrated service. This will improve accessibility, 
acceptability and output of the services including the reduction in adverse pregnancy 
outcome. In fact, the service ought to be evaluated by a joint and integrated supportive 
supervision and the integrated supervisory checklist.  
 
Integrated care aims to address fragmentation in patient services, and enable better 
coordinated and more continuous care, frequently for an ageing population which has 
increasing incidence of chronic disease in the western health system (Nuffiled trust 
2011:9). In Ethiopia there is the experience of the integration of mental health into the 
primary health units through the training of nurses and supportive supervision (Ayano 
2016:1).l The other integrative models piloted in Ethiopia were mental health into the 
chronic HIV care (Wissow et al 2015), and HIV service into family health (Kiersten  et al  
2012). In addition, the linkage of sexual and reproductive health (SRH) and HIV front-
line services (Rebecca, Tamil, Ana and Till 2014) is a well-documented practice of 
integration.The integration of mental health/substance abuse in primary care unit is a 
patient centered integration and improves and saves lives and reduces health care 
costs (Carey, Crotty, Morrissey, Jonas, Thaker, Ellis, Woodell, Wines and Viswanathan 
2013:345). Kuramoto (2014:44) and Dall (2011) showed that integration of mental 
health and behavioral change with primary health care is efficient and effective with a 
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sound outcome. Grazier, Smith, Song and Smiley (2014:67) indicated that the 
integration of depression into primary health care is feasible as well.  
 
However, as compared to the suggested DM and HIV integration to address pregnancy 
outcome, the aforementioned integrations are the integration of a new initiative into an 
already established primary health system. These integrations are not described based 
on the leutz theory of integration and could be tough as compared to the potentially 
easy integration of DM, HIV and pregnancy care at primary health units. This is 
because, the DM, HIV and pregnancy care services have already been established at 
the primary health units but with loose collaboration and linkage. Therefore, it could be 
more feasible to strengthen the linkage and integration of the already established 
services as compared to the introduction and integration of new initiatives into the 
health system. 
 
4.5.5 Summary of Phase I study fidings 
 
The combined findings of IDIs, FGDs and observations at the administrative level and at 
health facility level data produced seven key themes. The process by which the themes 
developed was assisted by the integrated theoretical frame work. The session 
answered the key objective of the study; exploring the functional, organizational and 
structural integration of DM, HIV and pregnancy care (Theme 1-5). Also, the researcher 
determined the intensity or level of integration of DM, HIV and pregnancy care (theme 
6). Eventually, this section assisted to bring about the suggested level of integration 
among DM, HIV and pregnancy care at administrative and health facility level (theme 7), 
the basis for the development of service delivery model of care including DM, HIV and 
pregnancy care. The next section describes the finding in phase II of the study. 
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4.6 PRESENTATION AND DESCRIPTION OF FINDINGS IN PHASE II  
 
The objectives of phase II were to: 
• describe pregnancy care, HIV and DM services at ANC, DM and HIV clinics in 
Addis Ababa health facilities, 
• determine the prevalence rate of DM among HIV females of childbearing age 
enrolled in HIV care during 2011-2016 in Addis Ababa health facilities, 
• determine prevalence rates of pregnancy among HIV and DM childbearing age 
females enrolled to care during 2011-2016 in Addis Ababa health facilities, and 
• determine prevalence rates of adverse events in pregnancy among HIV and DM 
childbearing females enrolled to care during 2011-2016 in Addis Ababa health 
facilities. 
 
Based on the theoretical and conceptual framework of the study (Chapter I, Figure 1.1), 
the following section are addressed – the output and the impact part of the conceptual 
framework. 
 
i) Output  
This addresses the description of HIV and DM services at ANC clinic, HIV and 
pregnancy care services at DM/NCD clinic and DM and pregnancy care services at HIV 
clinic. That is, it deals with the performance of service generated and in this research it 
is: 
• the number or the proportion of reproductive age mothers at HIV and ANC 
clinics counselled and screened for diabetes mellitus, 
• the number or the proportion tested for HIV at DM and ANC  clinics and, 
•  the number or the proportion of mothers at ANC screened and tested for DM 
and HIV. 
 
ii) Impact  
On the conceptual framework of the study, impact means patients’ outcomes. In this 
study it means: 
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• The prevalence of DM among HIV patients, 
• The prevalence of pregnancy among HIV and DM patients, and 
• The prevalence of pregnancy outcomes among HIV and DM patients. 
 
In the quantitative phase of this study, the data were collected using the checklist and 
the questionnaires where data source was the patients’ themselves and their clinical 
records. Data was collected at ANC, DM and HIV clinics by the orientated clinicians on 
the data collection tools for 11/2 days.  
 
The initially proposed data collection tool was refined and modified based on, 
1. The finding from the phase I or qualitative part of the study. Here, the flow and 
content were revised. For instance, to describe the HIV and DM services being 
given to mothers at the ANC, DM screening service at HIV, and HIV service the 
questionnaires and the checklist was modified accordingly to address these 
issues. Therefore, there were three data collection tools for the quantitative 
phase of the study. These were for HIV, DM and ANC/PMCTC (see Annexure E 
& I). 
2. The pre-test of the checklist where the order of the questions was rearranged. 
Repetition and redundancy of the some variables such as pregnancy and family 
planning and DM and HIV complications were removed. 
 
4.6.1 HIV and DM services at ANC 
 
To answer the objective; “to describe the DM and HIV services at ANC” about 326 
pregnant mothers attending ANC at 06 health facilities (about 54 pregnant mothers 
each) in Addis Ababa were randomly selected and approached.  
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4.6.1.1 Socio-demographic Characteristic  
 
The mean age of the pregnant mother during the data collection was 28.7 years with 
standard deviation (SD) of 4.5 years. About 46.0% of them were Gravida 2 while 51.1% 
were Para 1 (Table 4.5). 
TABLE 4.5: PARITY AND GRAVITY OF PREGNANT MOTHERS HAVING A FOLLOW UP AT THE 
ANC OF ADDIS ABABA HEALTH FACILITIES, FEBRURAY- MAY, 2018 
Variable 
Number of Gravity or Parity 
0 1 2 3 4 5 6 
Gravity (N=326)   62 150 81 25 4 4 
Percent (%)   19.0 46.0 24.8 7.7 1.2 1.3 
Parity (N=319) 73 163 60 20 3     
Percent (%) 22.9 51.1 18.8 6.3 0.9     
 
The mean Gestational age in weeks during the data collection (n=297) was 32.3 weeks 
with the maximum of 42 weeks and the minimum of 1 week.  
Most of the study participants (98%) were married. About 80%of them had attended at 
least a junior secondary school. Close to 56% were housewives (see table 4.6).  
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TABLE 4.6: SOCIO-DEMOGRAPHIC CHARACTERISTICS OF PREGNANT MOTHERS ATTENDING 
ANC AT ADDIS ABABA HEALTH FACILITIES, , FEBRUARY-MAY 2018 
Variables Frequency Percent 
Marital status 
a. Married 315 98.1 
b. Single 1 0.3 
c. Divorced 2 0.6 
e. Non-married with a partner 3 0.9 
Total 321 100 
Highest educational level 
a. Unable to read and write 29 9.0 
b. Primary school (1-6 grades) 32 9.9 
c. Junior Secondary school (7-8) 65 20.2 
d. High School (9-12) 107 33.2 
e. Above high school 89 27.6 
Total 322 100 
Occupation 
a. Unemployed 48 14.9 
b. Student 2 0.6 
c. Housewife 180 55.9 
d. House servant 1 0.3 
e. Daily laborer 4 1.2 
f. Merchant 86 26.7 
 commercial Sex worker 1 0.3 
Total 322 100 
Family history of DM 
a. yes 47 14.5 
b. no 277 85.2 
c. I do not know 1 0.3 
Total 325 100 
 
 
4.6.1.2 HIV counselling and testing service at ant-natal (ANC) care clinic 
 
The documented HIV testing and counselling was reported for 313 of the pregnant 
mothers (96%). Twenty-four (7.7%) of them were HIV positive. Almost all of HIV 
infected pregnant mothers were on ART as PMTCT option B+ (Table 4.7). 
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TABLE 4.7: HIV RELATED SERVICE AT ANC CLINIC FOR PREGNANT MOTHERS IN ADDIS ABABA 
HEALTH FACILITIES, FEBRUARY-MAY 2018 
HIV test result Frequency Percent 
a. HIV+ve 24 7.7 
b. HIV-ve 289 92.3 
Total 313 100 
ART started 
a.No  1 8.0 
b.Yes 312 92.0 
Total 313 100 
ART regimen type 
a.AZT ETC NVP 3 8.7 
b.AZTETCEFV 1 4.4 
c.TDFETCEFV 306 78.3 
d.TDF 3TC NVP 2 8.7 
Total 312 100 
 
4.6.1.3 DM services at ANC clinics 
 
Dip stick urine test, a comprehensive test for proteins, sugar, was the only DM related 
service reported that was reported for all mothers. Otherwise, there were no objectively 
recorded DM related services given to the pregnant mother. There was no report of 
RBS or FBS done and recorded in the patients’ files. Hence, there was no reported DM 
mother during the study period from 313 approached study participants. 
 
4.6.1.4 Pregnancy outcomes 
 
The respective 238, 100, 25 and 3 pregnant mothers on ANC reported that they had at 
least one, two, three and four pregnancies thus far. Those mothers who had the 
experience of at least one pregnancy reported a 6.1% spontaneous abortion while 4.8% 
had induced abortion. C-section was done for 37% of them. Hypertension during 
pregnancy was 7.7% (see table 4.8). 
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TABLE 4.8: GESTATIONAL AGE (GA) IN WEEKS AND THE NUMBER OF BIRTHS AMONG 
PREGNANT MOTHERS HAVING ANC FOLLOW UP AT ADDIS ABABA HEALTH FACLITIES, 2018 
Ser no. Gestational age during delivery 
No of first 
pregnancy 
(%) 
 No of 
second 
pregnancy 
(%) 
 No of 
third 
pregnancy 
(%) 
 No of fourth 
pregnancy 
(%) 
All 
pregnancy 
(%) 
1 <32 weeks 47 (25.7) 33 (25.6) 23 (29.1) 8 (53.3) 111 (27.3) 
2 32-36 weeks 40 (21.9) 23 (17.8) 18 (22.8) 1 (6.7) 82(20.1) 
3 37-40 weeks 80 (43.7) 50 (38.8) 34 (43.0) 4 (26.7) 168 (41.2) 
4 41-42 weeks 11 (6.0) 16 (12.4) 4 (5.1) 2 (13.3) 33 (8.1) 
5 >42 weeks 5 (2.7) 7 (5.4) 0 0 12 (2.9) 
6 Total 183 129 79 15 406 
 
Among the total of 406 total births (from first to fourth births experienced), about 20.1% 
and 2.9% were preterm and post term pregnancies respectively. In about 51.1% of 
births the gestational age was within a normal limit of 37-40 weeks (Table 4.9). 
There were 12(4.1%), 22(7.4%) and 14 (4.7%) very low birth weight, low birth weight 
and big baby reported in the total of 296 birth (Table 4.9). The proportion of deliveries 
with the normal birth weight 84%, the highest proportion of 94.4% in the third 
pregnancy. 
 
TABLE 4.9: SUMMARY OF BIRTH WEIGHT AMONG PREGNANT MOTHER HAVING ANC FOLLOW 
UP IN ADDIS ABABA HEALTH FACILITIES, 2018 
Ser 
no. 
Birth 
weight 
First 
pregnancy 
(%) 
Second 
pregnancy 
(%) 
Third 
pregnancy 
(%) 
Fourth 
pregnancy (%) 
Total 
pregnancy 
(%) 
1 <1500 7(3.5) 5 (6.4) 0 0 12 (4.1) 
2 1500-2499 15(7.8) 6(7.7) 1 (5.6) 0 22 (7.4) 
3 2500-4000 165(83.3) 64(82.1) 17 (94.4) 1000 248 (83.8) 
4 >4000 11(5.6) 3(3.8) 0 0 14 (4.7) 
5 Total 198(100) 78(100) 18(100) 2 (1000) 296 (100) 
 
Although the majority (46%) of the births were spontaneous vaginal delivery, especially 
in third pregnancy (68%), there were spontaneous or induced abortions (11.7%), 
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caesarean or instrumental deliveries (36.4%) and HPN during pregnancy (5.6%). 
Stillbirth was reported in 8.4%, 9.3% and 4.2% of the respective first, second and third 
pregnancies. Miscarriage was indicated in the 10% of the first pregnancy, 10.3% of the 
second pregnancy and 16.7% of the third pregnancy. Congenital malformation was also 
reported in 0.8% and 3.1% of the first and the second pregnancy among the mothers 
having ANC follow up in Addis Ababa health facilities (Table 4.10). 
TABLE 4.10: MATERNAL AND FETAL BIRTH OUTCOMES AMONG ANC ATTENDANTS’ MOTHERS 
IN ADDIS ABABA HEALTH FACILITIES, 2018 
 
Ser No Pregnancy outcomes 
Number (%) 
in the first 
pregnancy 
Number (%) 
in the second 
pregnancy 
Number (%) 
in the third 
pregnancy 
Number (%) 
in the fourth 
pregnancy 
Total number 
(%) of the 
pregnancy 
Birth outcome, maternal   
1 Spontaneous vaginal delivery 107 (42.2) 49 (49) 17 (68) 1 (33.3) 174(46.3) 
2 Spontaneous abortion 15 (6.1) 9(9) 2 (8) 1(33.3) 27(7.2) 
3 Induced abortion 12 (4.8) 3 (3) 2 (8)   17(4.5) 
5 Instrumental delivery 8 (3.2) 1 (1)     9(2.40 
6 C-section 87 (35.1) 36 (36) 4 (16) 1(33.3) 128(34.0) 
7 Pre-eclamsia 15 (6.1) 2 (2)     17(4.5) 
8 Eclamsia 4 (1.6)       4(1.10 
  Total 248 (100) 100 (100) 25(100) 3(100) 376 (100) 
Birth outcome, fetal   
1 Alive/normal birth 194 (77.3) 75 (77.3) 19 (79.2) 2 (66.7) 290 (77.3) 
2 Still birth 21 (8.4) 9 (9.3) 1 (4.2)   31(8.3) 
3 Miscarriage 25 (10) 10 (10.3) 4 (16.7) 1 (33.3) 40(10.7) 
4 Congenital Malformation 2 (0.8) 3 (3.1)     5(1.3) 
5 Other 9 (3.6)       9(2.4) 
  Total 251 (100) 97 (100) 24 (100) 3 (100) 375 (100) 
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4.6.2 DM and pregnancy care services at HIV clinic 
 
4.6.2.1 Socio-demographic characteristic of the study participants 
 
The mean age of HIV positive study participants was 32.5 years with SD of 5.3 years. It 
ranged from 19-45 years. The majority of them were married (65.6%), literate (96.7%) 
and housewives (29%) (Table 4.11). 
TABLE 4.11 SOCIO-DEMOGRAPHIC CHARACTERISTICS OF HIV+ MOTHERS IN ADDIS ABABA 
HEALTH FACILITIES, FEBRUARY-MAY 2018 
Variable Frequency Percent 
Marital status 
a. Married 236 65.6 
b. Single 62 17.4 
c. Divorced 26 7.3 
d. Widowed 18 5.05 
e. non-married with a partner 18 4.6 
Total 360 100 
Educational status 
a. Unable to read and write 14 3.7 
b. Primary school 61 17.1 
c. Junior school 29 7.9 
d. High school 144 44.4 
e. Above high school 108 26.9 
Total 360 100 
Occupation 
a. Unemployed 20 5.5 
b. Student 36 10.1 
c. Housewife 103 28.9 
d. House servant 22 6 
123 
 
e. Daily laborer 6 1.8 
f. Merchant 12 3.2 
h. Government employee 62 17.1 
i. Private employee 91 25.4 
k. Others 8 2.3 
Total 360 100 
 
4.6.2.2 HIV Counselling and testing service outlet 
 
The majority of HIV+ mothers (67.5%) on follow up were tested at HIV counselling and 
testing (HCT/VCT) or ANC clinics. At an outpatient department about 23.3% of the HIV+ 
mothers knew their HIV status (Table 4.12). 
 
TABLE 4.12: SERVICE OUTLETS WHERE HIV COUNSELLING AND TESTING WAS DONE FOR HIV+ 
MOTHERS IN ADDIS ABABA HEALTH FACILITIES, 2018 
Ser No Where was HIV diagnosis made? Frequency Percent 
1  HCT/VCT clinic          129 37.2 
2 ANC       105 30.3 
3 Family planning            3 0.9 
4  Outpatient Department (OPD)           81 23.3 
5 Inpatient  Department (IPD)            6 1.7 
6 Others            23 6.6 
  Total 347 100 
 
Among the HIV+ mothers, fourteen cases of TB (4.0%) and three case of HPN (0.8%) 
mothers were reported 
4.6.2.3 Pregnancy rate among HIV+ mothers 
 
Among the 280 (77.8%) mothers having an experience of pregnancy thus far, 275 
(98.2%) were successful delivered live births while 271(96.8%) children were alive 
during the study. About 78.4% of the HIV+ females had at least one pregnancy while 
21.6% had never got pregnant (Table 4.13). 
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TABLE 4.13: NUMBER OF PREGNANCIES EXPERIENCED BY THE HIV+ MOTHERS ON HIV CARE 
AND TREATMENT AT ADDIS ABABA HEALTH FACILITIES, FEBRUARY-MAY, 2018 
No of pregnancy 
Number females get 
pregnant thus far (%), 
N=357 
Number females with live 
deliveries (%), N=343 
Number of females having 
alive child/ren (%), N=342 
0 77 (21.6) 82 (23.9) 86 (25.2) 
1 117 (32.8) 122 (35.6) 121 (35.4) 
2 86(24.1) 93 (27.1) 90(26.3) 
3 45 (12.6) 32 (9.3) 33 (9.7) 
4 24 (6.7) 11 (3.2) 9 (2.6) 
5 4 (1.1) 1 (0.3) 2 (0.6) 
6 1 (0.3) 1 (0.3) 1 (0.3) 
7 2 (0.6)     
8 1 (0.3) 1 (0.3)   
 
4.6.2.4 DM services at HIV clinic 
 
The following bar graph shows that only 16.2% of HIV+ mother were tested for DM. 
About 8.4 % of HIV+ mothers were tested for DM at the study health facilities, 
while7.8% of them were evaluated at other health facilities (Figure 4.1). Fasting blood 
sugar (FBS) was the main means of DM testing (32 out of 41 tested, 78%), the other 
being random blood sugar and urine dipstick. Five cases of DM (1.5%) were reported 
among HIV+ mothers.  
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Figure 4.1: DM testing status and testing service outlets in Addis Ababa health facilities, 
2018 
 4.6.2.5 Pregnancy outcome among HIV positive mothers 
 
4.6.2.5.1 Maternal birth outcome 
 
About 80.5% and 7.6% of the total pregnancies ended in term (37-40weeks GA) and 
post-date (41-42 weeks of GA) deliveries respectively. Twenty-nine (7.8%) pregnancies 
reported to be delivered before 32 weeks of GA, and 13 (3.5%) were pre-term 
deliveries. Two deliveries (0.5%) were post term (Table 4.14). 
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TABLE 4.14: SUMMARY OF GESTATIONAL AGE OF DELIVERIES AMONG HIV INFECTED 
MOTHERS IN ADDIS ABABA HEALTH FACILITIES, 2018 
Ser 
no. 
Gestational 
age during 
delivery 
No of first 
pregnancy 
(%), N=216 
 No of second 
pregnancy 
(%), N=105 
 No of third 
pregnancy 
(%), N=38 
 No of 
fourth 
pregnancy 
(%),N=11 
All 
pregnancies 
(%), N=370 
1 <32 weeks 12 (5.6) 8 (7.6) 6 (15.8) 3 (27.3) 29 (7.8) 
2 32-36 weeks 6 (2.8) 4 (3.8) 2 (5.3) 1 (9.1) 13 (3.5) 
3 37-40 weeks 176 (81.5) 88 (83.8) 28 (73.7) 6 (54.5) 298 (80.5) 
4 41-42 weeks 21 (9.7) 5 (4.8) 1 (2.6) 1 (9.1) 28 (7.6) 
5 >42 weeks 1 (0.5) 0 (0) 1 (2.6) 0 (0) 2 (0.5) 
 
In the first to fourth pregnancy, 326 (74.1%) of the pregnancies were normal deliveries 
while 63 (14.3%) ended in abortion. Eighteen (4.1%) pregnancies were assisted through 
instrumental deliveries or C-section. The HPN during pregnancy was 23 (5.2%); ranged 
from 2.1-10.7%.Two (0.5%) and 8 (1.8%) pregnancies were complicated by systemic 
infection and haemorrhage respectively (Table 4.15). 
 
TABLE 4.15: MATERNAL DELIVERY OUTCOME AMONG HIV INFECTED MOTHERS IN ADDIS 
ABABA HEALTH FACILITIES, 2018 
Ser 
No. 
Maternal delivery 
outcome 
Number of 
first 
pregnancy (%) 
Number of 
second 
pregnancy 
(%) 
Number of 
third 
pregnancy 
(%) 
Number of 
fourth 
pregnancy 
(%) 
Total 
pregnancy 
(%) 
1 Spontaneous vaginal delivery 188 (76.1) 98 (77.8) 31 (64.6) 9 (47.4) 326 (74.1) 
2 spontaneous abortion 23 (9.3) 17 (13.5) 13 (27.1) 6 (31.6) 59 (13.4) 
3 Induced abortion 2 (0.8) 0(0) 1 (2.1) 1 (5.3) 4 (0.9) 
4 Instrumental delivery  6 (2.4) 6 (4.8) 1 (2.1) 1 (5.3) 14 (3.2) 
5 pre-eclamsia 20 (8.1) 2 (1.6) 1 (2.1) 0(0) 23 (5.2) 
6 C-section 1 (0.4) 2 (1.6)   1 (5.3) 4 (0.9) 
7 APH 2 (0.8) 0(0)   0(0) 2 (0.5) 
8 Systematic infection 5 (2) 1 (0.8) 1 (2.1) 1 (5.3) 
8 (1.8) 
9 Total 247 126 48 19 440 
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4.6.2.5.2 Foetal birth outcome 
 
The mean birth weight were 2999.3, 3136.5, 2659.8, 2327.6 grams for the respective 
first, second, third and fourth pregnancies. Overall, 4.6% of very low birth weight and 
7.8% of low birth weight were reported.  Big baby was 2% of the pregnancies. The 
normal birth weight was in the range of 62.5% and 87.4% (Table 4.16). 
TABLE 4.16: BIRTH WEIGHT IN HIV INFECTED MOTHERS IN ADDIS ABABA HEALTH FACILITIES, 
FEBRUARY-MAY, 2018 
Ser 
no. 
Birth 
weight 
Number of 
first 
pregnancy 
(%) 
Number of 
second 
pregnancy 
(%) 
Number of 
third 
pregnancy 
(%) 
Number of 
fourth 
pregnancy (%) 
Total 
pregnancy 
(%) 
1 <1500 6 (4) 2 (2.7) 2 (8) 2 (25) 12 (4.6) 
2 1500-2499 13 (8.6) 5 (6.8) 2 (8) 0 (0) 20 (7.8) 
3 2500-3999 132 (87.4) 63 (85.1) 21 (84) 5 (62.5) 221 (85.7) 
4 >4000   4 (5.4)   1 (12.5) 5 (2) 
5 Total 151 74 25 8 258 
 
There were a total of 74 (17.1%) stillbirths or miscarriage. Congenital malformations 
(down syndrome and mental retardation) was reported in 9 (2.1%) of the births; high 
(42.9%) in the fourth pregnancy and low during the first pregnancy (1.8%). Otherwise, 
345 (80%) of the births were normal deliveries (Table 4.17). 
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TABLE 4.17: FOETAL BIRTH OUTCOME AMONG BIRTHS OF HIV+ MOTHERS IN ADDIS ABABA 
HEALTH FACILITIES, FEBRUARY-MAY, 2018 
Ser 
No 
Fetal birth outcome 
First 
pregnancy 
(%) 
Second 
pregnancy 
(%) 
Third 
pregnancy 
(%) 
Fourth 
pregnancy 
(%)  
Total 
number of 
deliveries 
1 Live/normal birth 198 (80.5) 106 (85.5) 31 (67.4) 10 (55.6) 345 (79.7) 
2 Still birth 4 (1.6) 4 (3.2) 1 (2.2)   9 (2.1) 
3 Miscarriage 32 (13) 14 (11.3) 13 (28.3) 6 (33.3) 65 (15.0) 
4 
 Congenital 
malformation 8 (3.3)     1 (5.6) 9 (2.1) 
5 Other 3 (1.2)   1  (2.2) 1 (5.6) 5 (1.2) 
6 Total 245 (100) 124  (100) 46 (100) 18 (100) 433 (100) 
 
 4.6.3 Diabetes Mellitus  
 
The mean age of the 158 diabetic women involved in the study was 43.5 years (95% CI, 
42.5-44.7 years) ranging from 24 to 47 years. About 96.7% of the study participants 
were diagnosed at out- patients department (OPD) of the study health facilities. The rest 
(3.3%) were diagnosed and referred from other health facilities. Forty-one (27.2%) of 
the females had type I DM, and type II DM was reported in 109 (72.2%) the females. 
Sixty-one out of 103 study participants (59.2%) said at least one of their close relative or 
family had DM as well. History of DM in the family was reported by 72.5% of type II DM 
mothers while 9.1% of the type I DM reported presence of DM in the family. The 
average FBS during the data collection period was 194mg/dl and the range was 
293mg/dl (103-386 mg/dl). The mean weight of the DM females during the data 
collection was 66.4 kg ranging from 53-80 kg. As shown in the bar graph below, about 
27.2% of DM females were over-weight or obese.  
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Figure 4.2: The summary of BMI based on WHO definition among Addis Ababa diabetes 
females, 2018 
About 7% (11) DM patients documented to have TB disease and 5.7% (9) of them were 
hypertensive. 
 
4.6.3.1 HIV service at DM 
 
Out of the 152 diabetic patients, 67.8% of them were offered PITC at NCD, whereas 
25% were referred to HIV counselling and testing clinic or outpatient department for 
testing and counselling service. About 7.2% of diabetic patients had not given HIV 
testing and counselling service (Figure 4.3). Two (1.4%) DM patients were found to be 
HIV positive. 
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Figure 4.3: Service outlets where HIV counselling and testing was provided for DM 
females in Addis Ababa health facilities, 2018 
 
Among the DM females who responded for the question of “Have you ever got 
pregnant?”, about 79% said they had experienced at least one pregnancy so far. About 
20% of them had not got pregnant thus far (Figure 4.4).Two (1%) of them were 
pregnant during the data collection, the GDM. 
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Figure 4.4: Experience of pregnancy among DM females in Addis Ababa health facilities, 
2018 
 
4.6.3.2 Pregnancy outcome among diabetes mothers 
 
There were a total of 93 reported pregnancies with identified gestational age, 35-43 
weeks at birth. Two (2.2%) were preterm deliveries and three (3.2) were post term 
(Table 7.18). 
TABLE 7.18: GESTATIONAL AGE IN WEEKS AT BIRTH FOR DIFFERENT STAGES OF 
PREGNNACY AMONG DM FEMALES IN ADDIS ABABA HEALTH FACILITIES, FEBERUARY-MAY 
2018 
Ser 
No. 
Stage of pregnancy Number of 
pregnancy 
Mean 
GA in 
weeks 
Minimum 
GA in 
weeks 
Maximum 
GA in 
weeks 
1 First pregnancy 
78 39.6 37 43# 
2 Second pregnancy 
30 39.4 37 42.3 
3 Third pregnancy 
7 38 35* 40 
 
*Two pregnancies was reported to be born at 35 and 36 gestational age) 
# Three pregnancies ended in post term (GA>42eeks) 
79% 
20% 
1% 
Birth expereince among diabetic females in Addis Ababa, 
N=149 
Ever gor pregnant
Never
 Now pregnant
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The mean birth weight in the first, second and third pregnancy in grams were reported 
as 2886, 3010 and 3083 respectively. As shown the table below, the proportion of low 
birth weight and big baby was 3.2% each. 
 
TABLE 4.19: BIRTH WEIGHT AMONG THE DM FEMALES IN ADDIS ABABA HEALTH FACILITIES, 
FEBRUARY-MAY, 2018. 
Ser 
No 
Birth weight 
in gram 
First pregnancy 
(%), N=57 
Second pregnancy 
(%), N=29 
Third pregnancy  
(%), N=7 
Total  (%), 
N=93 
1 <2500 3.5 3.4 0 3.2 
2 2500-4000 96.5 89.7 85.7 93.5 
3 >4000 0 6.7 1 3.2 
 
More than 90% of pregnancies were normally delivered without a complication. 
However, still birth was 1.5% with the highest in the third pregnancy. Abortion was 
reported in 2.1% of the deliveries. Besides, 2 (1%) of the cases were congenital 
malformation and 4.6% was delivered by instrumental or caesarean-section (Table 
4.20). 
 
TABLE 4.20: PREGNANCY OUTCOME AMONG DM MOTHERS IN ADDIS ABABA HEALTH 
FACILITIES, 2018 
 
 
Ser 
No. Birth Outcome 
First 
pregnancy 
(n=111) , % 
Second 
pregnancy 
(n=60) , % 
Third 
pregnancy 
(N=25) , % 
Total  
(N=196) 
, % 
Fetal birth outcome 
1 Alive normal 96.4 95.0 91.7 95.4 
2 Still birth 0.9 1.7 4.2 1.5 
3 Miscarriage/ abortion 1.8 3.3 0.0 2.1 
4 Congenital malformation 0.9 0.0 4.2 1.0 
Maternal Birth outcome 
5 
Spontaneous vaginal 
delivery 96.4 95 92 95.4 
6 Instrumental delivery 0.9 1.7 4 1.5 
7 C-section 2.7 3.3 4 3.1 
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4.6.4 Summary 
 
This section described the DM, HIV and pregnancy care services at HIV, DM and ANC 
clinics. It also tried to respond for the objectives of determining the magnitude of DM 
among HIV, prevalence of pregnancy and pregnancy outcome among HIV and DM 
patients. The next section summarizes, describe and triangulate the findings in phase I 
and phase II.  
4.7 DESCRIPTION AND TRIANGULATION OF PHASE I AND PHASE II FINDINGS 
 
4.7.1 Introduction 
 
This section addresses the combined findings in phase I and phase II. These findings 
deal with the DM, HIV and pregnancy care services at the study health facilities. It also 
presents the magnitude of DM among HIV, the prevalence of pregnancy and pregnancy 
outcome among HIV and DM patients. 
 
4.7.2 DM testing service at ANC and HIV clinics 
 
As shown in table 4.21, there was no pregnant mother at ANC and only 16.2% of PLHIV 
that were tested for DM. This shows a routine DM service at both HIV and ANC clinics 
is minimal or absent. During the interview (Theme 7, Category 7.2) it was also indicated 
that the lack of awareness of the fact that DM could cause APO in pregnant mothers is 
a reason for the HCW not to practice the routine DM screening ANC/PMCTC clinics. In 
theme 5 and Category 5.1, the interviewees commented that such direction should have 
come from FMOM or RHB. 
 
A systemic review by Tieu, McPhee, Crowther, Middleton and Shepherd (2017:1) 
comparing the universal screening of DM among pregnant women with risk factor-based 
screening leads to more women being diagnosed with GDM. Therefore, more mothers 
with DM could be found out if DM screening is active and routine. Yet, the cost 
effectiveness and resource issue should be taken into consideration. Therefore, if the 
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universal DM screening is not feasible, at least risk profile based screening can be 
considered in Ethiopian setting. 
 
In the Theme 7 and category 7.4, it was also mentioned that there was not routine 
screening of PLHIV for DM, because HCW are not well aware of the fact that HIV or 
ARV could be a risk factor for DM. However, DM evaluation for HIV infected mother 
would be done if there are signs and symptoms of DM. This might explain the lower 
proportion of HIV infected mother were tested for DM. 
 
4.7.3 HIV testing and counselling service at ANC and NCD clinics 
 
HIV testing counselling service was done for 95% pregnant mothers. As indicated in 
phase I of the study, HIV testing and counselling is universal for all pregnant mother at 
ANC (Theme 6, category 6.1). That might be the reason why the higher proportions of 
pregnant mothers were tested for HIV. Similar to this study, Mayer et al (2018: 
e1002547) found that integrating HIV services into the MCH platform during the 
postnatal period was a simple and effective intervention, and this should be considered 
for improving maternal and child outcomes in the context of HIV. 
 
Though the HIV testing service at ANC is higher than the 67.8% for diabetic females 
(p=0.00), the HIV service at DM clinic seems more of the PITC approach rather than the 
routine or universal one (Category 7.3).The high rate of HIV testing for DM mothers is 
because diabetes mother could be offered  HIV testing and counselling at other OPDs. 
 
4.7.4 Prevalence of DM among HIV patients 
 
About 1.5% of the HIV infected mothers were found to be diabetic. This might be a low 
figure because complaint based DM evaluation is given for PLHIV (Theme 7, category 
7.4). That is, DM screening is not routine for all PLHIV at HIV clinic. Yet, the 1.5% of DM 
burden among PLHIV is higher or equivalent to the prevalence of 0.5-1.2% reported by 
Misganaw, Mariam, Ali & Araya (2014:1) in the general population. However, with 
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minimal or symptom based DM screening, the burden of DM among HIV infected 
mothers is not   low indicating that there could be missed or hidden DM cases among 
HIV patients. That is why the proportion is still much lower than the prevalence rate of 
6.5% at hospital settings in Addis Ababa (Gizaw et al 2015:74) and the 25% in Hawassa 
(Tesfaye et al 2014:102). In fact,  these studies are among all ages and both sex at 
referral hospitals as compared to this study that  included only female in their 
reproductive ages from two hospitals and 4 health centers.Hence, the need of routine 
DM screening among is unquestionable and need to be part of the clinical care. 
 
However, the prevalence of 1.5% among HIV infected mother is lower than the 10.3% in 
United States of America (U.S.A) (Hernandez-Romieu et al 2017: e000304). The 
difference might be due to the difference in the study setting and population, where DM 
is highly prevalent in the general population of U.S.A as compared to the population in 
Ethiopia, specifically among the reproductive age females in this study. According to the 
systematic review in Africa (Prioreschi et al 2017:e013953), there is no association 
between the prevalence of T2DM    and HIV infection or ART.  Other evidences 
indicated that the probably increase in the burden of DM among HIV could be age 
dependent (Mohammed, Shenkute & Gebisa 2015:197). 
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TABLE 4.21: SUMMARY OF DM AND HIV SERVICES AND PREVALENCE RATE OF DM, 
PREGNANCY AND APO IN ADDIS ABABA HEALTH FACILITIES, 2018 
Ser No. 
Variables 
Among pregnant 
mother on antenatal 
care N (%) 
Among 
diabetic 
females (%) 
Among HIV infected 
females (%) 
1 DM testing service 0 NA 54 (16.2) 
2 HIV testing and counseling service 313(96) 103(67.8) NA(Not applicable) 
3 Prevalence of pregnancy (ever get pregnant) NA  111(69.8) 280 (77.8) 
4 Prevalence of DM 0 NA  5 (1.5) 
5 Key adverse pregnancy outcome identified       
5.1     Spontaneous abortion or miscarriage 27(7.2) 4 (2.1) 59 (13.4) 
5.2     Pre-term 82 (22.2) 2 (2.2) 13 (3.5) 
5.3    Low birth weight 12 (4.1)  3(3.2) 32 (12.4) 
5.4    Big baby 14 (4.7) 3 (3.2) 5 (2) 
5.5    still birth 31 (8.3) 3 (1.5) 9 (2.1) 
5.6    c-section 127 (34) 6 (3.1) 4(0.9) 
5.7    Congenital malformation 5 (1.30) 2 (1.0) 9(2.1) 
5.8    HPN during pregnancy 21 (5.6)   23 (5.2) 
5.9    systemic infection     8(1.8) 
 
4.7.5 Prevalence of pregnancy among DM and HIV infected females 
 
Among the 360 HIV infected mothers, there were a total of 280 mothers that reported 
they had ever got pregnant (77.8%). There were a total of 370 pregnancies from the 
280 HIV infected mothers. Each mother had an average of 1.3 children. 
 
Among the 111 diabetic mothers, there were a total of 196 reported pregnancies. Hence 
the pregnancy rate was 69.8% .Each DM mother had 1.8 children. 
 
In both diabetic and HIV infected mother, the number of children per women is lesser 
than the fertility rate in Urban Ethiopia of 2.3 (Central Statistical Agency/CSA/Ethiopia 
and ICF 2016:13). This might be due to the evidence of reduced occurrence of 
pregnancy because HIV virus itself or ART can have a risk of infertility (Kushnir & Lewis 
2011:550-51; Marston et al 2017:S69; Ombelet 2008:605).  Similarly, a high glucose 
level impairs implantation and affects the level of hormones essential for pregnancy 
paving a way for infertility or reduced incidence of pregnancy (Livshits & Seidman 
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2009:701). Nevertheless, studies from African countries demonstrate that the rate of 
new pregnancies was significantly higher among women receiving ART (9.0/100 PY) 
compared to women not on ART (6.5/100 PY) (Myer et al. 2010: e1000229). On the 
other hand, Houle et al (2016:10) show that fertility patterns are not homogenous 
among different setting and countries.  
 
4.7.6 Adverse pregnancy outcomes among HIV and DM female patients 
 
The outcomes are grouped as follows: 
 
4.7.6.1 Spontaneous abortion or miscarriage  
 
Among HIV and DM females, the proportion of spontaneous abortion was 13.4% and 
2.1% respectively. The interviewees also confirmed that pregnancy among DM mother 
could end in miscarriage or abortion. They also indicated that the recurrent abortion is 
common. 
Gunatilake & Perlow (2011:106) indicated that a high glucose levels are reported to 
increase a woman’s chance of miscarriage by 30-60%. Even when implantation does 
occur, there is an increased risk of birth defects due to damage caused to embryonic 
cells form the high levels of glucose in the blood. 
  
4.7.6.2 Pre-term birth 
 
The preterm birth was computed to be 3.5% among HIV infected females and 2.2% 
among the diabetic mothers and there is no significant difference in the proportion 
(p=0.53). 
 
All the HIV infected mothers in this study were on ART due to the already implemented 
‘test and treat’ strategy. According to the studies by DOS RIES eta (2015:111) and Kim 
eta al (2012:1), pregnancies among mothers on ART can be complicated by pre-term or 
premature deliveries.  
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The study in a teaching hospital in Southwest Ethiopia shows that the preterm among 
HIV infected mothers was16.6%, much higher than the finding of 3.5% in this study 
(Kebede,  Andargie & Gebeyehu 2013:254). The difference in the rate of preterm could 
be due to the difference in the study design, setting and population type yet warrants an 
investigation. On the other hand, Gibb et al (2012:e1001217) demonstrate that there is 
no significant difference in the occurrence of pre-term birth in pregnancies that occurred 
before and after ART.  
 
The preterm delivery among diabetes mothers in this study is lower than the reported to 
preterm of 13.7% by Soliman, Salama, Al Rifai, De Sanctis, Al-Obaidly, Al Qubasi and 
Olukade (2018:11). The difference could be due to the variation in the study design and 
sample size. 
4.7.6.3 Low birth weight  
 
The low birth was 12.4% among HIV infected mothers and 3.2% among diabetic 
mothers (p=0.01). During the interview, the study participants mentioned low birth 
weight as one of the APO among HIV patients. They reasoned out that HIV infected 
mothers could face nutritional problem which could also affect their fetus. Hence, they 
justified that the low birth weight is inevitable among HIV pregnant mother if the mother 
get birth. 
 
Studies have indicated that LBW and malnutrition are more frequent in HIV-infected 
children (DOS REIS et al 2015:111; Kim et al 2012:1). The research at Gondar 
University Hospital in Northwest Ethiopia by Kebede, Andargie & Gebeyehu (2013:254) 
indicated the higher (21.4%)  LBW among HIV infected mother as compared the rate in 
this study (12.4%).  Adane et al (2014:90), in similar setting, shows 11.2% low birth 
weight rate among the ANC attendants. However, Gibb et al (2012:e1001217) further 
demonstrate that there is no significant difference in the occurrence of low birth weight 
in pregnancies that occurred before and after ART.  
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In this study almost all of the HIV infected mothers were on ART that could attribute to 
the higher proportion of LBW. Snijdewind, Smit, Godfried, Bakker, Nellen, Jaddoe, Van 
Leeuwen, Reiss, Steegers and van der Ende (2018: e0191389) showed that the use of 
ART prior to conception is associated with intrauterine growth restriction resulting in 
LBW. 
4.7.6.4 Big baby  
 
The birth weight of more than 4000gm, the big baby, was reported in 4.5%, 3.2% and 
2% of births among mothers on ANC follow up, diabetic mothers and HIV infected 
mothers respectively. There is no significant statistical difference among these 
proportions (P>0.05). Nevertheless, the HCW were explaining that overweight is the 
typical characteristic of births from diabetic mothers as compared to other births. They 
indicated that this could lead to other APO such as obstructed labor and shoulder 
dystocia 
The lower sample size of DM female might contribute to the lower rate of big baby. 
Otherwise, high glucose levels can lead to a big baby or macrosomia (Gunatilake & 
Perlow 2011:106). Soliman  et al (2018:11) also showed that macrosomia was more 
prevalent in babies of DM – about 6.4%. 
4.7.6.5 Still birth  
 
The interviewees worried about the potential high rate of HIV and DM associated 
perinatal death. They attributed the death to intra-uterine fetal death among HIV 
infected mothers and hypoglycemia induced death soon after birth in diabetic mothers. 
The respective 8.3%, 1.5% and 2.1% of births ended in death at term among ANC 
attendant mothers, diabetic and HIV infected mothers (Table 4.20). There is no 
significant statistically difference in the birth death among birth of diabetic and HIV 
infected mothers (p=0.6). 
 
The study by Adane et al (2014:90) in Gondar University Hospital, Northwest Ethiopia 
shows there was 7.1% stillbirth which is lower than the finding among ANC attendants 
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(8.3%) and higher than the reported still births among DM (1.5%) and HIV infected 
mothers (2.1%) in this study. This might be due to the difference in the study design, 
setting and population. 
 A systematic review in developing countries shows that frequently observed ART 
related adverse birth outcomes included low birth weight (LBW), preterm Birth (PB), 
Small for Gestational Age (SGA), while still birth and congenital anomalies were 
infrequent (Alemu et al 2015:31). Nevertheless, Sunjaya, and Sunjaya (2018:1031) 
showed that diabetes mothers with poor glucose control in pregnancy has been found to 
increase rates of infant mortality suggesting early detection of DM pregnant mother so 
that adverse pregnancy outcomes such as death would  be averted. 
 
4.7.6.6 Caesarean section  
 
As expected, the proportion of C-section among mothers on ANC follow up (34%) was 
greater than the same procedure among DM (34% versus3.1%, p=00) and HIV infected 
mothers (34% versus 0.9, p=00). Besides, more C-section was done among DM 
mothers as compared to HIV infected mother (3.1% vs 0.9%, p=0.04).  
 
The lower C-section procedure in this study might be due to the fact that spontaneous 
vaginal delivery is usually recommended among PLHIV pregnancies to avoid C-section 
induced MTCT and post operation complications which are higher among HIV infected 
mothers in developing countries(Jamieson, Read, Kourtis, Durant, Lampe and 
Dominguez 2007:S96; Kourtis, Ellington, Pazol, Flowers, Haddad and Jamieson 
2014:2609) . Hence, in these settings, C-section or instrumental deliveries are avoided 
as much as possible, except in the form of elective delivery procedures (Kennedy, Yeh, 
Pandey, Betran, and Narasimhan2017:1579). However, a population based cohort 
status in USA indicated that there is a higher rate of cesarean delivery (OR 3.06, 95% 
CI 2.79-3.36) as compared to non-HIV infected mothers. This is because in USA there 
is a better facility and infrastructure including infection control so that C-seciton is 
preferable to vaginal delivery for HIV infected mothers (Arab, Spence,  Czuzoj-Shulman 
and Abenhaim 2017:599). 
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A big baby (macrosomia) resulting in a c-section, which increases a mother’s chance of 
infection is also another effect of hyperglycemia in pregnancy (Gunatilake & Perlow 
2011:106). Unlike this study, the proportion of DM women who underwent Cesarean 
section in the study of Soliman et al (2018:11) was significantly higher in the DM, i.e 
51.9%. The difference might be due to the variation in the settings where western health 
facility is well facilitated to do elective C-section for DM pregnant mothers. 
4.7.6.7 Congenital malformation  
 
The reported congenital malformations were Down Syndrome and mental retardation. 
Among the ANC attendants this was 1.3%, and it was 1% among the births of diabetic 
mothers and 2.1% among HIV infected mothers. Nevertheless, there was no significant 
difference in the proportion of the reported congenital malformation between ANC 
attendance and HIV (P=0.36), DM and ANC attendance (p=0.14) and HIV and DM 
females (p=0.32). The occurrence of possible congenital malfunction among HIV 
females was indicated during IDI and FGD. The interviewees mentioned that HIV could 
affect the growth of the brain, and thus leads to congenital anomalies. 
A systematic review in developing countries shows that frequently observed ART 
related adverse birth outcomes included low birth weight, preterm Birth, Small for 
Gestational Age (SGA), while still birth and congenital anomalies were infrequent 
(Alemu et al 2015:31). 
Regarding DM, however, Soliman et al (2018:11) indicated that the prevalence of 
congenital anomalies does not differ between DM and non-diabetic patients. The 
difference with this study could be due to the design and sample size difference. 
However, the IDI and FGD participants stressed that the congenital malformation 
among in birth from diabetic mothers with a poorly controlled blood  glucose level is 
inevitable.   
Hypertension during pregnancy (Pre-eclamsia and Eclamsia) was reported only among 
HIV infected mothers and mothers with ANC attendance. Hence, the proportion of HPN 
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during pregnancy were 5.6% among the ANC attendance mothers and 5.2% among the 
HIV infected mothers on ART, without a statistical difference in the proportion (p=0.8). 
4.7.6.8 Systemic infection  
 
The systemic infection or infection after birth was reported among HIV infected mother 
on ART as a complication of birth. This was reported in 8 births (1.8%). 
 
In the quantitative data analysis, there were no reports of HIV infected children of HIV 
infected mothers or diabetic infants or children of diabetes mothers. This could be due 
to the implementation of the strong PMTCT option B+ and too early to detect diabetic  
children from diabetic mothers. The risk of mother-to-child transmission is as low as 2% 
in settings where treatment with ART medication has prolonged life expectancy for 
many potential parents with HIV (Myer et al 2010: e1000229). However, during the 
phase I study, the HCWs commented there could be MTCT among births of PLHIV and 
diabetic children among diabetic mothers later in their life.  
 
In fact there were participants who confidentially spoke out that there will not be any 
APO due to HIV, ART or DM. 
 
4.7.7 Conclusion 
 
It was shown that the DM screening service is at infancy level at HIV and ANC units 
though these are units where high risk mothers and their pregnancy for DM have a 
follow up at. The magnitude of DM among HIV patients is a bit higher than the general 
population in need of integrated routine DM screening among HIV and pregnant 
mothers in the reproductive age. All sorts of APO were also noted and witnessed by the 
HCW. Hence, not only should the HIV and DM considered to be screened but also other 
causes of APO among DM and HIV infected mothers should be explored and looked 
into so that the higher APO is addressed. The following chapter, therefore, is aimed to 
develop the integrated DM/HIV/pregnancy care services to deal with APO. 
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CHAPTER 5 
 
DEVELOPMENT OF AN INTEGRATED SERVICE DELIVERY 
MODEL FOR HIV, DM AND PREGNANCY CARES 
 
5.1 BACKGROUND TO THE MODEL DEVELOPMENT 
 
According to Walker and Avant (2005:28) theory is defined as,”... an internally 
consistent group of relational statements that presents a systemic view about a 
phenomenon that is useful for description, explanation, prediction and prescription or 
control”. Chinn and Kramer (2011:155) defined empiric theory as a creative and 
rigorous structuring of ideas that projects a tentative, purposeful, and systematic view of 
a phenomenon. Walker and Avant (2005:28) described a model as a graphic 
representation of a theory. Models are delivery strategies that prescribe specific ways in 
which professionals will work together to provide healthcare services. Citing Baltes, 
Reese, and Nesselroade (1977:17) walker and Avant (2005:28) also indicate that a 
model is any devise used to represent something other than itself. Hence, the parts of 
the theory should correspond to the parts of the theory they represent, Walker and 
Avant (2005:28) (citing Brodbeck 1968:583). The authors also stated that description, 
explanation, prediction and prescription/control are the phase of theory building. 
 
According to Walker and Avant (2005:29), a model can be drawn schematically using 
symbols and arrows or a mathematical model. In addition, Chinn and Kramer 
(2011:157) described a model as a symbolic representation of an empiric experience in 
the form of words, pictorial or graphic diagrams, mathematical notation or physical 
materials. The schematic drawing is used to develop a model in this study. Chinn and 
Kramer (2011) and Walker and Avant (2005) are the basis for the development and 
evaluation of the model in this study. 
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5.2 PURPOSE OF THE MODEL DEVELOPMENT 
 
As explained in chapter 1 and chapter 4, the HIV and DM are a missed link to address 
APO and there is a loose collaboration between HIV and DM though both are the risk 
factors for the APO. Hence, the development of the service delivery model inclusive of 
HIV and DM could be a better strategy to deal with pregnancy related complication in 
the reproductive age females having the two disease conditions. The developed model 
aimed to guide the program managers, program officers and HCWs to prevent the APO 
in HIV and DM mothers. 
 
5.3 COMPONENTS OF THE MODEL 
 
There are two main components of the model. These are, 
1. Administrative level integration of DM, HIV and pregnancy care, and 
2. Facility level integration of DM, HIV and pregnancy care. 
 
5.3.1 Administrative level integration of DM, HIV and pregnancy care 
 
This is the model that can be applicable at the federal ministry, region, sub-cities or 
zones, districts or woredas. 
 
5.3.2 Facility level integration of DM, HIV and pregnancy care 
 
This is the model that works at hospitals, health centers and health posts. 
 
5.4 BUILDING THE MODEL 
 
This model was developed through a process of literature review, findings in phase I 
and II, observing clinical practice and expert consultation. Therefore, the development 
of the model mainly depends on the theme 6 where the integration status among HIV, 
DM  and pregnancy care was explored at administrative and health facility levels.  The 
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process of the model development is also using the Theme 7 where integrated 
approaches are suggested by HCWs at facility level and program officer and managers 
at administrative levels (FMOH, RHB, sub-cities and districts). Hence, inductive 
reasoning was applied  where findings of phase I and phase II were combined to find 
the pattern; in this case the parts of the model (Heit and Rotello 2010:805). While 
developing the model the intensity or degree of integration by Leutz (1999) (cited in 
Nuffiled trust (2011) and domains of integration (Kobner 2009) are taken into 
consideration. 
 
5.4.1 Organizational integration 
 
Organizational integration refers to the extent that services are produced and delivered 
in a linked-up fashion. It is an inter-organizational relationship by pooling the skills and 
expertise of the different organizations (Kodne & Spreeuwenberg 2002:3). In this study 
this is taken as an integration relationship between health care organization or 
administrations such as FMOH, RHB, sub cities and district levels (Kodner 2009:11) 
and assigned by the following diagram (Figure 5.1). 
 
 
 
Figure 5.1: Organizational integration 
 
5.4.2 Clinical or service integration  
 
Clinical or service integration refers to the coordination of services in a single process 
across time, place and discipline (Kodner 2009:11-12). Also, Kodner and 
Spreeuwenberg (2002:4) described clinical integration as the coordination of person- 
focused care in a single process across time, place and discipline. This is considered at 
health facility level in this study. Based on Theme 7, clinical integration in this study is 
Organizational 
integration: 
administrative level 
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among DM, HIV and pregnancy care at facility level. The facility level integration is 
indicated by the following box in the model (Figure 5.2).  
 
 
 
 
Figure 5.2: A box respresenting the clinical or service integration 
 
5.4.3 Program or service types  
 
The NCD, MCH or family health and HIV or HAPCO are currently standalone units both 
at administrative and health facility levels. That is why they are shown with the full 
border lined box and in different colours below. 
 
5.4.3.1 At the administrative level 
 
At the FMOH, RHB or sub cities DM is under DPCP directorate or medical service 
process owner, pregnancy care is within MCH or family health directorate or core 
process and HIV is within HAPCO or DPCP core process or directorate.  
 
 
 
Figure 5.3: Three different units at administrative levels 
 
 
 
NCD/DM (DPCP) HIV/HAPCO 
MCH/Family 
health 
Clinical or service 
integration: facility 
level 
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5.4.3.2 At the facility level 
 
At the health facilities DM is within NCD clinic, pregnancy are service is delivered at 
ANC and family planning clinic and HIV prevention, care and support is rendered at HIV 
clinic. Hence, these are represented in box as follows. 
 
 
 
 
Figure 5.4: Three different units at facility level; NCD, ANC and HIV 
 
5.4.4 Linkage 
 
Linkage is taking place between existing organizational units with a view to referring 
patients to the right unit at the right time, and facilitating the communication between 
professionals involved in order to promote continuity of care. Responsibilities are clearly 
aligned to different groups with cost shifting. While exploring the existing intensity of 
integration, this degree of integration was noted between DM and ANC or between HIV 
and DM (Table 4.2). However, it is not applied in the development of the mode because 
it was not suggested to be degree of integration to be practised among DM, HIV and 
pregnancy care (Table 4.3). Linkage was reported to be a poor collaboration (theme 6). 
It is represented by the following dotted straight line. 
 
 
 
Figure 5.5: Broken line representing  linkage level of integration 
 
 
NCD clinic 
ANC clinic HIVclinic 
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5.4.5 Coordination 
 
Citing Leutz (1999), Kodner (2009:12) described coordination as structured, inter-
organizational response involving defined mechanisms to facilitate communication, 
information sharing and collaboration while retaining separate eligibility criteria, service 
responsibilities and funding. The implementation of the coordination is inside the 
existing organizational units so as to coordinate different health services, share 
clinicians’ information and manage transition of patients between different units (Kodne 
& Spreeuwenberg 2002:5). It is shown with a dotted line to indicate that there are some 
services that need consultation or formal referral. The service at the blunt side is to be 
coordinated at the service outlets at end of the arrow end. The double arrow is to show 
a bilateral coordination. 
 
 
 
 
Figure 5.6: Diagram indicating unilaternal and bilateral coordination  of integration 
 
5.4.6 Full integration 
 
According to Kodner (2009:12), full integration refers to a ‘new’ entity that consolidates 
responsibilities, resources and financing in a single organization. The same authors also 
indicates that full integration pools resources, allows a new organization to be created 
alongside development of comprehensive services attuned to the needs of specific 
patients group. According to Theme 7, it is suggested that almost critical services of DM 
and HIV could be given at ANC and also important services of pregnancy care and DM 
services could be rendered at HIV unit. Funding, planning, monitoring and evaluation, 
capacity building and policy guideline could be arranged in such way that HIV and 
pregnancy care could be fully integrated. 
Coordination 
Coordination 
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The representation of full integration is an arrow with the bold border and written 
internally as ‘Full integration’. The service at the blunt edge is to be fully given in the 
service outlet shown with the arrow (Figure 5.7 ).  
 
 
 
 
 
 
 
Figure 5.7: Diagram indicating unilateral and bilateral full integration 
 
5.4.7 Horizontal integration 
 
Horizontal integration is improving the overall health of people and populations by 
cross-sectorial collaboration (Kobner 2009:13). Horizontal integration in this study is 
suggested to be among HIV, DM and pregnancy care at health facility level. It is 
represented with the following symbol. 
 
 
 
 
 
Figure 5.8: Diagram representing horizontal integration 
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5.4.8 Virtual integration 
 
Virtual integration takes the form of alliances, partnerships and networks created by a 
number of organisations (Nuffiled trust 2011:9). This is exemplified by the alliance 
between HAPCO, DPCP and MCH directorate at FMOH. The dotted line is to show that 
there are other stakeholders other than the aforementioned. 
 
 
 
 
Figure 5.9: Figure representing virtual integration 
 
5.4.9 Components of the tripartite  
The tripartite is the term used to desribe the three health care conditions such as DM, 
HIV and pregancy care. At the adminstrative level, these represente the unit that 
address each of these health conditions. The three unit are HAPCO for HIV, DPDP for 
DM, MCH or family health for pregnacy care. Thus, at the adminstrative level. the 
tripartite is indicated  by the following diagram (Figure 5.10) 
 
 
 
 
 
 
Figure 5.10 : The components of tripartite at the administrative level 
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The three item at the facility level are HIV clinic for HIV, NCD clinic for DM and ANC  
clinic for pregnancy care, and shown by the folloiwng diagram (Figure 5.11). 
 
 
 
 
 
 
Figure 5.11: The component of tripartite at the health facility  
 
In the health facility level integration, coordination is exemplified by the integration of 
HIV service at DM clinics. All the HIV related services could be given at DM clinic 
except treatment and follow up. The SOPs on the HIV prevention and testing and HIV 
testing registers could be put at DM clinic. In addition, the pregnancy care service at DM 
and HIV clinic could be taken as coordination kinds of integration. This is because 
referral of pregnant mothers to ANC is inevitable though HIV testing, counselling 
services are given at DM or HIV units. Also, pregnancy care services such as 
pregnancy counselling and testing and short term FP services could be given at NCD 
and HIV clinics. Hence, guidelines, protocols, recording and reporting tools related to 
the pregnancy care could be developed and put at NCD and HIV. However, for the full 
follow up of pregnancy and for the special consultation, one can make a referral to ANC. 
All the comprehensive HIV care and treatment and care could be offered at ANC as 
PMCTC at facility level and represented by a single arrow. Also, all the packages of DM 
services could be rendered at ANC or HIV that warrants full integration of DM in to HIV 
and ANC (Figure 5.12).  
 
 
 
 
NCD clinic 
HIV clinic 
ANC clinic 
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Figure 5.12:  Integration at facility level:  clinical service and horizontal integration 
 
In the administrative leve, common financial, planning, capacity building, policy 
guideline development and monitoring and evaluation related to HIV could be 
implemented at MCH/family healthy and vice versa. This is shown with green double 
arrow. Policy guides need to be produced encompassing DM, HIV and pregnancy care 
together with joint funding, planning and monitoring system. 
The joint financing, planning, supportive supervisions related to HIV and DM care could 
be coordinated among HAPCO and NCD units or NCD and family health unit at 
administrative level that is represented by the double arrows of the coordination (Figure 
5.13). 
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Figure 5.13:  Integration at administrative level: organizational and virtual integartion 
 
5.4.10 Functional integration 
 
The functional integration defined as a mechanism by which financing, information, and 
management modalities are linked to add the greatest overall value to the system 
(Kodner & Spreeuwenberg 2002:4; Kodner 2009:12). It supports clinical and 
professional integrations (See sections 5.4.12 and Figure 5.16). In this study, functional 
integration includes the coordination of developed policy guidelines and protocols, 
financial and human resource management, strategic planning and information 
management (Themes 1,2, 3 and 5) that bridge the gap and links administrative level or 
organization integration (see Figure 5.13) and facility level or clinical integration (see 
section 5.4.12).  The double arrow  shown in figure 5.14 shows that there is a bilateral 
coordination played by the functional integration (Kodner 2009:12). This is drawn 
between facility and administrative integration level (Figure  5.15).  
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Figure 5.14: Diagram of functional integration  
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Figure 5.15. The diagram showing the bilaterla coordination played by the functional 
integration between facility and administrative level 
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5.4.11 Vertical integration 
 
Kodner (2009:13) related vertical integration to the idea that diseases are treated at 
different (vertical) levels of specialization and the integration of care across sectors, 
e.g., integration of primary care services with secondary and tertiary care services. In 
this study it is the integration between administrative and facility levels services. Hence, 
vertical integration is among FMOH, RHB, sub-cities; and among health facilities such 
as between hospitals and health centers. The connection is through planning, training, 
funding, and monitoring and evaluation and already represented by the functional 
integration (see section 5.4.10). Therefore, the mechanisms of vertical integration, as 
represented in the functional integration in this model development, are monitoring and 
evaluation such as supportive supervision and recording and registration, budget or 
financing, joint planning and police guides and protocols or algorisms inclusive of DM, 
HIV and pregnancy care (Theme 1-5). 
 
Both vertical (Section 5.4.11) and horizontal integration (Section 5.4.7) are paramount 
to counteract the fragmentation of services in a health system (Nuffiled trust 2011:8-9). 
Hence, in the development of this model, both vertical and horizontal integration are 
used. Firstly, this is because incorporating vertical and horizontal integration can 
improve the provision of continuous, comprehensive, and coordinated services across 
the entire care continuum. Secondly, partnerships across traditional organizational and 
professional boundaries are needed in order to improve the efficiency and quality of a 
system (Kodner 2009:12; Kodner & Spreeuwenberg 2002:4). 
 
5.4.12 Professional integration 
 
Kodner (2009:12) defined professional integration as a health care provider’s 
relationship within and between administrative/organization and clinical unit or health 
facilities. Professional integration could be practiced at facility level for the clinical 
integration in the form of horizontal integration. This is the communication among HCW 
at DM, HIV and pregnancy care (Theme 6 and category 6.7). Also, it is taken as a 
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partnership between health care officers that are expertise of HIV, DM and pregnancy 
care (Theme 6 and Category 6.7). Professional integration is a cross-cutting at health 
facility or administrative level. Hence, this is represented by the symbol of wider line 
(Figure 5.16). It surrounds and connects administrative/organizational and 
clinical/facility level integration (Figure 5.17 ). 
 
 
 
 
 
 
 
 
Figure 5.16:The figure representing the professional integration 
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Figure 5.17 : Professional integration surrounding  and connecting  administrative and 
facility level integration 
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5.4.13 The tripartite integrated model of care:DM/HIV/pregnancy care 
 
As described through sections 5.4.1 to 5.4.12, the overall model related to 
DM/HIV/pregnancy care is represented by the following diagram (see Figure 5.18). It is 
named tripartite integration model because three programs or health entities such as 
DM, HIV and pregnancy care are involved. The entire model could be named as The 
Tripartite Integration: DM/HIV/Pregnancy care service delivery model. 
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Figure 5.18: the tripartite integrated model of care: DM/HIV/pregnancy care 
 
5.5 EVALUATION OF THE TRIPARTITE DM, HIV AND PREGNANCY CARE 
SERVICE DELIVERY MODEL 
 
The HIV, DM and MCH experts were approached to look into and evaluate the model. 
The experts used the following criteria to evaluate the model. 
a) Clarity: to check whether the model is easily understandable. 
b) Simplicity: to check whether it is not complex to look at. 
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c) Consistency: to check whether the model can service similarly at all levels. 
D) Generalizability/Transferability: to check whether it could be applicable in 
other regions of Ethiopia, other than the study region. 
e) Importance: to check that the model is paramount for Ethiopia. 
f) Practicality: to check whether it is suitable and works in Ethiopia. 
g) Feasibility of the model: to check whether the model feasible in the health 
finance and health policy of Ethiopia. 
 
A brief aim of the model, how the model was developed and the description of the 
model was summarized and given to the experts. After reading the summary and 
looking into the diagram of the model, the experts were asked to evaluate the model 
using the table at end of the summary with the aforementioned criteria. Each criterion 
was assessed as, 1) Totally disagree 2) Disagree 3) Just agreed and 4) Totally agreed. 
That is, the Likert  scale was used to evalaute the model using the aforementioned 
criteria.The evaluators were also asked to put their remark about the model. They were 
also requested to criticize, put any suggestion and recommendations regarding the 
model (see Annexure K). Accordingly, the following section presents and discusses the 
finding of the evaluation, including the remarks and recommendations by the experts. 
 
5.5.1 Experts participated in the evaluation of the model 
 
Describing the aim of the model and the purpose of the evaluation, the DM, HIV and 
MCH experts were approached at FMOH (3), RHB (2), and stakeholders or partners 
working on HIV program (4). 
 
The experts were nine in number. Four were working on HIV program, three on NCD 
and two on MCH. The age of the evaluators ranged from 33-59 years. Seven were 
males. They did have 11-26 years of work experience. Almost all of them had a 
minimum of 3 years work experience at health facilities. Eight of them had at least a 
second degree or specialization in pediatric or internal medicine. 
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5.5.2 The findings of the evaluation  
 
The following table summarized the finding from the experts’ evaluation of the tripartite 
model.  All in all, there were 60 responses (95%) that indicated that the experts at least 
agreed with the developed model using the 7 criteria ( See  Table 5.1). 
 
TABLE 5.1: THE RESULT OF THE EVALUATION OF THE TRIPARTITE SERVICE DELIVERY MODEL 
OF HIV, DM AND PREGNANCY CARE, ADDIS ABABA 2018  
Ser  
No. Criteria 
Totally 
disagree Disagree Agree 
Totally 
agree 
1 Clarity     4 5 
2 Simplicity     7 2 
3 Consistency   1 3 5 
4 Generalizability or transferability     7 2 
5 Importance     7 2 
6 Practicality     4 5 
7 Feasibility   2 5 2 
8 Total out of 63  0 3 37 23 
 
5.5.2.1 Clarity of the model 
 
All of the experts commented that the model is clear and understandable. However, an 
expert commented the writing of the professional integration should have been inside 
the arrow.  
5.5.2.2 Simplicity of the model 
 
Again all of the evaluators stated that the model is simple to read but the 
organizational/administrative and facility/clinical level integration are not easily identified 
in the first look. Hence, they should be bold to be seen easily and was corrected as 
suggested. 
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5.5.2.3 Consistency of the model 
 
Eight of them reported the model is consistence while describing the degree of relevant 
integration. However, one of the experts was not agree as to the consistence of the 
model because the way coordination was explained at administrative and facility level 
was not the same. 
 
5.5.2.4 Generalizability/Transferability 
 
The experts rated this criterion as just agreed justifying that the model could be used in 
all administrative levels in Ethiopia, and in all kinds of health facilities including private 
health facilities. One of the experts said that the HIV and DM issue as related to MCH is 
cross-cutting and so the model could be applicable all over. 
Nevertheless, they commented that advocacy work need to be done to convince 
decision makers as to the importance of the integration so that it would be applicable in 
other regions of the country. 
 
5.5.2.5 Importance 
 
All of the experts did not have a doubt on the importance of the model; seven of them 
rating this as just agreed and the rest totally agreed. The experts commented that the 
model helps to reduce the workload of HCWs including the work of laboratory 
technicians as it assists to deal with diseases conditions of a patient at once. The 
importance of the model is unquestionable as far as there is a sound communication 
among the HIV, DM and MCH clinicians where the model serves as a time and resource 
efficient. In addition, the experts said that the model addresses the challenge faced by 
the young pregnant women who could have HV or DM. 
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5.5.2.6 Practicality of the model  
 
One of the experts doubted the immediate implementation of the model. This is 
because the health structure and health system of Ethiopia might not accommodate the 
model. Thus, the pilot work was suggested before putting the model into practice. 
Otherwise, the remaining experts rated the practicality of the model as at least just 
agreed. 
 
They suggested that the practicality should be assessed before the wider scale up of 
the model. The other practical challenge to the practical implementation of the model, 
as stated by the NCD expert, is that the full integration could be hindered by the 
challenging financial system where MCH and NCD have an isolated resource or budget. 
To address such kinds of issue the role of relevant organization, stakeholders and 
donors is critical. 
 
5.5.2.7 Feasibility of the model 
 
Again two of the experts doubted the implementation of the model as it is now. They 
said that HIV and maternal and child health programs are a matured and well-funded 
program, unlike the NCD. That is, NCD is a young program in Ethiopia and just being 
decentralized. The attention given and the financing of the NCD program are limited as 
well. On top of these, the national health policy in Ethiopia is geared towards the 
prevention and control of communicable deceases and on the health of maternal and 
child health (The Federal democratic Republic of Ethiopia Ministry of Health 2015:12). 
Hence, the integration of HIV and DM may be challenged unless otherwise it is piloted. 
Policy revision may consider the roaring burden of NCD in Ethiopia. Hence, it was 
commented that feasibility needs discussion with the stakeholders. 
The other HIV expert also pointed out that the model could be used as the opportunity 
to strengthen the health system so that the direction should be coming from the FMOH 
for the feasibility of the integration. 
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All in all, the experts gave their opinion that the optimal integration and coordination of 
the DM, HIV and pregnancy care in the form of tripartite model is clear, simple and 
consistence as described with minimal modification of the original model. The current 
health system, health policy of the country, joint financing, shared planning and 
monitoring may consider the integration approach of service delivery. For the effective 
implementation of the model advocacy works, building the capacity of the HCWs and 
program leads, revising policy guides to accommodate the integration of NCD services 
to communicable diseases prevention and control are the key area of revisions. 
 
5.6 THE COMPARISON OF THE INTEGRATED THEORETICAL FRAMEWORK AND 
THE TRIPARTITE SERVICE DELIVERY MODEL FOR HIV, DM AND PREGNANCY 
CARE 
 
As indicated throughout this study, the integration theoretical framework applied in this 
study is well fit to guide this study. It was also used as a sound directing tool to come up 
with the tripartite service deliver integration model of DM/HIV/pregnancy care. 
 
The model developed here is not serving as theoretical model upon which feature 
studies are relying on, but it supports the practical quality improvement, care and 
treatment of DM, HIV and pregnancy care so that mothers could give birth to a healthy 
baby. The model, if rightly adopted and practiced, could also address clinical and 
pregnancy complications among DM and HIV patients could be averted.  
 
5.7 CONCLUSION 
 
An integrated care  deals with the coordination for the betterment of the patient care. A 
single model could not be a suitable for all sitautions and contexts; however, the 
analysis of of various integrative processes are essential to support the integartion 
within a cerain circumstance. 
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It is also paramount to have a know-how of the dynamics between different degrees or 
intensities of itegration that can happen in both ways, like in the case in figure 5.18, 
interms of fully inteartion and  potentially framgmenting servcies. As Leutz points out, 
‘one man’s integration is another’s fragmentation’ (Leutz, 1999). In other words, 
integration within one part of a health system may well facilitate movement along the 
continuum, but it can also result in fragmentation elsewhere. In short, this chapter 
presented the process of the tripartite model development and evaluation. Chapter 6 
wraps up the study by conclusions, limitations and recommendations. 
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CHAPTER 6 
 
CONCLUSIONS, LIMITATIONS AND RECOMMENDATIONS 
 
6.1 INTRODUCTION 
 
The objective of this chapter is to provide the study conclusions, limitations and 
recommendations. The purpose of this study was to develop a model for integration of 
DM, HIV and pregnancy care services. 
 
6.2 RESEARCH DESIGN AND METHOD 
 
The researcher applied a sequential exploratory mixed method under the pragmatic 
paradigm to achieve the objective of the study. Phase I of the study explored the 
intensity and the domains of integration among HIV, DM and pregnancy care using IDI 
and FGD  among HCWs and program officers, and observation at health facilities and 
departments of where HIV, DM and pregnancy care are addressed in the FMOH, 
AACHB and sub-cities. An open code and theme based data analysis was carried out. 
Phase II of the research applied a descriptive quantitative deign where DM, HIV and 
pregnancy care services were described and the burden of DM among HIV and the 
prevalence rate of pregnancy and pregnancy outcome among DM and HIV patients 
were determined. At end, both qualitative and quantities data were triangulated to assist 
in the development of the integrative service delivery model of DM/HIV/pregnancy care 
among the reproductive age females. 
 
6.3 SUMMARY AND INTERPRETATION OF THE RESEARCH FINDINGS 
 
6.3.1 The burden of DM among HIV females 
 
There was scarce knowledge among the HCW as to where HIV and its treatment are 
risk factors for chronic illness such as DM. However, the 1.5% burden of DM among 
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HIV patients in Addis Ababa is higher than the general population in Ethiopia in the 
background of absent routine and active screening of DM among HIV patients. 
 
6.3.2 The prevalence of pregnancy and APO among DM females 
 
The prevalence of pregnancy (70%) among DM mothers (or 1.8 per diabetic mother) 
was lower than the general population of 2.5 per woman. LBW (3.2%), big baby (3.2%), 
C-section (2.2) and pre-term birth (2.2%) are the main APO among DM mothers. 
 
6.3.3 The prevalence of pregnancy and APO among HIV females 
 
HIV infected mothers had also a pregnancy rate of 78%, or 1.3 per mother, and a high 
APO such as abortion (13.4%), LBW (12.4%), still birth (2.1%), pre-term birth (3.5%), 
congenital malformation (2.1%). These necessitate strengthening the pre-conception 
counseling for HIV infected females. 
 
Hence, the higher APO among DM and HIV infected mothers warranted an integrated 
model of care to improve the pregnancy outcome. 
 
6.3.4 An integrated DM, HIV and pregnancy care services at facility level 
 
Except the notable integration service between pregnancy care and HIV care, the DM 
service at HIV and ANC, and pregnancy care at DM were not more than the linkage 
level of integration. However, these were the gray area for the better intensity of 
integration. Thus, HCWs and program managers suggested the possible full integration 
of DM and HIV services at ANC, and DM services at HIV clinics. Also, coordination can 
be practiced for pregnancy care at DM and HIV clinics and also for HIV service at NCD 
clinic. 
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6.3.5 The integrated DM, HIV and pregnancy care service at administrative level 
 
At administrative level, HIV and pregnancy care services could fully be integrated 
between HAPCO and MCH units. Bilateral coordination is feasible for pregnancy care 
and DM services between MCH and NCD units; and for HIV and DM services between 
HAPCO and NCD/DPCP. 
 
6.3.6 The tripartite DM/HIV/pregnancy care service delivery model 
 
The model developed is termed as the tripartite integration model of DM, HIV and 
pregnancy care. It was developed based on the triangulated findings from phases I and 
II, literature review and evaluation from the experts. It aims to improve pregnancy 
outcome among DM and HIV infected mothers. The model has two main components: 
the integration at facility and the administrative levels. The tripartite model at facility 
levels tells us that a routine HIV testing, counseling and referral could be done at DM 
clinics. An active and a routine DM screening, diagnosis and treatment services could 
be given at HIV and ANC clinics for diabetic and HIV positive pregnant mothers. At 
least, pregnancy counseling and testing, and the provision of short term family planning 
services could be given at DM or HIV clinics. 
 
The tripartite model of service delivery at administrative level assists the practical 
implementation of the model at facility levels by developing policy guidelines, SOP and 
algorism containing the integrated service delivery among HIV, DM and pregnancy care. 
This is through the joint planning, financing or budgeting, supportive supervision, 
monitoring and mentoring as well as building the capacity of officers and clinicians on 
the integrated service delivery of DM, HIV and pregnancy care. 
 
There is a place for stakeholder and other partners that need to give a hand technically 
and financially on the integrated service delivery both at facility and administrative 
levels. Above all, the model also deals with the need to have an integrated mentality 
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among professionals working both at facility and administrative levels to address the 
APO though the integrated HIV and DM services. 
 
6.4 CONTRIBUTION OF THE STUDY 
 
The model was designed to provide an integrated DM, HIV and pregnancy care service 
to improve a pregnancy outcome for reproductive age females. The tripartite model 
would fill the gap of the missed link between the HIV and an accelerating DM in Ethiopia 
in terms of reducing APO. In addition, the model could contribute to the effort of 
reducing the current higher child and maternal mortality and morbidity rates in Ethiopia. 
That is, the application of the model could play a role in improving APO and hence 
morbidity and mortality among mothers and children. It could be used by both clinicians 
and program managers at all levels. 
 
6.5 LIMITATIONS 
 
1. The concept of integration is a complex idea, and the researcher could not explain 
and describe the whole set of the integration but tried to describe as it was 
practically applied to the related items of DM, HIV and pregnancy care or outcome. 
Hence, the ‘co-variates’ and preconception part of the integration theoretical 
framework was not addressed in this study. Hence, future studies could explain 
factors associated with APO among DM and HIV infected mothers using the 
framework. 
2. This study does not include the district level interview or structured data collection. 
This is because the district health office is near to the primary health care unit or 
health centers and the structure and the staff is similar. 
3. From the NCDs, only DM was included in this particular study. Together with DM, 
the integration of other NCDS, such as HPN, to HIV or pregnancy care may be 
possible. DM was given due attention because it has an objective relation with both 
HIV and its treatment, and the pregnancy care. As far as there is strong scientific 
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evidence of the relation of other NCD, that are given together with DM at NCD, with 
HIV and pregnancy care they could be part of the tripartite integration model.  
6.6 RECOMMENDATIONS 
 
The recommendations for this study are as follows: 
 
6.6.1 Recommendation to the HCWs 
 
HCWs could use the model to practice an active and routine DM screening and 
evaluation at HIV and ANC units; to give routine pregnancy care service at DM and HIV 
clinics. They may consider the comprehensive disease entity rather than having 
separate clinics for a patient with multiple and related illnesses for the effective and 
efficient approach of rendering health service. This necessitates the mentality of 
integrated service delivery. However, these all neccessiated the direciton from FMOH or 
RHBs. 
 
6.6.2 Recommendation to program managers and policy makers (FMOH, RHB, 
Zones/sub-cities, district/woreda)  
 
1. There is a need to prepare the policy guide on the routine and active screening of 
DM at HIV and ANC. They might also prepare SOPs, implementation guidelines and 
algorism regarding the integrated service delivery of DM/HIV/pregnancy care. 
Hence, advocacy work to the decision makers may be done on the need of 
integrated service delivery model among the related communicable and non-
communicable diseases to address the maternal and child morbidity and mortality in 
Ethiopia.  
2. The officers and team leaders working on DM, family health and HIV could make 
use of the tripartite DM/HIV/pregnancy care service delivery model to address the 
maternal and child morbidity and mortality associated with HIV and DM through a 
joint annual planning, financing, and joint supportive supervisions. 
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3. To support the scale-up of an integrated DM/HIV/pregnancy care in Ethiopia, there is 
a critical need to strengthen leadership and co-ordination at the national, regional, 
zonal and district levels. Expanding indicators for routine monitoring of HIV and DM 
pregnancy care and addressing the clinical complication associated with HIV and 
DM, mainly the adverse pregnancy care among HIV and DM patients, are critical. 
 
6.6.3 Recommendation to the stakeholders or partners 
 
Donors and stakeholders working on the NCD, MCH and HIV ought to take into 
consideration the interrelated disease entities such as HIV and DM and effects of HIV or 
DM on pregnancy. This could assist them to give a hand to the government health 
structure in the integrated manner so that their financial and technical support will be 
efficient and cost-effective and also helps in the strengthening of the health system in 
general. All in all, the non-governmental stakes and donors working on health should 
consider the chronic nature of HIV and an accelerating burden of DM in Ethiopia, being 
a double burden to impact pregnancy outcome, to focus their support in an integrative 
manner. Together with the government, this model could be piloted by the stakeholder 
and guide the scale up of the integrated HIV, DM and pregnancy care in Ethiopia. 
 
6.6.4 Recommendations to the researchers 
 
1. This is the first of its kind model developed and there is a need to explore the 
challenges or barriers to the integration of HIV, DM and pregnancy care in the 
Ethiopian context. 
2. The client’s side perspective as to whether DM/HIV/pregnancy care is practical 
and feasible could be explored in the future studies. 
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6.7 CONCLUDING REMARKS 
 
In the face of the high burden of both communicable and non-communicable diseases 
affecting maternal and child health in Ethiopia, the ANC, HIV and DM services can be 
reorganized into an integrated format, replacing separate clinics and service records. 
Currently, mothers have to attend on separate days for DM, ANC, family planning and 
HIV services. The tripartite integration can be started with the preparation of joint 
registers, training manuals after the ministry gives direction on the integrated approach 
and prepared the training manual on the DM/HIV/pregnancy care. An integrated check-
list can be made for supervision and inventory supplies. This integrative approach could 
be institutes after when, the attendance is expected to increase and clients more readily 
accept the routine and active screening, evaluation and treatment of HIV and DM so 
that the pregnancy outcome may be improved. This should be done simultaneously with 
capacity building of HCW using the integrated DM/HIV/pregnancy training manual. 
Direction and policy guide on the tripartite integration model of DM/HIV/pregnancy care 
should first be developed and come from the ministry of health.  
 
6.8 COMMUNICATING THE FINDINGS 
 
Communicating the findings involves the development and distribution or giving out of a 
research report to appropriate audiences (Brink et al 2014:50). The researcher will 
communicate the results of the study to others who may find it useful. The findings of 
the study will be communicated through the research report which will be set to the 
FMOH in Ethiopia and the health facilities where the study was conducted. Also, 
dissemination of the findings will be done through publication of the research in the 
scientific journals or even presentation at relevant for such as workshops, conferences, 
congresses and updates. 
 
 
 
174 
 
MY JOURNEY THROUGH THIS RESEARCH 
  
As a public health professional in Ethiopia, I have been assisting the health system to 
deal with infectious diseases such as Tuberculosis and HIV for the last one decade. I 
had been worried about the increasing burden of DM in the background of the epidemic 
state of HIV. Besides, the nation faces the high level of maternal and child death. Soon 
after I completed MPH at UNISA, I was so eager to join the next level of education so 
that I become part of a solution to improve DM and HIV services to deal with maternal 
and child death. My dream came true when I joined UNISA. Throughout the course, it 
was my duty to manage a big family of 8-12 members and to manage my course at 
UNISA in my spare time. I learnt time management, being disciplined and facing 
frequent stressful period. It was a tough time writing chapter after chapter, collecting 
data at FMOH, RHB, sub-cities and health facilities amid the terrific traffic in Addis 
Ababa. Above all, transcribing and translating the interviews and rearranging related 
literature was tiresome. Stamina, perseverance and hope were the life principles I have 
learnt as experiences for the future life of mine. 
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ANNEXURE A: DETAILED THEMES AND CATEGORIES IDENTIFIED FROM FGDs 
AND IDIs BASED ON DOMAINS OF INTEGRAITON 
Domain: Functional integration; financial and administrative 
Type of approach: Focuses group discussion 
 
Program Main theme Category Units 
HIV, 
DM/NCD, 
Pregnancy 
care/family 
health 
  
Joint planning 
  One plan from 
the higher level of 
administration It usually comes from higher up, RHB 
  We usually cascade what has come from higher up (RHB). 
 
  Woreda based 
planning (Joint and 
one plan) As an office there is one planning 
  All core process will meet and there will be one plan/joint common 
planning 
Budget   A separate budget 
Every core process has its own budget. 
  Separate/isolated SS 
There is no direction from above (RHB/FMOH0 to do (SS) 
together 
  
Supportive 
supervision 
(SS) 
  DM or maternal health is not under our core process (diseases 
promotion and prevention) 
      
we are not mentoring or supervising them to do a routine DM test 
or screening,  
      there is no direction for higher up (FMOH) to do joint supervision 
      all the core process are doing it (SS) separately. 
      It is a separate feedback system, after SS 
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 Domain: Functional integration; financial and administrative 
Type of approach: in-depth interview 
Program Main theme Category Units 
DM/NCD NCD structure 
Presence of focal 
person at sub-city like HIV there is a focal person (for NCD at sub-city and FMOH) 
Standalone NCD 
unit  
HPN, DM, etc are made to be seen in isolated room 
A follow up from our side as medical service core process (to stand alone 
NCD/DM clinic) 
NCD/DM gained 
emphasis recently 
NCD is a new unit. It is very young. 
Previously, there was a lesser focus or no structure so far. 
The emphasis was on communicable diseases…. just currently NCD 
becomes a problem. 
An emphasis is gained  
It is considered in the structure 
NCD/HIV/ANC 
Plan Joint plan 
There a common plan 
A common and  comprehensive plan out of which we will take ours 
related to (family health, NCD/DM & HIV) 
Joint planning is done; there is what we call woreda based planning  
Budget Common budget 
There is no a program budget. 
No earmarked budget for each program-for TB, HIV, NCD/DM 
The budget is for the core process of DPDP core process (HIV), medical 
service (DM/NCD) core process and  for family health (pregnancy care). 
Monitoring 
system and 
tools 
Program specific  
SS 
we do an integrated supervision occasionally when there are activity in 
need of joint monitoring. 
We (NCD supervisors) do not get into that (ANC or HIV). 
The works (SS of HIV, DM, ANC) can be done in different times. 
I (NCD/DM) am under the medical service core process. HIV is not under 
medical service. HIV is standalone under the HIV/AIDS core process… 
we are not going together (for supervision). 
… Same is true with reporting. Similarly, the unit reporting to me 
(NCD/DM) is the one that I am going to and supervise. 
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There is a unit which is mainly dealing with pregnant mothers… 
Regarding the mother it is up to the family health unit…  
Mother/pregnancy related issues are for family health core processes 
There is collaboration at health facilities among health care process...  
There is no routine DM test you do not also tell the HCW at health facility 
to do it routinely 
No direction from FMOH on joint SS 
Supervision 
checklist 
….But here there is no joint supervision or checklist alignment. 
DM related item  does not exist in my checklist (of the family health 
supervision checklist) 
Shared activity on 
intra-referral activity 
We assess the outreach  joint activity using the internal referral;  
the referral from NCD to ANC, from NCD to HIV, ANC to HIV 
we looked at the referral papers to ensure the internal  referral linkage. 
What is being done at reproductive health on mother, on family planning, 
when looked into the referral papers,  we can assess how much we 
worked together. 
combined 
DM/HIV/ANC 
guidelines 
there is no guideline thus far 
there should be a guideline  
It should come in the form of guideline/direction 
We do have a good experience on syphilis/VDRL so long… like syphilis if 
emphasis is given we can handle DM together with ANC  
If the focus on HIV were extended to DM, 
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 Domain: Organizational integration 
      Type of approach: Focused group discussion 
Program Main theme Category Units 
DM/HIV/ANC 
Combined 
information 
management 
Common recording and  
reporting mechanism 
We make a line ourselves (on NCD register); we do not 
have an isolated register (for pregnancy test and HIV 
test register) 
If we are to do it we can do it on HMIS register ( e 
register for all diseases entity) 
Yes I do have register (for family planning service at 
ART).  
There is HIV result registration at NCD clinic 
there is FP registration at HIV, not for DM 
screening/testing registration 
No registration or reporting on the screening /testing of 
DM at HIV 
Co-location of 
services Service and location There are NCD day of NCD stand-alone clinics 
Joint Trainings 
Common family 
planning (FP) and 
ART/HIV training 
There is no training on FP in ART training 
 
 Domain: Organizational integration 
      Type of approach: In-depth interview 
Program Main theme Category Units 
DM/HIV/pregnancy 
care 
Co-location 
of services 
NCD/DM service 
outlet 
  Yes, there is an isolated room for it (NCD/DM). 
Standalone clinic (NCD/DM).  
It is OPD but only DM and HPN together 
NCD/DM service 
outlet 
 There is a trained person at health center as focal 
person (on NCD/DM). 
Combined 
information 
management 
Common 
register/recording 
there is (a family planning register ) at ART clinic 
Yes I have a register of family planning at ART clinic. 
Common reporting 
system 
Not on CND report.. but through family health, ANC, in 
the DP 
I have for HIV (reporting) but not for DM 
Yes, with family planning unit we make a report 
monthly (with ART clinic). 
Joint 
Trainings 
Joint training manual 
and activity No I have not (not trained on DM/HIV) 
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No, there is no (a training manual combining DM, HIV 
and maternal care), but PMCTC (HIV and pregnancy 
care, family planning). 
No,  not at all (No direction from sub-city or FMOH) 
regarding the joint DM/HIV training of DM/HIV) 
 
 
 
 
 Domain: Clinical integration-structural  
      Type of approach: Focused group discussion 
Program Main theme Category Units 
DM/HIV/Pregnancy 
care 
Guidelines and 
protocols 
regarding joint 
service delivery 
Common 
guideline/algorism 
No,  not at all (combined guiding or protocol) 
 No direction from sub-city or FMOH regarding 
guidelines/algorism of DM/HIV 
I have (guideline & algorism) for HIV,, but not for DM 
 
 
 
 Domain: Clinical integration-structural  
       Type of approach: In-depth interview 
Program Main theme Category Units 
DM/HIV/Pregnancy 
care 
Guidelines and 
protocols 
regarding joint 
service delivery 
Common 
guideline/algorithm 
No guideline or algorithm related to HIV and DM. 
No, this guideline is for the general population. 
Not specific group is addressed. 
 The DM/ANC, DM/HIV etc… are not addresses 
in the NCD guideline 
On can get PITC algorithm at NCD, HIV, ANC 
you also get PITC algorism. 
PTC is common algorithm 
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Domain: Clinical integration-process integration 
        Type of approach: Focus group discussion 
Program Main theme Category Units 
HIV/pregnancy 
care 
Integrated 
HIV/pregnancy 
care service 
delivery 
PMTCT 
… And if pregnancy occurred we link or refer to ANC. 
 After they get pregnant they will stay at PMTCT for 1 and ½ years. 
We do PICT for all pregnant mothers and their partner.   
If the mother is HIV+, we offer full PMCT service to have HIV free birth 
Family 
planning 
service 
We counsel and advice on the use of family planning (FP) and it is integrated 
with ARR. 
We give short term FP in this (HIV) clinic 
When they need a long term FP, we link to FP clinic. 
Condom, depo-, we will give them here (HIV clinic) 
 For Norplant and IUCD we refer them to FP 
At HIV we render FP including long term FP 
In this clinic (HIV); mainly, mother uses dual FP 
We just planned to start the long term, just trained  health care providers very 
recently 
pregnancy 
counseling, 
testing 
 Depends on the women complaint (if she has signs of pregnancy, morning 
sicknesses, and if she reported the monthly census is absent. I will send (for 
pregnant test); specially, if she is amenuric. If it is confirmed, I will link to PMTCT. 
We cannot prevent them from getting pregnant. With very low CD4, they might 
want to get pregnant. Here, we tell them it is a problem both for their mother and 
fetus.  
We tell that there are cases where they can give HIV infected child even with 
follow up due to high viral load. 
They want to get pregnant. We advise them to do mating during the ovulation 
rather than doing sex all over the month, advice on the timing.  
DM/pregnancy 
care 
DM service 
integrated to 
pregnancy 
care and HIV 
DM service 
at HIV 
if HIV+ have DM, this will be linked to DM clinic 
We ask about feeling thirst, weakness, fatigue, dry mouth, urine in the night, then 
we do lab tests (fasting blood sugar). 
Before initiation of ART, we usually do baseline investigation such as… FBS. 
 DM test per the complaints on the follow up, Monthly. In fact, we will assess for 
any new event, including DM. 
Regarding DM… If the symptoms of DM are detected, we will send investigate 
for the client. 
No, such service (routine DM screening) at HIV  
DM services 
at ANC 
DM testing is not a routine service for pregnant mother. 
DM screening can be routine. 
In the initial visit, we will you send urine sugar, if plus 2 or 3, that is the indication 
for DM, we will send for FBS.  
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If she comes up with history of DM, dehydration, frequent urination, we will do 
FBS 
There is such service (counseling service on family planning or pregnancy care). 
Pregnancy 
care at DM 
If the young girl/women come, of age 18 or 19, we will give her the detail 
counseling and advice (regarding pregnancy).. 
It is better if the mother gets counseling service on FP (at NCD/DM).  
Before birth, she should get counseling or advice to prevent complications. 
As an institutes, based on the symptoms by the DM  mother, we can do an 
investigation (pregnancy test (PT)) 
we ask for amenuria (absence of menses) and if we suspect for pregnancy, we 
send for PT. 
DM/HIV/ANC 
Behavior and 
practice of 
integrative 
service 
delivery 
Long term 
FP at HIV 
clinic 
We do not have such service (family planning). We will send to FP. 
It need standardized procedure (on long term FP). 
 It needs special training (on long term FP). 
DM services 
for pregnant 
mothers 
Mothers with DM and pregnancy will have a follow up at hospitals.  
The other can have follow up at health center (HC). There is a focal person at 
health center who can decide whether mothers can have a follow up at HC or 
Hospitals. 
 They can be started on medication at hospitals and then referred to health 
center for follow up 
Pregnant mother with DM are having a follow up at Hospital. 
If she has both HIV and DM she will be linked to hospitals, especially for DM.  
(Because there could be delivery problems: Macrosomia (Big baby), obstructed 
labor, and dystocia and birth complication). 
Yes, after birth she will be having a follow up here (at health center).  
 
HIV services 
at NCD/DM 
clinic 
If any patients come to chronic OPD we do PITC. 
if HIV+, will send to ART 
 I do  PITC, occasionally. 
Pregnancy 
care at HIV 
clinic 
Even then they come up with getting pregnant irrespective of the advice, we send 
them to PMCTCT. 
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Domain: Clinical integration-process integration 
      Type of approach: In-depth interview 
Program Main theme Category Units 
DM/HIV/ANC 
Integrated 
service 
delivery 
DM service at ANC 
No pregnant  mother specific screening for HPN or DM 
In the focused,  ANC there are basic tests , but things related with DM 
,nothing is being done 
HIV service at DM 
HIV screening and testing is not done daily for every mother at NCD/DM 
But PITC is done, symptom based HIV testing and counseling. 
Here PICT can be done at NCD clinic if they suspect for HIV, if positive at 
DM, they will link to ART. 
Like other OPD there PITC is done. 
For only the suspected one for HIV 
DM services at HIV 
There is no DM screening service, but if the patient complains with 
symptoms, not routine testing, however, at chronic HIV clinic. 
There is a linkage. 
Based on the symptoms (of DM), random blood sugar (RBS) may be done. 
Otherwise, like HIV, there is no emphasis or routine test for DM. 
DM services at ANC 
If we see ANC, DM screening is not in the focused ANC, or hardly 
implemented. 
DM is not integrated into ANC 
No risk factor related to DM are considered at ANC 
No routine screening  service of DM in ANC 
May be previous history or sign and symptoms of DM 
Behavior 
and 
practice 
of service 
delivery. 
Health care 
providers 
collaboration/linkage 
Not all pregnant women are screening for DM currently 
No such activity of routine offer of DM testing at ANC 
If a mother with HIV+ is DM, they (health care providers (HCP)) will talk 
together and decide whether the patients should be treated here or should 
be referred to better health facility. 
For diabetic pregnant mother, the HCPs communicate and discuss together 
and might refer to hospital for better follow up and treatment.  
There is a linkage. 
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4.7.9 Domain: clinical integration-service delivery (Suggestions) 
      Approach: Focused group discussion 
 
 
 
  
Program Main theme Category Units 
DM/HIV/ANC 
Suggested 
integrated 
approach 
Routine DM screening 
and diagnosis at HIV 
That is sound and preferable, the routine (of screening DM for HIV infected 
people) is important but the supply (reagents for DM testing) is challenging. 
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4.7.10 Domain: clinical integration-service delivery (Suggestions) 
          Approach: In-depth Interview (IDI) 
 
Program Main theme Category Units 
DM/HIV/pregnancy 
Suggested 
service 
integration 
Integrated 
monitoring 
 
 
Mentors can see whether the DM being also screened at HIV care. 
Pregnancy care and FP 
service at HIV clinic 
Health care provider (HCP) should be trained in short and long term, so, 
they could give all methods (of FP) at ART. Referral to FP for long term 
might be stigmatizing. 
 
 
Integrated monitoring: 
Joint supportive 
supervision, the 
feedback and 
supervision  checklist 
 
It would have been better to do (the supportive supervision) together and 
give the feedback at the same time on one paper (a common checklist). 
It could have been better to organize the checklist together and do the 
feedback together. 
Disease prevention, medical service and HIV should have done it (JSS) in 
common, including the preparation of the supervision template. 
Policy  guideline and 
training manual 
Police guideline should guide a full and a comprehensive health service for 
a client. 
The integration should be started from higher up, FMOH and RHB 
 
Things from federal should have come on integrated service delivery  
 
Hence, works from up  from the (FMOH/RHB)  should come down together 
Related service 
integration (One-stop-
shopping for related 
services) 
Like PMTCT with HIV similar guideline for similar service, can be prepared 
to render similar service at one. 
  HCW at ART can be trained and can give FP & DM service at ART 
  Related services can be integrated. 
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Integration 
behavior 
among HCWs 
Internal consultation, internal referral, internal communication….should be 
there  
One-stop-shop 
mentality 
All programs that are related should be integrated 
Services should be interlinked 
Only diseases consideration have to be left out  
We have to treat patients… just think of patient, not disease entity.  
Comprehensive packages of interlinked diseases for a patient. 
Policy  
guideline and 
training manual 
of integrated 
service 
HIV guideline when prepared, it should include other related burden like 
DM at the same time 
 The guideline should clearly state what to do if a diseases entity (DM) 
occurred with HIV 
Guideline should be standardized & comprehensive 
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ANNEXURE B: SAMPLE OF FIELD NOTES AND MEMOS 
 Observation  
 Observation on the structural organization at FMOH, region and sub-cities 
At sub-sites, the structural organization of DM, HIV and ANC is that all are located in the same building and in the 
same floor. There is a difference in the structure. In some sub-cities the NCD is under the medical service with the 
unit that is responsible for all the health facility services, while in the other sub-cities the NCD unit is under the 
diseases promotion and diseases prevention (DPDP). HIV or ART is under the disease prevention and promotion in 
almost all sub-cities. The family health unit which deals with family planning pregnancy care is under the medical 
service while the PMTCT is under the HIV program. There is an inconsistence structure and assignment of HIV, 
DM/NCD and maternal health in different sub-cities.  In the other sub-cities HIV related prevention activities are under 
the diseases prevention and promotion while ART/HIV care treatment is under the medical service. This uneven 
arrangement can pose the risk of integrative service provision, planning, budgeting, monitoring and evaluation 
activities of these programs.  
At federal level NCD is well established with the policy and guideline, including the commonest NCDs in Ethiopia 
such as  DM, HPN, breast cancer, cervical cancer and etc. NCD at Federal level is under the disease prevention and 
control directorate and established as a unit. Team leader of the NCD is assigned. The officers on DM, HPN, different 
cancers are already recruited. The health extension workers (HEW) are also included in the community awareness of 
DM, HPN, cervical cancer and etc. 
 The NCD register, without HIV testing or pregnancy care testing/counseling, is prepared and being used in some 
selected hospitals. There are cancer centers at regions as well. However, there is no joint supportive supervision 
(JSS), joint mentoring, budgeting or annual planning at the federal ministry of health (FMOH). There is an isolated 
planning, budgeting, supportive supervision, monitoring, and capacity building at FMOH. 
Trainings at federal levels are not designed in such a way to addresses HIV or pregnancy care with NCD. The NCD 
register does not have HIV screening or pregnancy testing result column. There are rarely shared forums where the 
NCD is collaborating with HIV or maternal and child health (MCH) unit. 
At health facilities DM screening and evaluation is done based on the complain of the patients. DM is usually 
diagnosed at the general OPDs.DM suspects at ANC, and some ART clinics are usually referred to OPD clinicians or 
DM/NCD clinician for confirmation. There are three scenarios by which DM service is given at the study health 
facilities- NCD clinic with all weekday, NCD clinic with NCD day and NCD integrated into OPDs in the country as a 
whole 
I. The follow up and DM medical service is given together with other chronic illness such as HPN, cervical 
cancer, chronic live diseases, breast cancer and etc. This is given at standalone NCD clinics where 
there are trained physician and a nurse at the study health facilities. Here, there is NCD register where 
all necessary data set related to common NCD are recorded. However, there are no columns 
addressing the HIV or pregnancy screening. The NCD service in this scenario is given throughout the 
week. The report is generated to sub-cities quarterly relating to the NCDs.  
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II. In the second scenario the health facilities have got NCD day at NCD room or clinic. Patients with DM, 
HPN, and different cancers having a follow up are usually appointed in specific day in a week. For 
example, there were health centers where Thursday is NCD day at NCD clinic. These days and clinics 
are usually meant for follow up. in these scenario the diagnosis is usually made at OPD and referral are 
from other health facilities.  
III. In the third scenario, patients with all types of NCD can come at their own day of appointment at any 
days in a working day for the follow up. There are no specific days in a week designated for the NCD or 
there is no NCD clinic. All clinicians at ODP or to her give about lets can suspect, screen, evaluate and 
confirm the diagnosis. Here all HCWs are expected to have a capacity of identification of DM suspect, 
evaluate and investigate DM, confirm the diagnosis and put on the appropriate treatment, and refer the 
DM case to NCD clinics for the follow up. 
In some health facilities there is no capacity of diagnosing DM at ANC and ART clinics. There is thinking that 
diagnosis of DM is a work of clinicians at DM or OPD so there is usually a referral of DM suspect at OPD, NCD clinics 
or other health facilities with NCD clinics or NCD experts. 
The pregnancy testing at DM is rarely entertained. It is only when the patients requested the pregnancy test that 
pregnancy test might be ordered or counseling on the pregnancy care. Whenever they need the service of pregnancy 
care, they are referred to family planning. However, pregnancy care and DM is usually taken care of at hospital 
setting for better care. 
 Observation at Health facilities 
DM/NCD clinics: they are old peoples who were having a follow up. The pregnant mothers with DM, on insulin are 
referred to hospitals for the better treatment and care. DM at HIV clinic is investigated if the patients show up with 
symptoms and if s/he self-reports. Otherwise, there is no routine screening of DM at HIV clinics for HIV infected 
patients. During the informal observation or interview, the reason was mentioned as, 
1. “ There is no as such direction from the federal level “ and 
2. “ there is no convincing evidence that HIV or ART is a risk factor for DM” 
 
Participants/ Informal observation  
Health care workers (HCW) are not well aware of how HIV or ART are a risk factor for DM, so they do not believe on 
the fact that DM screening should be a routine at HIV clinic. Also, there is no awareness of adverse pregnancy 
outcome (APO) by HIV/ART on mother, thinking that PMTCT is optimal. So, pregnancy counseling might not be 
routinely given. So, most mothers come to ART getting pregnant without the knowledge of HCW. Knowledge of the 
effect of poorly controlled DM on pregnancy outcome is not optimal. So, DM routine screening is not thought of. 
Guideline, policy direction, algorisms on HIV &DM related APO is not being considered and not in place in the 
country. They are not also well aware to practice optimal integration of service of these items. Besides, supervision 
and mentoring are vertical so HCW does not belief it is important to give routine DM screening testing at ANC and 
HIV. HCW are well aware of the accelerating and increasing magnitude of DM in Ethiopia. However, they think that is 
not well funded, well recognized and integrated with chronic illness such as HPN, cancer illness etc. That might hide 
the attention needed by DM. 
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 Memo or field notes of Health center: FGD 
Participants: ANC, PMTCT and chronic care/DM focal person 
DM officer coordinated and at ANC and the FGD was carried out. ART focal person could not be part of the FGD. 
Four of us carried out the discussion which took 45 minutes. 
Suggestions 
DM officers: counseling and advising on pregnancy at DM before they get pregnant 
Give all follow up and care for DM/Pregnant care at HC after capacitating the HCWs at health centers. “… limited 
capacity of mothers to have a follow up at HC to take care of diabetic and HIV infected mothers without other 
complication will be beneficial for mothers…also routine pregnancy counseling and provision of  at least short term 
family planning is essential at chronic care unit”. 
“At ANC it is also important to have a routine FBS/RBS, like HIV, can be a practice. …however, this has to come to 
health facilities in the form of policy or direction guideline from FMOH”. 
DM screening and treatment or evaluation algorism and guidelines are not available at DM/ANC or ART/HIV clinic. 
However, pregnancy counseling and family planning provision guidelines and algorism are available at ART and 
ANC/PMNTCT clinics. 
HIV screening algorism is available at all service outlets 
No guideline or algorism that is a comprehensive DM, HIV, and pregnancy care in all service outlets 
DM, HIV and pregnancy care algorism, guidelines and pregnancy care are important if available, designed, availed 
and implemented in the country and feasible and practical. 
Routine FBS/RBS, DM counseling on prevention, algorism of screening and treatment are feasible, acceptable and 
practically if implemented at ANC, ART clinics. 
“…HIV program is well funded…ehee.. With rich resource….guideline are available with supply policy…but the 
magnitude is decreasing…ehheee..While DM is silently affecting a lot of people “ 
The member of the FGD stressed the fact that DM is a ‘silent killer’, as there are a lot of asymptomatic, undiagnosed 
DM patients. Hence, one of the members of the FGD described. “….the silent nature of the diabetic mellitus… can be 
identified...if.we are in high index of subspecies…emmmm. ,,to identify the underdiagnosed DM among HIV and 
pregnant mothers… routine screening of DM is a solutions…” 
HIV at DM: “PITC” whenever the DM patients should show signs and symptoms of immunodeficiency. HIV 
counseling and testing is not routine done for every clients visiting DM/NCD clinic. 
DM at ANC: Whenever the mother comes up with the signs and symptom of DM. FBS/RBS is not a routine 
investigation/screening at ANC. 
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DM at HIV: the same as at ANC or HIV. If DM is diagnosed, referral is made to chronic care. At DM if HIV is 
confirmed , s/he is sent to ART using the intra-facility referral form. 
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ANNEXURE C:  WRITTEN CONSENT FORM FOR PATIENTS INTERVIEW (English 
Version) 
My name is -----------. Here at ….. Hospital HIV care unit/Diabetic clinic/ANC or Delivery 
clinic, I am abstracting clinical data from patients files and registers. I am also 
interviewing women who know their HIV/diabetic status. This is to evaluate the impact 
their disease condition brought about on pregnancy outcome. We believe that this study 
would help to indicate a model of care linking diabetic and HIV care to pregnancy 
outcomes among diabetic and HIV positive others. We would like to assure you that 
your name will not be mentioned in the data abstraction form or questionnaire and the 
information that you give us will be kept confidential and only used for research 
purposes. You have a full right to refuse to take part or to interrupt the interview at any 
time. But the information that you will give us is quite useful to achieve the objective of 
the study. It will take 20-25 minutes to respond to the interview. Are you willing to 
participate in the study? 
 
1- Yes                                                  2 - No 
(If the answer is yes, thank the patient. Then have the signature and conduct the 
interview. Otherwise, the patient is not forced to participate) 
Name and signature…………………………………………….Date………………… 
Name and signature of interviewer…………………………….Date………………… 
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ANNEXURE D:  WRITTEN CONSENT FORM FOR PATIENT INTERVIEW (Amharic 
version) 
በጥናት ለመሳተፍ የፍቃደኝነት መገለጫና የፈቃደኝነት ስምምነት ቅጽ 
የጥናቱ ርዕስ፡- በአድሰ አበባ ሆሰፕታሎች የምወለዱት ህፃናት ን ጠና ለማሻሻል የኤች ኤይ ቪና ስኳር ህመምን ስለማጣመር 
ስሜ …………………………….. ሲሆን፡ እጃ ጋ ለየእች.አዪ.ቭና የስኳር ህመም የህክምና ክትትል ያላቸዉን እናቶች ቃለ-ምልልስ እያደረግን 
ነዉ፡፡ምክንያቱም የሁለቱ ህመም ተጠቂ የሁኑት እናቶቸ ጤናማ ህጻን ስለመዉለዲ ጥናት እተደረገ ነዉ፡፡ የጥናቱ ዋና ዓላማ በሁለቱ በሽታ ምክንያት የምከሰተዉን 
የጽንስ ችግር ላመሰወገድ የምቻልበትን መላ ለማበጀት ነዉ፡፡ 
 
በግምት 5-10 ደቂቃ የሚወስድ ቃለ መጠይቅ የማደርግልዎ ሲሆን የሚሰጡኝ መልስ በሚስጥር እንደሚያዝ ላሳውቅዎ እወዳለሁ፡፡ እርሰዎን የምሠጡን መረጃ በዚህ 
ጥናት ከሚሳተፉ የጤና ባለሞያዎች ውጭ ለማንም አይሰጥም፡፡ ውጤቱም ስንጽፍ በዚህ ጥናት የተሳተፉ ሰዎች ስምና ሌሎች መለያዎች አይካተትም፡፡በዚህ ጥናት 
መሳተፍ ካልፈለጉ ለመተው ወይም ለማቆም መወሰን ይችላሉ፡፡በጥናቱ ለመሳተፍ ለሚያደርጉት ትብብር የላቀ ምስጋናየን አቀርባለሁ፡፡ 
ስለዚህ በዚህ ጥናት ለመሳተፍ         ተስማምቻለሁ----------------------------------------------- 
                                            አልተስማማሁም---------------------------------------------- 
በጥናቱ የሚሳተፈው ሰው ፊርማ---------------------ቀን-------------------- 
እኔም ለጥናቱ ተሳታፊ ስለ ጥናቱ አላማ በዝርዝር ማስረዳቴን አረጋግጣለሁ፡፡ 
ቃለ-መጠይቁን የሚያካሂደው ሰው ስም፡- ------------------ ፊርማ---------------------ቀን----------------------- 
ለማንኛዉመ ዝርዝር ጥያቀዎች የጥናቱ ዋና ሓላፊን በምከተለዉ አድራሻ መግኘት ይቻላል፡፡ 
ዶ/ር ዘዉዱ ጋሹ ደመመዉ፡ ዩኒሳ፤ደቡብ አፍሪካ ዩኒቨርሲቲ 
ስልክ ቁጥር፡+251911768081 
 44934599@mylife.unisa.ac.za 
አዲስ አበባ  
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ANNEXURE E: DATA ABTRACTION CHECKLIST AND QUESITONARRIE 
Human Immunodeficiency Virus and Diabetes Mellitus: A Missed Link to Improve Pregnancy Outcome in 
Ethiopia 
Patient Instruction: You have been selected to take part in this interview. It will take a few minutes. Because the 
Diabetes and HIV can affect the outcome of pregnancy, it is important to ask you some questions about your fertility 
and the outcomes of your pregnancy outcomes. Your name, address or any identification will not be collected. Your 
answers will remain confidential so please be honest. 
A. Data abstraction- ANC 
ALL PREGNANT MOTHERS 
Name of health facility……………… …………….                MRN___________________________________ 
Type of health facility       a. Public Hospital               b. Private Hospital 
  
I. Socio-Demographic Characteristic (Pregnant women) 
1. Current age in years ……………. 
2. Gravidity……                                              
3.  Parity ……… 
4. Gestation age in weeks……… (For current pregnancy) 
5. History of diabetes mellitus in the family:     a) yes          b) no             c) I do know 
 
 
6. 
       
II. DM services at ANC clinics (Health care workers at the HIV clinic ONCE!) 
1. If the DM diagnosed,  
1.1 Date diagnosed with DM ……………………………………… 
1.2 Type of DM     
a. Type I                b. Type II                c. GDM                   d. Other type 
  No of ANC visit               Iron folate      FBS /urine test (result)     T est for HIV (result)         VDRL (result)        Tetanus  
Toxoid   
1st pregnancy___                Yes    NO         Yes    NO (------)                Yes   NO (--------)                     Yes    No  (------)               
Yes No         
2nd pregnancy_____             Yes    NO        Yes    NO (-------)                  Yes   NO (-------)                       Yes    NO   (-----)          
Yes No        
3rd pregnancy____               Yes   NO         Yes    NO (-----)                  Yes   NO (-------)                         Yes    NO  (------)           
Yes No          
4th pregnancy____               Yes    NO        Yes    NO (-------)                   Yes   NO  (-------)                       Yes    NO (------)           
Yes No          
Current  
Pregnancy ---------                Yes   NO          Yes    NO  (……….)           Yes    NO (………..)                      Yes    NO (….)            
Yes No         
5 What is your current marital/relationship 
status? 
         a. Married                      b. Single      
       c. Divorced                  d. Widowed  
       e. Non-married with partner    
        f. No response 
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1.3 Regimen                                                                                     Time Period (Date) 
        --------------------------------------                               ---------------------------------------------------- 
        ------------------------------------------                           ---------------------------------------------------- 
III. HIV/ART service at ANC clinic 
1. If the tested for HIV, the date of the test (DD/MM/YY)______________________     No tested 
2. HIV test result                      a. HIV+ve             b. HIV-ve            c. Unknown 
3. If HIV+ in the current pregnancy, have you started ART?              
a. Yes,                                         b. Not started yet. 
4. If ART started, the date it is started (DD/MM/YY E.C)? ………………………….                                                                          
 Regimen type                                                  Date (DD/MM/YY) 
------------------------------------------                       ------------------------------------------             
------------------------------------------                        --------------------------------------------- 
 
                   0 month                12   months           24 months            36 months       the latest/Current 
6. Height       ______            _________              ___________                _______          __________   
7. Weight        ______             _________             ____________             _______             __________ 
8. Viral load    ______              __________            ____________               _______         __________  
9. CD4(+) count    ______            ___________             __________                 ________        __________ 
10. FBS             ______             ___________              __________              ________         __________  
 
5. Documented Clinical complications                                                        Date 
      Check   TB              yes           No                                          --------------------------------------- 
       Others----------------------------------------                                            ---------------------------------------- 
6. Other non-communicable diseases                  Date Detected/Diagnosed—Chronic illnesses 
Check HPN             Yes            No-----                           ---------------------------------------- 
Others -----------------------------------------------                              ------------------------------------------ 
7. First pregnancy 
7.1 Date confirmed……………….  
7.2 date delivered……………….. 
7.3 Gestational AGE--------------- 
7.4 Birth weight-------------------- 
 IV Pregnancy outcome 
7.3. Outcome (more than one option is possible) 
7.3.1 ##Mother: ___________________ 
              7.3.2 **Foetus:_____________________ 
 
6. Instrumental delivery (vacuum 
extraction or forceps) 
7. Breech delivery 
8. Caesarean section 
9. Pre-eclampsia  
10. Eclampsia 
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##Maternal survival/ Complication 
1. Alive 
2. Spontaneous abortion 
3. Induced Abortion  
4. Not recorded or unknown 
5. Spontaneous vaginal delivery 
 
**Infant survival/Complication 
1. Live/normal birth                                         4. Congenital malformation (from live births)           
2. Stillbirth                                                        5. Other, specify………….. 
3. Miscarriage 
 
8. Second pregnancy  
8.1 date confirmed……………………. 
8.2 date delivered…………………….. 
8.3 Gestational Age----------------------- 
8.4 Birth weight------------------------- 
9. Third pregnancy 
9.1 date confirmed…………………….  
9.2 date delivered……………………. 
9.3 Gestational age--------------- 
9.4 Birth weight---------- 
10. Fourth pregnancy  
10.1date confirmed…………………….  
10.2 date delivered……………………… 
10.3 Gestational age----------------- 
10.4 Birth weight----------------------- 
 
 
 
 
B. Data abstraction-DM clinic 
All Females 15-45 during enrollment 
At least 3 months of follow-up 
Name of health facility………………     MRN____________________________________ 
Type of health facility,    a. Public Hospital       b. Private Hospital 
I. Socio-Demographic Characteristic (Baseline data, at enrollment, 18-45 years females) 
1. Age                                                   ……years 
16. Systemic infections 
17. Eclampsia  
18. ant-partum Haemorrhage  
19. Systemic infections  
20. Maternal near miss 
21. Others specify………….. 
22. No complication 
 
8.3. Outcome 
8.3.1 ##Mother___________________ 
8.3.2 **Foetus_____________________ 
9.5. Outcome 
9.5.1 ##Mother:________________________ 
9.5.2 **Foetus:_________________________ 
10.5. Outcome 
10.5.1 ##Mother:________________________ 
10.5.2 **Foetus: __________________________ 
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2. Date DM diagnosed (DD/MM/YY) -------------------------------------------- 
3. DM diagnosed at: 
 a. OPD                                                c. IPD                 
 b. DM/NCD clinic                                 d. HIV clinic                        e. Other health facility 
4. Type of DM   
a. GDM          b. TYPE I                   c.TYPE II                          d.Other, specify……………. 
5. History of diabetes mellitus in the family:                     a) yes          b) no             c) I do know 
6.Date diabetic treatment started (DD/MM/YY)---------------------------------------- 
 Regimen                                                                                     Time Period 
--------------------------------------                               ---------------------------------------------------- 
------------------------------------------                           ------------------------------------------------ 
--------------------------------------                               ----------------------------------------------------- 
    
                    0 month          12   months            24 months           36 months     the latest/Current 
7 .Height     ______           _________                   ___________              _______             __________ 
8. Weight     ______           _________                  ____________             _______              __________ 
9. FBS        ______             ___________                 __________              ________            __________  
 
10.   Documented Clinical complications                                      Date Detected/Diagnosed 
                ------------------------------------------                                          --------------------------------------- 
-----------------------------------------------                                          ---------------------------------------- 
11. Other co-morbid Infectious diseases                                                     Date (DD/MM/YY) 
Check TB  yes    NO      -------------                                  ---------------------------------------- 
Others ---------------------------------------                                ----------------------------------------- 
12. Other non-communicable/ Chronic illnesses                     Date (DD/MM/YY) 
Check for HPN   Yes  No----------------                         ---------------------------------------- 
Others -------------------------------------------                       ------------------------------------------ 
II. HIV service at DM (Health care workers at DM +PATINETS+ FILE+REGISTER) 
1. HIV counselling and testing offered at DM          
a. Yes                 b. Referred to HCT/OPD for counselling and testing                    c.    Not   at all 
2. Date tested for HIV (DD/MM/YY)………………………. 
3. HIV test result                   a.  HIV+                                                    b. HIV-ve                                   c. Unknown 
               
                          0 month          12   months          24 months         36 months      The latest/Current 
4. Viral load           ________           __________          ____________           _______         __________ (HIV+) 
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5. CD4 (+) count         ________            ___________         __________              ________         __________(HIV+) 
6. Have you started ART? (HIV+)             
a. Yes, I have started ART                                       b. No, I haven’t started ART yet. 
7. If ART started, date it is started (DD/MM/YY E.C)? ………………………….     (HIV+)                                                                     
Regimen type                                                          Date (DD/MM/YY) 
------------------------------------------                       ------------------------------------------             
------------------------------------------                        --------------------------------------------- 
-------------------------------------------                        ---------------------------------------------            
8. Documented Clinical complications                                    Date-Diagnosed 
---------------------------------------------                              ---------------------------------------- 
-----------------------------------------------                           ------------------------------------------ 
9.Other Infectious diseases                                                       Date-Diagnosed 
Check  TB  yes    NO      -------------                                  ---------------------------------------- 
Others ---------------------------------------                                ----------------------------------------- 
10.Other non-communicable diseases                                        Date-Diagnosed 
Check for HPN   Yes  No----------------                         ---------------------------------------- 
Others -------------------------------------------                       ------------------------------------------ 
III. Family planning and Pregnancy care at DM/NCD clinic                                               
1. Have you ever got pregnant    a. Yes                b. Never                          c. Now pregnant 
2. First pregnancy 
2.1 Date confirmed………………….  
2.2 Date delivered…………………… 
2.3 Gestational age at birth…………………. 
2.4 Birth weight………………………. 
Pregnancy outcome 
##Maternal survival/ Complication 
1. Alive 
2. Dead 
4. Spontaneous abortion 
5. Induced Abortion  
6. Not recorded or unknown 
7. Spontaneous vaginal delivery 
 
 
**Infant survival/Complication 
4. Live/normal birth 
5. Stillbirth 
3. Miscarriage  
2.5. Outcome (more than one option is 
possible) 
2.5.1 ##Mother:___________ 
2.5. 2 **Fetus:_____________ 
8.Instrumental delivery (vacuum extraction or 
forceps) 
9.Breech delivery 
10.Caesarean section 
11. Pre-eclampsia  
12. Eclampsia 
13. Postpartum haemorrhage 
14. Puerperal endometritis  
15. Eclampsia  
16.Ant-partum  haemorrhage  
17. Maternal near miss 
18. Others specify………….. 
19. No complication 
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       4. Congenital malformation (from live births)                 
       5. Other, specify………….. 
 
3. Second pregnancy  
8.1 date confirmed………………….  
8.2 date delivered…………………… 
8. 3 Gestational age at birth---------------- 
8.4 Birth weight---------------------------- 
4. Third pregnancy  
9.1 date confirmed…………………….  
9.2 date delivered…………………….. 
9.3 Gestational age at Birth------------------ 
9.4  Birth weight------------------------------- 
5. Fourth pregnancy 
10. 1 date confirmed…………………….  
10.2 date delivered……………………… 
10.3 Gestational age……….. 
10. 4   Birth weight--------------- 
C. HIV CLINIC 
All Females 15-45 during enrollment 
At least 3 months on follow-up 
Name of health facility…………                    MRN___________________________________ 
Type of health facility,   a. Public Hospital       b. Private Hospital 
I. Socio-Demographic Characteristic ((Baseline data, at enrollment, 18-45 years females)IN Take  
1. Age                                                   ……years 
3. History of diabetes mellitus in the family:                     a) yes          b) no             c) I do know  
 
II. HIV AND ART HISTORY (PRE-ART/ART REGISTER) 
1. Date diagnosed with HIV (DD/MM/YY Ethiopian Calendar (E.C).................................. 
2. Where HIV diagnosis made?  
         a. HCT/VCT clinic         b.DM/NCD clinic              c. ANC/PMTCT       d. Family planning  
          e. Outpatient department                 f. In-patient department               g. Other, specify……… 
 
8.5 Outcome 
8.5.1 ##Mother: ___________ 
8.5.2 **Fetus: ____________ 
9.5 . Outcome 
9.5.1 ##Mother:______________ 
9.5.2 **Foetus:_______________ 
 
10.5. Outcome 
10.5.1 ##Mother__________________ 
10.5.2 **Fetus____________________ 
 
223 
 
                     0 month         12   months           24 months               36 months     The latest/Current 
3. Height          ______            _________                   ___________              _______                 __________ 
4. Weight         ______               _________                  ____________             _______                __________ 
5.Viral load     ______              __________                 ____________             _______                __________ 
6.CD4 (+) count    ______             ___________                 __________              ________                 __________ 
8.  ART initiation status?       a. Started ART                               b. Not started, yet 
9. If ART started, date started (DD/MM/YY E.C) ………………………….                                                                          
                Regimen type                                                           Time Period (DD/MM/YY) 
--------------------------------------                               --------------------------------------- 
--------------------------------------                               ---------------------------------------- 
--------------------------------------                               ---------------------------------------- 
10. Documented Clinical complications    Date Detected/Diagnosed (DD/MM/YY)—HIV/AIDS related 
Check For TB     a. YES    b. NO                              --------------------------------------- 
Others -------------------------------                                        -------------------------------------- 
     ---------------------------------------                                        --------------------------------------- 
11. Other Infectious diseases (co-morbidity)    Date Detected/Diagnosed (DD/MM/YY)--HIV/AIDS related 
----------------------------------------                                                      ---------------------------------------- 
----------------------------------------                                                       ---------------------------------------- 
---------------------------------------                                                       ----------------------------------------- 
12. Other non-communicable diseases —chronic illnesses                Date detected/Diagnosed 
Check HPN          a. yes     b. No                                                   ---------------------------------------- 
Others     ---------------------------------                                                 ------------------------------------------ 
      --------------------------------------------                                              ----------------------------------------- 
III. FERTILITY HISTORY (=PATIENTS) 
1. How many pregnancies have you had?                                                                   ……..pregnancies 
2. So far, how many live births/deliveries have you had?            ........ live births/deliveries 
3. How many are alive now?                                                        ……. Children 
     
IV. DM status for HIV infected women at HIV clinic (PATIENTS + register + HCW) 
1. Tested for DM at 
a. HIV clinic                                            c.  IPD                        
b. OPD                                                 d. other health facility                     e. Never tested                  
2. If tested for DM, tested by 
a. Symptoms or clinical screening                   d. FBS 
b. Urine dipstick                                               e. 2 hour Oral glucose tolerance test (OGTT) 
c. RBS                                                              f. Glycosylated Haemoglobin IC (HbIC) 
 
3. If the DM diagnosed, date (DD/MM/YY E.C)……………………………………. (DM+HIV PATIENTS) 
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    Regimen                                                                                     Time Period 
--------------------------------------                               ---------------------------------------------------- 
------------------------------------------                           ------------------------------------------------ 
--------------------------------------                               ----------------------------------------------------- 
0 month           12   months               24 months               36 months      The latest/Current 
4.  FBS  ______                ___________                 __________              ________             __________  
5. Documented  clinical complications   (PATIENTS FILES, REGISTER, PATIENTS)                      
      Clinical   Complications                                                             Date                                        
Check for   TB    yes No ---- --                                    --------------------------------------- 
Check for HPN   Yes No------                                  ---------------------------------------- 
Others-------------------------------------------------                       ------------------------------------------ 
-------------------------------------------------------------                        --------------------------------------- 
 
V. Family planning and Pregnancy care at HIV clinic (Health care workers at HIV clinic)                     
1. (PATINETS at HIV clinic) Have you ever got pregnant   a. Yes     b. Never.    c. Now pregnant 
2. If yes, date first pregnancy confirmed……………. (E.C) 
2.1 Date gave to birth……………….. (E.C) 
2.2 Gestational age at delivery………… 
2.3 Birth weight……………… 
Pregnancy outcome 
##Maternal survival/ Complication 
1. Alive 
2. Dead 
3. Spontaneous abortion 
4. Induced Abortion  
5. Not recorded or unknown 
6. Spontaneous vaginal delivery 
 
**Infant survival/Complication 
6. Live/normal birth 
7. Still birth 
3. Miscarriage  
       4. Congenital malformation (from live births)                 
       5. Other, specify………….. 
  
7. Second pregnancy date confirmed………………..  
7.1 Dates delivered………………….. 
7.2. Gestational age at delivery………… 
7.3 Birth weight……………… 
8. Third pregnancy date confirmed……………………. 
8.1 Date delivered…………………………… 
6.4. Birth outcome (more than one option is 
possible) 
6.4.1   ##Mother: ________________ 
6.4.2   **Foetus: ___________________ 
11. Instrumental delivery (vacuum 
extraction or forceps) 
12. Breech delivery 
13. Caesarean section 
14. Pre-eclampsia  
15. Eclampsia 
12. Postpartum haemorrhage 
13. Puerperal endometritis  
 
14. Eclampsia  
15. Ante-partum haemorrhage  
16. Systemic infections  
17. Maternal near miss 
18. Others specify………….. 
19. No complication 
 
7.4 Outcome 
7.4.1 ##Mother:_______________ 
7.4.2 **Fetus:________________ 
8.4 Outcome 
8.4.1 ##Mother:_________________ 
8.4.2 **Fetus:__________________ 
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8.2 Gestational age at delivery………… 
8.3 Birth weight……………… 
9. Fourth pregnancy date confirmed…………………….  
9.1 Date delivered…………………………… 
9.2 Gestational age at delivery………… 
9.3 Birth weight……………… 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9.4. Outcome 
9.4.1 ##Mother: __________________ 
9.4.2 **Fetus: ___________________ 
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ANNEXURE F. LEVEL OF INTEGRATION ASSESMENT: DM/HIV/Pregnancy care 
(ONE TIME INTERVIEW QUESTION FOR EACH STUDY HEALTH FACLITY) 
I.DM services at HIV clinics (Health care workers at HIV clinic) 
1. Screening service of HIV infected mother for DM 
a. Yes, always  for every HIV infected patients          
b. Occasionally                  
2. If responded  a-c, means/tools of screening (More than one option is possible) 
a. Symptoms or clinical screening                                            d. Fasting blood sugar (FBS) 
b. Urine dipstick                                                                        e. 2 hour Oral glucose tolerance test (OGTT) 
c. Random blood sugar (RBS)                                                    f. Glycosylated Hemoglobin IC (HbIC) 
3. Documented DM testing for HIV infected females (Verify) 
a. Yes, always                             b.    No, not at all.                   c.   Occasionally 
4. Is there a register for DM screening and testing at the HIV clinic (verify)     a. Yes         b. No 
5. Column with DM screening and testing in pre-ART or ART register         a. Yes      b.    No        
6. Where is the full evaluation of DM being done 
   a. At HIV clinic     b. Referred to DM/OPD for evaluation          C. Other, specify______________ 
7. Treatment and follow up for DM among HIV patients is 
      a. Done at HIV clinic        b. Refer to DM/OPD                       c. Other specify_____________ 
II. DM services at ANC clinics (Health care workers at ANC clinic) 
1. Screening service of pregnant mother for DM 
c. Yes, always  for every HIV infected patients          
d. Occasionally                  
3. If responded  a-c, means/tools for screening (More than one option is possible) 
d. Symptoms or clinical screening                                            d. Fasting blood sugar (FBS) 
e. Urine dipstick                                                                        e. 2 hour Oral glucose tolerance test (OGTT) 
f. Random blood sugar (RBS)                                                    f. Glycosylated Hemoglobin IC (HbIC) 
3. Documented DM testing for pregnant mothers (Verify) 
a. Yes, always                             b.    No, not at all.                   c.   Occasionally 
4. Is there a register for DM screening and testing at ANC clinic (verify)     a. Yes         b. No 
5. Column with DM screening and testing in ANC register         a. Yes      b.    No        
6. Where is the full evaluation of DM being done 
   a. At ANV clinic     b. Referred to DM/OPD for evaluation          C. Other, specify______________ 
7. Treatment and follow up for DM among pregnant women is 
      a. Done at HIV clinic        b. Refer to DM/OPD                       c. Other specify_____________ 
III. Family planning and Pregnancy care at the HIV clinic (Health care workers at HIV clinic) 
1. Counselling on family planning and pregnancy 
       a. Available            b. Not available at all                        c. Only for those who asked actively 
c. Only when they come with symptoms of DM 
d. No, not at all (skip to 3) 
 
c. Only when they come with symptoms of DM 
d. No, not at all (skip to 3) 
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 2. Is pregnancy test being done at HIV clinic?    
a. Yes                                     b. No                                 c. Referred to ANC for the test 
3. Family planning service      
  a. Available              b. Not available at all             c. Referred to family planning for the service 
4. If yes, available family planning service (tick all available) 
a. Condom                          e.    Bilateral tubal ligation                               
b. OCP                                f.   Sterilization                       
c.  Implants                         g.   No taking any 
Injectable                        h. Referred to family planning     
 
IV. Family planning and Pregnancy care at DM/NCD clinic 
1. Counselling service on family planning/pregnancy     
  a. Available   b. Not available at all   c. Referred to FP for test 
2. Is pregnancy test being done at DM clinic?             
      a. Yes             b. No               c. Referred to ANC for test 
3. Family planning service   a. Available       b. Not available at all      c. Referred to FP for test D. Other, 
specify……………… 
4. If available, family planning service (More than one option is available) 
a. Condom                                     d. Injectable                            
b OCP                                          e.    Bilateral tubal ligation             
c.  Implants                                                              
V. HIV service at DM (Health care workers at DM +PATINETS+ FILE+REGISTER) 
1. HIV counselling and testing offered at DM          
b. Yes                 b. Referred to HCT/OPD for counselling and testing                    c.    Not   at all 
2. Date tested for HIV (DD/MM/YY)………………………. 
3. HV test result                   a.  HIV+                                                    b. HIV-ve                                   c. Unknown 
VI. HIV/ART service at ANC clinic 
1. Does ANC clinic provide HIV counselling and testing?         
1. Yes  
2. No  
2. Does the ANC unit provide ART service for HIV +ve pregnant mothers? 
1. Yes  
2. No  
3. Does the ANC unit provide a follow up for HIV pregnant mothers? 
1. Yes  
2. No  
   f.   Sterilization           
  g.   No taking any    
  h. Referred to family planning       
3. Refer to HIV counselling and testing clinic 
4. Refers to other health facility 
3. Refer to ART clinic 
4. Refers to other health facility 
 3. Refer to ART clinic 
4. Refers to other health facility 
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ANNEXURE G: CONSENT TO PARTICIPATE IN IDI and FGD for the STUDY  
ON ‘HUMAN IMMUNODEFICIENCY VIRUS AND DIABETES MELLITUS: A MISSED 
LINK TO IMPROVE PREGNANCY OUTCOME IN ETHIOPIA’ 
 
You are asked to participate in a research study conducted by “Zewdu Gashu Dememew”, a doctoral student at the 
University of South Africa (UNISA).  
If you have any questions or concerns about the research, please feel free to contact the investigator: ‘Zewdu Gashu 
Dememewu’ (Tele: +251 911768081).  
PURPOSE OF THE STUDY  
The purpose of the study is to develop an integrated model of care regarding HIV, DM and pregnancy care  
PROCEDURES  
If you volunteer to participate in this study, you will be asked to participate in an in-depth interview which will take not 
more an hour. You cannot be identified through your responses.  
POTENTIAL RISKS AND DISCOMFORTS  
The study will not impose any significant risk for participants expect minimal discomfort that might be encountered 
while dealing with organizational process. If you experience discomfort and wish to receive psychological support, 
please contact the investigator of the study for a referral.  
POTENTIAL BENEFITS TO PARTICIPANTS AND/OR TO SOCIETY  
There will no direct benefit that would be gained by you from attending in this study. However, the results of this study 
can contribute to the development of integrated DM/HIV model of care essential for mothers with HIV and DM 
diseases. 
PAYMENT FOR PARTICIPATION  
There is no payment for participating in this study.  
CONFIDENTIALITY  
The principal investigator is responsible for ensuring confidentiality at any time. The completed data will be stored in a 
locked cabinet for five years and will be destroyed after five years. Only electronic copies of the data will be kept with 
passwords after five years. The result of the study will be communicated through journals or other outlets.  
PARTICIPATION AND WITHDRAWAL  
You can choose whether to be in this study or not. If you volunteer to be in this study, you may withdraw at any time.  
RIGHTS OF RESEARCH PARTICIPANTS  
You have full right to withdraw your consent at any time and discontinue participation without consequence. This 
study has been reviewed and received ethical clearance through the UNISA and Addis Ababa Health Bureau. If you 
have questions regarding your rights as a research participant, please contact the investigator of the study.  
SIGNATURE OF RESEARCH PARTICIPANT/LEGAL REPRESENTATIVE  
I have read the information provided for the study as described herein. My questions have been answered to my 
satisfaction, and I agree to participate in this study.  
Signature of the Participant _________________ Date: ____________  
Signature of the Witness ____________________ Date: _____________  
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ANNEXURE H: QUESTION GUIDE FOR IDI AND FGD 
 
In-depth Interview IDI): federal ministry of health, regional health bureau and the sub-city 
1. What is the effect of HIV infection on the occurrence of DM in HIV infected mothers? (Probe :How does HIV 
affects the occurrence of DM? OR mention if HIV can lead to DM or ARV affects the occurrence of DM 
among HIV infected mothers) What is the effect of HIV infection to the pregnancy of HIV infected mother? 
(Probe: In terms of fertility, stigma and discrimination, on pregnancy, during delivery, outcome of 
pregnancy). 
2. What is the effect  of DM on the pregnancy of the pregnant diabetic mother? ( Probe:In terms of fertility, 
stigma and discrimination, on pregnancy, during delivery, outcome of pregnancy). 
3. What is the effect of DM and HIV on the pregnancy of mothers having both diseases at the same time? 
(Probe: In terms of fertility, stigma and discrimination, on pregnancy, during delivery, outcome of pregnancy) 
What is the problem of screening and diagnosing DM or/and HIV in the health facilities? (Patients factor, 
Health care worker  factors, health facilities factors) 
4. How should Health care workers, health system, etc. handle HIV and/or DM? 
5. What should the HIV and DM integration look like (probe: To what level should both be integrated?) 
6. What should be done at DM/HIV/ANC/delivery room to reduce perinatal complication due to HV/DM? 
7. Why do you think pregnancy rate is high/low among HV/DM as compared to non-DM/HIV? 
8. Why do you think…..? (Adverse pregnancy outcome) is so frequent among DM/HIV as compared to 
DM/HIV? 
 
 
Functional, financial & administrative integration: FMOH, regions and Sub-city program officers 
A. NCD program B. HIV program C. Family/maternal health 
1. Describe joint planning of NCD 
with HIV program 
1. Describe joint planning of 
HIV with NCD program 
1. Describe joint planning of family planning with 
HIV program 
2. Describe joint planning of NCD 
with Family planning program 
2. Describe joint planning of 
family planning with HIV 
program 
2. Describe joint planning of family planning with 
NCD program 
3. Describe joint planning of NCD,  
HIV program, and family planning 
3. Describe joint planning of 
NCD,  HIV program, and family 
planning 
3. Describe joint planning of NCD,  HIV program, 
and family planning 
4. Can you tell us about the common 
budget for NCD/DM, HIV and 
maternal health 
4. Can you tell us about the 
common budget for NCD/DM, 
HIV and maternal health 
4. Can you tell us about the common budget for 
NCD/DM, HIV and maternal health 
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5. Can you describe the presence of 
guidelines, training materials, 
screening and diagnostic algorithm 
of HIV and pregnancy care 
5.Can you describe the 
presence of guidelines, 
training materials, screening 
and diagnostic algorism of 
NCD  and pregnancy care 
5. Can you describe the presence of guidelines, 
training materials, screening and diagnostic 
algorithm of HIV and DM care 
6. How is the HIV, DM and 
pregnancy care integrated during 
supportive supervision  
6. How is the HIV, DM and 
pregnancy care integrated 
during supportive supervision  
6. How is the HIV, DM and pregnancy care 
integrated during supportive supervision  
7. Describe joint needs assessment 
of DM, HIV and pregnancy care 
7.Describe joint need 
assessment of DM, HIV and 
pregnancy care 
7. Describe joint needs assessment of DM, HIV 
and pregnancy care 
8. Can you please tell us about joint 
recording and reporting system of 
DM/NCD, HIV and pregnancy care 
8. Can you please tell us about 
joint recording and reporting 
system of DM/NCD, HIV and 
pregnancy care 
8. Can you please tell us about joint recording and 
reporting system of DM/NCD, HIV and pregnancy 
care 
9. How do you see the inter-sectoral 
planning with regard to HIV, NCD 
and maternal health programs 
9. How do you see the inter-
sectoral planning with regard 
to HIV, NCD and maternal 
health programs 
9. How do you see the inter-sectoral planning with 
regard to HIV, NCD and maternal health programs 
 
A. Focused group discussion (FGD): Health care workers at DM, HIV and ANC workers 
1. What is the effect of HIV infection on the occurrence of DM in HIV infected mothers? (Probe: How does HIV 
affects the occurrence of DM? OR mention if HIV can lead to DM or ARV affects the occurrence of DM 
among HIV infected mothers) What is the effect of HIV infection to the pregnancy of HIV infected mother? 
(Probe: In terms of fertility, stigma and discrimination, on pregnancy, during delivery, outcome of 
pregnancy). 
2. What is the effect  of DM on the pregnancy of the pregnant diabetic mother? (Probe: In terms of fertility, 
stigma and discrimination, on pregnancy, during delivery, outcome of pregnancy). 
3. What is the effect of DM and HIV on the pregnancy of mothers having both diseases at the same time? 
(Probe: In terms of fertility, stigma and discrimination, on pregnancy, during delivery, outcome of pregnancy) 
What is the problem of screening and diagnosing DM or/and HIV in the health facilities? (Patients factor, 
health care workers factors, health facilities factors) 
4. How should Health care workers, health system, etc. handle HIV and/or DM? 
5. What should the HIV and DM integration look like (probe: To what level should both be integrated?) 
6. What should be done at DM/HIV/ANC/delivery room to reduce perinatal complication due to HV/DM? 
7. Why do you think pregnancy rate is high/low among HV/DM as compared to HIV.DM? 
8. Why do you think…..? (Adverse pregnancy outcome) is so frequent among DM/HIV as compared to 
DM/HIV? 
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Organizational Integration 
A. DM B. HIV C. ANC 
1. How do you provide HIV 
counselling and testing service 
at NCD/DM clinic? -(Probe: Is 
there HIV counselling and 
testing? How do you record the 
results?)  
1. How do you provide NCD/DM 
counselling and testing service at HIV 
clinic? (Probe: Is there HIV counselling 
and testing? How do you record the 
results?)  
1. How do you provide HIV counselling 
and testing services at ANC clinic? 
(Probe: Is there HIV counselling and 
testing? How do you record the results?)  
2. How is the pregnancy care 
service being issued at NCD/DM 
clinic for females in reproductive 
age group (probe: Is there family 
planning counselling and 
provision? How is the recording 
and registration, reporting of 
family planning service?) 
2. How is the pregnancy care service 
being issued at HIV clinic for females in 
reproductive age group (probe: Is there 
family planning counselling and 
provision? How is the recording and 
registration, reporting of family planning 
service?) 
2. How is the NCD/DM service being 
issued at ANC clinic for females in 
reproductive age group (probe: Is there 
NCD/DM counselling and provision? How 
is the recording and registration, reporting 
of NCD/DM service?) 
 
Clinical Integration 
Structure 
A. DM B. HIV C. ANC 
1. Describe the presence of HIV  Protocol, 
guideline, training materials to address 
HIV among diabetic mothers 
1. Describe the presence of HIV  Protocol, 
guideline, training materials to address 
HIV among diabetic mothers 
1. Describe the presence of HIV  Protocol, 
guideline, training materials to address 
HIV among diabetic mothers 
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2. Describe the presence of a pregnancy 
care protocol, guideline, training materials 
to address pregnancy care among 
diabetic mothers 
2. Describe the presence of NCD/DM  
Protocol, guideline, training materials to 
address NCD/DM among HIV infected 
mothers 
2. Describe the presence of HIV  Protocol, 
guideline, training materials to address 
HIV among pregnant  mothers at ANC 
clinic 
3. How do you communicate with HIV or 
ANC clinic if you get HIV+ pregnant 
mother/ (Probe: referral linkage, feedback 
system) 
3.How do you communicate with NCD/DM 
or ANC clinic if you get NCD/DM or 
pregnant mother(Probe: referral linkage, 
feedback system) 
3.How do you communicate with HIV or 
NCD/DM clinic if you get DM  pregnant 
mother (Probe: referral linkage, feedback 
system) 
 
Service delivery  
A. DM B. HIV C. ANC 
1. What do you think regarding joint 
training among DM, HIV and pregnancy 
care? (Is there joint training inclusive of 
all the three entities? Do you think it is 
feasible? Is it important?) 
1. What do you think regarding joint 
training among DM, HIV and pregnancy 
care? (Is there joint training inclusive of 
all the three entities? Do you think it is 
feasible? Is it important?) 
1. What do you think regarding joint 
training among DM, HIV and pregnancy 
care? (Is there joint training inclusive of 
all the three entities? Do you think it is 
feasible? Is it important?) 
2. How do you thing multidisciplinary 
team should work regarding the 
integration of DM, HIV and pregnancy 
care? (Probe: is there such MDT 
discussion/working about HIV, DM and 
pregnancy care? Do you think it is 
important to have such team?) 
2. How do you thing multidisciplinary 
team should work regarding the 
integration of DM, HIV and pregnancy 
care? (Probe: is there such MDT 
discussion/working about HIV, DM and 
pregnancy care? Do you think it is 
important to have such team?) 
2 .How do you thing multidisciplinary 
team should work regarding the 
integration of DM, HIV and pregnancy 
care? (Probe: is there such MDT 
discussion/working about HIV, DM and 
pregnancy care? Do you think it is 
important to have such team?) 
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3.What do you feel about the importance 
of putting screening and diagnostic 
algorisms of DM at HIV and ANC clinic? 
(Probe: Is there such service so far? Do 
you think it is usefully? Is it feasible to do 
so?) 
3. What do you feel about the importance 
of putting screening and diagnostic 
algorisms of DM at HIV and ANC clinic? 
(Probe: Is there such service so far? Do 
you think it is usefully? Is it feasible to do 
so?) 
3. What do you feel about the importance 
of putting screening and diagnostic 
algorisms o DM and HIV at ANC clinic? 
(Probe: Is there such service so far? Do 
you think it is useful? Is it feasible to do 
so?) 
 
 
 
Process 
A. DM B. HIV C. ANC 
1. What is your opinion regarding the 
experience and culture of having HIV 
counselling and testing at DM 
1. What is your opinion regarding the 
experience and culture of having 
NCD/DM counselling and testing at HIV 
1. What is your opinion regarding the 
experience and culture of having 
NCD/DM counselling and testing ANC? 
 
Access 
A. DM B. HIV C. ANC 
1. What are the HIV related services being 
provided at DM? (Probe: counselling, 
testing, linking, treatment, follow-up) 
1. What are the NCD/DM related services 
being provided at HIV? (Probe: counselling, 
testing, linking, treatment, follow-up) 
1. What are the HIV related services be  
provided at ANC? (Probe: counselli  
testing, linking, treatment, follow-up) 
2. What are the pregnancy care related 
services being provided at DM clinic? 
(Probe: counselling, testing, linking, 
treatment, follow-up) 
2. What are the pregnancy care related 
services being provided at HIV clinic? 
(Probe: counselling, testing, linking, 
treatment, follow-up) 
2. What are the NCD/DM related servi  
being provided at DM clinic? (Pro  
counselling, testing, linking, treatme  
follow-up) 
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ANNEXURE I: SAMPLE OF COMPLETED DATA ABSTRACTION AND 
QUESTIONARRIE 
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ANNEXURE J: ETHICAL CLEARANCE AND SUPPORT LETTERS 
ANNEXURE J 1: Ethical clearance letter from REC of UNISA 
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ANNEXURE J2: Ethical clearance and support letter from Addis Ababa IRB to 
study sub-cities 
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ANNEXURE J3: Ethical clearance and support letter from Addis Ababa IRB to 
study hospitals 
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ANNEXURE J4: Ethical clearance and support letter from Addis Ababa IRB to 
study health centers 
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ANNEXURE K: EXPERTS’ EVALUATION OF THE “THE TRIPARTITE SERVICE 
INTGRATION MODEL OF DM, HIV ANAND PREGNANCY CARE 
     Experts’ Evaluation of the “The Tripartite Integration: DM/HIV/Pregnancy care model”. 
Date: ---------------------- 
Educational status (just circle) -------------- ( Diploma, first degree, second degree, speciality, third degree) 
Age: ------------- 
Sex/Gender ------------------ 
Year of experience ( in year):  ---------------------  
♦ At health facility (working as a clinician) ------------- 
The clinic or department you spend most of your time as a clinician-----------------------------------------------
---------- 
♦ On the program ---------------- 
Mention the name of the program you spend most of your time-------------- 
Dear peer, 
This is a newly suggested model of care at administrative level (FMOH, region and sub cities) and health facility 
level at A.A.  
Aim of the evaluation to check (with you as an experienced health care worker) whether the suggested care of 
model is applicable as it is or need to be revised or not applicable at all. After reading the following section you are 
asked to evaluate the model based on the criteria mentioned in the table. THANK YOU FOR TAKING YOUR TIME 
TO EVALUTE! 
Objective of the model 
The model is developed based on the suggestion from HCW and program officers at FMOH, AACHB, sub-cities and 
health facilities in A.A. The main objective of the model is to reduce or minimize adverse pregnancy outcome among 
reproductive age group females with DM and HIV by integrating the pregnancy care,  DM and HIV services at all 
levels. 
Definition of terms 
Pregnancy care: counselling on conception/being pregnant, urine pregnancy test, provision of one of the modern 
family planning, all comprehensive anti-natal care (ANC) and delivery service. 
HIV services: counselling on HIV prevention, testing of HIV, clinical and laboratory evaluations, adherence support, 
provision of ART and the follow-up care. 
DM care:, screening for DM using urine or blood test of fasting or random sugar, treatment of DM and follow up care. 
 
The model: description of the model 
Please put “X” inside the box you think you grade/evaluate the item based on the criteria (You may look at the 
model/diagram again before evaluation). 
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Ser  
No. Criteria 
Totally 
disagree disagree Agree totally agree 
1 Clarity     
2 Simplicity     
3 Consistency     
4 Generalizability or transferability     
5 Importance     
6 Practicability     
7 Feasibility     
 
 
 
 
 
General comment (Brief suggestion and area for improvement) -----------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------ 
 
 
THANK YOU AGAIN FOR TAKING YOUR TIME TO EVALUTE! 
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ANNEXURE L: CONDENSED CV DEMEMEW, Zewdu Gashu Dememew 
  
Home address      
Nifas Silk Lafto sub-city, Kebele 12   
House No. 3471, Addis Ababa, Ethiopia     
Tel+ 251-911768081     
E-mail: zewdugashudememew@yahoo.com, zgashu@msh.org      
Skype: hiruy.gashu 
 
Education 
1997-2004: Doctor of Medicine (MD), Addis Ababa University, Ethiopia 
2010-2014: MPH, UNISA-University of South Africa University, Department of Health Studies. 
2016-till now: a candidate of Doctor of literature and philosophy at University of South Africa University, Department 
of Health Studies. 
 
 
Research and publication experience 
1. Zewdu Gasu et al. The Yield of Community-Based “Retrospective” Tuberculosis Contact Investigation in a 
High Burden Setting in Ethiopia. 
(http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0160514) 
2. Dememew, Z.G., et al., 2016. Trends in tuberculosis case notification and treatment outcomes after 
interventions in 10 zones of Ethiopia. The International Journal of Tuberculosis and Lung Disease, 20(9), 
pp.1192-1198. (http://www.ingentaconnect.com/contentone/iuatld/ijtld/2016/00000020/00000009/art00014). 
3. Zewdu Gashu et al. 2018. Seasonal patterns of tuberculosis case notification in the tropics of Africa:A six-
year trend analysis in Ethiopia. PloS one. 
4. Joanna L, Gashu Z, et al. 2018. Provider barriers, enablers, and incentives associated with the use of 
Isoniazid Preventative Therapy among HIV    Patients in Ethiopia. The Union J. 
5. Asfaw Ayelew, Zewdu Gashu et al. 2018. Improvement in tuberculosis infection control practice via 
technical support in two regions of Ethiopia. BMC Infectious Diseases 
6. Yirdaw, K.D., Jerene, D., Gashu, Z et al. 2014. The beneficial effect of isoniazid preventive therapy and 
antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia. PloS one,9(8), 
p.e104557. ( http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126726/) 
7. Tadesse, Y., Gebre, N., Daba, S., Gashu, Z et al.  2016. Uptake of Isoniazid Preventive Therapy among 
Under-Five Children: TB Contact Investigation as an Entry Point. PloS one, 11(5), p.e0155525. 
(http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0155525) 
8. Habte, D., Melese, M., Hiruy, N., Gashu, Z., et al. The additional yield of GeneXpert MTB/RIF test in the 
diagnosis of pulmonary tuberculosis among household contacts of smear positive TB 
9. Trends in Treatment Outcome of New and Retreatment Tuberculosis Cases in Two Regions of Ethiopia 
(Poster presented on The Union conference 2015/Cape Town) 
10. The additional yield of GeneXpert MTB/RIF test in the diagnosis of pulmonary tuberculosis among 
household contacts of smear positive TB cases. International Journal of Infectious Diseases, 49, pp.179-
184. (http://www.ijidonline.com/article/S1201-9712(16)31109-2/fulltext?rss=yes) 
11. The experience of scaling up a decentralized, ambulatory model of care for management of multidrug-
resistant tuberculosis in two regions of Ethiopia 
(http://www.sciencedirect.com/science/article/pii/S2405579416300407) 
12. Use of indicators of standards of care to improve tuberculosis program management in Ethiopia 
https://www.sciencedirect.com/science/article/pii/S2405579417300438 
13. Dememew ZG & Phaladz N.Fertility Desire, Intention and Associated Factors Late in HIV Epidemic among 
People Living with HIV: A cross-sectional study in Southern Ethiopia (UNISA Library). 
 
Short-term trainings 
244 
 
• Certificate of the 28th Annual Graduate Summer Institute of Epidemiology and Biostatistics, including two 
weeks workshop I & II of data analysis using STATA and Conducting Epidemiologic Research, at Johns’ 
Hopkins University Bloomberg School of Public Health, July 2010. 
• A Certificate on  ‘’PH207x: Health in Numbers: Quantitative Methods in Clinical & Public Health Research 
with STATA, a course of study offered by Harvard, an online learning initiative of Harvard University through 
edx. October 1, 2012-February 1, 2013. (Four month course with STATA software) 
• Credit Certificate on Qualitative and Mixed Method (QMM) of research using Nvivo software in Belgium, 
Antewerpen, and January 27-February 22, 2014. 
            Research Ethics Training Curriculum, FHI June 21, 2012 
• Certificate on From Research to Practice: Workshop on SRH including STI/HIV Research, Geneva, 
Switzerland August 27-September 2, 2012. 
•  Certificate on From Research to Practice: Training Course on SRH Research Adolescent. The Geneva     
Foundation for Medical Education and Research in collaboration with WHO, May-November 2011  
 
Work experience 
1. May 3, 2016-Till now: Senior TB/HIV and Childhood TB adviser, Challenge TB/USAID 
 
2. June 16, 2014 – April 30, 2016:  Implementation Research Coordinator (M/E and Operational Research 
Unit), Heal TB/MSH/USAID 
2. November 1, 2011-December 30, 2013: Lead TB/HIV Advisor, Technical Support for the Ethiopian HIV/AIDS 
ART Initiative (TSEHAI), Addis Ababa, Ethiopia  
 
3. October 12, 2010- Nov1, 2011: TB/HIV and ART Advisor, Technical Support for the Ethiopian HIV/AIDS ART 
Initiative (TSEHAI) HAWASSA, Ethiopia. 
4. June 6, 2007-October 12, 2010: HIV/AIDS Clinical Advisor (Mentor) and Site Support Team Lead, Technical 
Support for the Ethiopian HIV/AIDS ART Initiative (TSEHAI) Hawassa, Ethiopia. 
5. September 11, 2004--June 1, 2007: Attat Hospital (Rural Hospital in SNNPR) 
Language: 
Amharic (Speak, read and write) 
English (Speak, read and write) 
Oromiffa (speak, read and write) 
 
Basic computer skills 
Introduction to computer, MS Word, MS Excel, MS Access, PowerPoint, STATA and EPI-INFO, Nvivo, SPSS 
 
